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Abstract 
A previous study from the Gilchrist lab measured transcription in the 
Xenopus tropicalis embryo for the first 66 hours of development at a high temporal 
resolution. This data showed that early transcription in Xenopus tropicalis is a very 
dynamic process, indicating that the mechanisms regulating it should also present 
dynamic behaviours. 
The aim of this project was to understand the dynamics of enhancer usage 
and investigate whether this correlates with gene transcription, using p300 as an 
enhancer proxy and Xenopus tropicalis as a model. A 12.5-hour p300 ChIP-seq 
high-resolution time series, covering the end of the blastula stages, gastrulation 
and most of neurulation, was generated. ChIP-seq time series data analysis was 
optimised, including through the development of a normalisation method which 
allows for varying levels of background reads in different ChIP-seq samples. A 
dataset of 9,807 candidate enhancers and their respective usage dynamics was 
generated, a potentially useful tool for the Xenopus community. Furthermore, I 
showed that p300 binding dynamics at promoters and nearby candidate enhancers 
correlate well, reinforcing the enhancer-promoter loop model for transcription 
regulation. Additionally, I showed that p300 binding dynamics at promoters 
correlate with gene transcription, suggesting that the loop is maintained for the 
duration of transcription. I used both results to create a method to predict candidate 
enhancer-gene pairs and, with the addition of differential DNA motif analysis, to 
predict candidate target genes for some well-known transcription factors. The data 
generated in this project helped shed light on transcriptional regulation and led to 
the development of some useful tools both for Xenopus and transcription 
researchers. 
 4 
 
 
 
 
 
 
 
 
 
For grandad 
Obrigada por existires 
 
 
 
 
 
 
 
 
  
 5 
 
Acknowledgements 
I would like to thank several people without whom this thesis would not have 
been possible. 
Firstly I would like to thank Mike Gilchrist, for giving me the opportunity to do 
this PhD, for his guidance and advice. I would also like to thank Jim Smith for 
taking me into his lab in the final months of my PhD and, together with Peter 
Thorpe and Jean-Paul Vincent, for all the help and comments as part of my Thesis 
Committee. Thanks to Brook and Elena for all the frog and lab advice and help, to 
Ian and Ilya who had to suffer with my endless computational questions and the 
biggest thank you to Nick, for inspiring me and always being there to help me. You 
all made the Gilchrist lab a great group to work with. Thanks to the animal and the 
sequencing facility members for all the technical support and thanks to every past 
and current member of the Elgar and Smith lab for all the help, as well as 
availability for parties! A special thank you to Bathilde and Christina for listening to 
my constant whining and for all the fun in the 4NE corner of the Crick. And of 
course, to Rita, my fellow Portuguese, doing our PhDs at the same time was a gift 
and you were always my go-to person during these four years, for science advice 
and gossip (“o que é o vento?”). Thanks to all the fellow Portuguese people for our 
Monday lunches, making me feel closer to home. 
This PhD was done as part of the DevCom Marie Curie Initial Training 
Network. I would first like to thank the European Union for funding me, with the 
hope that many more people after me may get the same privilege. I would like to 
thank everyone that was part of it, it was the best opportunity of my life. A special 
thank you to Gert Jan Veenstra and José Luis Goméz-Skarmeta for all the advice 
and collaboration. Thanks to Simon van Heeringen for the long conversations and 
 6 
 
email chains, your help and endless patience was essential for this PhD. Thanks to 
all the students for making all the courses and conferences so much fun. 
I would also like to thank all my friends and family, unfortunately I cannot 
mention everyone, but you were all essential and a bit of this thesis is also yours. 
Thanks to all the PG people, especially my three “Pauls”, you kept me sane in 
these past five months. Thanks to Joe and Meena for all the party nights but also 
serious and supportive conversations. Thanks to Carolina, Filipa and Rita for our 
travels and skype calls. Thanks to my two “persons”, Diane and Pedro, I miss you 
so much but know you are always there for me. Thanks to Rita (Táta) for the advice 
on how to make pretty images and for pushing me to the finish line. Thanks to 
Pádua for arranging my post-PhD holidays. Thanks to Jane, Nigel, Holly and Emily 
for taking me into their family and always making me feel at home. Thanks to Sofia, 
Leonor and Rita for filling my heart with pure love. Thanks to Inês and Ana for 
always supporting and believing in me, “Ró consé!”. Pai and Mãe, no words can 
ever thank you for all you have done for me, I hope I have made you proud. And to 
Tom, for being there every day, through the highs and lows that a PhD brings. 
Thanks for making me look forward to the future. 
 
 
 7 
 
Table of Contents 
 
Abstract ............................................................................................................... 3 
Acknowledgements ............................................................................................ 5 
Table of Contents ................................................................................................ 7 
Table of Figures ................................................................................................ 11 
List of tables ...................................................................................................... 14 
Abbreviations .................................................................................................... 15 
Chapter 1. Introduction ................................................................................ 17 
1.1 Transcription and its Regulation ......................................................... 17 
1.1.1 Enhancers ......................................................................................... 20 
1.1.1.1 Enhancers and disease ............................................................... 22 
1.1.2 Insulators .......................................................................................... 23 
1.1.3 Enhancer-promoter looping ............................................................... 23 
1.1.4 Chromatin structure ........................................................................... 26 
1.1.4.1 Accessible chromatin regions ...................................................... 26 
1.1.4.2 Histone modifications ................................................................... 28 
1.1.4.2.1 H3K4me ................................................................................... 28 
1.1.4.2.2 H3K36me ................................................................................. 29 
1.1.4.2.3 H3K27me ................................................................................. 29 
1.1.4.2.4 H3K9me ................................................................................... 30 
1.1.4.2.5 H3K20me ................................................................................. 31 
1.1.4.2.6 Histone acetylation .................................................................. 31 
1.1.5 Enhancer RNAs ................................................................................ 33 
1.1.6 Transcriptional adaptor p300 ............................................................ 34 
1.1.6.1 p300 and transcriptional regulation .............................................. 36 
1.1.6.2 p300/CBP and disease ................................................................ 38 
1.1.6.3 p300 and enhancer prediction ..................................................... 39 
1.1.7 Sequence conservation ..................................................................... 42 
1.1.8 Enhancer validation ........................................................................... 43 
1.1.9 ChIP-seq ........................................................................................... 45 
1.2 Xenopus tropicalis ................................................................................ 46 
 8 
 
1.2.1 Dynamics of early transcription in Xenopus tropicalis ....................... 47 
1.2.2 Enhancers and histone modifications in Xenopus tropicalis embryos49 
1.2.3 p300 in Xenopus embryos ................................................................ 50 
1.3 Thesis Aim ............................................................................................. 51 
Chapter 2. Materials & Methods .................................................................. 52 
2.1 Embryo in vitro fertilisation .................................................................. 52 
2.1.1 Oocyte collection ............................................................................... 52 
2.1.2 Sperm collection ............................................................................... 52 
2.1.3 Fertilisation and embryo development .............................................. 53 
2.2 Chromatin Immunoprecipitation (ChIP) .............................................. 54 
2.2.1 Chromatin cross-linking ..................................................................... 54 
2.2.2 Chromatin extraction ......................................................................... 54 
2.2.3 Chromatin fragmentation ................................................................... 55 
2.2.4 Chromatin immunoprecipitation ........................................................ 55 
2.2.5 Reverse cross-linking ........................................................................ 56 
2.2.6 DNA purification and sequencing ...................................................... 56 
2.3 Pilot p300 ChIP-seq time series collection.......................................... 57 
2.4 Long p300 ChIP-seq time series collection......................................... 57 
2.5 Solutions ................................................................................................ 58 
2.6 ChIP-seq analysis .................................................................................. 61 
2.6.1 Sequencing reads analysis ............................................................... 61 
2.6.2 Peak calling ....................................................................................... 62 
2.6.3 p300 region-Gene assignment .......................................................... 62 
2.6.4 p300 region clustering ....................................................................... 62 
2.6.5 Random region generation ................................................................ 62 
2.6.6 Genome browser and heatmaps ....................................................... 63 
Chapter 3. Identification of Candidate Enhancers and p300 Dynamics .. 64 
3.1 Introduction ........................................................................................... 64 
3.2 p300 ChIP-seq ........................................................................................ 67 
3.2.1 p300 ChIP-seq pilot time series ........................................................ 67 
3.2.1.1 Embryo Collection ........................................................................ 67 
3.2.1.2 Sequencing results ...................................................................... 68 
3.2.1.3 Peak calling .................................................................................. 71 
3.2.1.4 Pilot time series correlation .......................................................... 73 
 9 
 
3.2.1.5 Conclusions from pilot p300 ChIP-seq time series ...................... 74 
3.2.2 p300 ChIP-seq long time series ........................................................ 75 
3.2.2.1 Embryo Collection ........................................................................ 75 
3.2.2.2 Sequencing results ...................................................................... 77 
3.2.2.3 ChIP-seq normalisation ................................................................ 79 
3.2.2.4 Pilot and long time series show high replicability ......................... 84 
3.2.2.5 Time series adjacent time points correlate better than biological 
replicates 86 
3.2.2.6 Gaussian processes and data filtering ......................................... 88 
3.2.2.7 p300 regions are mainly distal, however there is more promoter-
p300 binding than expected for random sequences ..................................... 92 
3.2.2.8 p300 binding is highly dynamic in early development .................. 94 
3.2.2.9 p300 is highly correlated to the less dynamic H3K4me1 mark .. 100 
3.2.2.10 p300 binding in promoter and exonic regions is less dynamic .. 105 
3.3 Discussion ........................................................................................... 109 
3.3.1 Pilot time series ............................................................................... 109 
3.3.2 Long time series .............................................................................. 109 
Chapter 4. p300 and Gene Transcription .................................................. 113 
4.1 Introduction ......................................................................................... 113 
4.2 Active genes are more likely to have p300 binding nearby ............. 115 
4.3 p300 dynamics and nearest gene’s expression ............................... 118 
4.3.1 Net transcription rate ....................................................................... 119 
4.3.2 Active genes near early p300 binding are transcribed early on in the 
time series ................................................................................................. 120 
4.4 Promoter vs distal p300 ...................................................................... 124 
4.5 p300 binding at promoters, transcript levels and net transcription 
rate 127 
4.6 Candidate enhancers – gene pairing ................................................. 131 
4.6.1 Method testing ................................................................................ 135 
4.7 p300 and eRNA dynamics .................................................................. 140 
4.8 Discussion ........................................................................................... 146 
Chapter 5. p300 in Xenopus development ............................................... 152 
5.1 Introduction ......................................................................................... 152 
5.2 p300 differential motif binding ........................................................... 154 
 10 
 
5.2.1 Foxh motif ....................................................................................... 158 
5.2.2 Pou motif ......................................................................................... 160 
5.2.3 Sox motif ......................................................................................... 162 
5.2.4 Zic motif .......................................................................................... 164 
5.2.5 Tcf7/Lef1 motif ................................................................................ 165 
5.2.6 Gata/Lmo motif ............................................................................... 167 
5.2.7 Grhl motif ........................................................................................ 169 
5.2.8 p300 differential motif binding summary .......................................... 171 
5.3 Predicting transcription factor candidate target genes ................... 172 
5.3.1 Candidate Foxh1 target genes ........................................................ 173 
5.4 Discussion ........................................................................................... 176 
Chapter 6. Discussion ................................................................................ 178 
6.1 Candidate enhancers and p300 dynamics ........................................ 179 
6.1.1 p300 ChIP-seq analysis .................................................................. 179 
6.1.2 p300 binding dynamics ................................................................... 180 
6.2 p300 and transcription ........................................................................ 181 
6.2.1 p300 and active genes .................................................................... 181 
6.2.2 p300 binding at promoters and candidate enhancers ..................... 181 
6.2.3 p300 binding and gene transcription ............................................... 182 
6.2.4 Candidate enhancer-gene pairing ................................................... 182 
6.2.5 Enhancer RNAs .............................................................................. 183 
6.2.6 Genome annotation ......................................................................... 184 
6.3 p300 differential motif analysis .......................................................... 185 
6.4 Future work .......................................................................................... 186 
6.5 Conclusion ........................................................................................... 187 
Chapter 7. Appendix ................................................................................... 188 
7.1 Appendix 1 – Predicted enhancer-gene pairs ................................... 188 
Reference List ................................................................................................. 196 
 
 
 
 11 
 
Table of Figures 
 
Figure 1 - Model of eukaryotic gene regulation. ...................................................... 18 
Figure 2 – Histone modifications and transcriptional regulation. ............................. 32 
Figure 3 – CBP and p300 protein domains. ............................................................ 34 
Figure 4 - Example of genes’ transcription profiles in the first 23.5 hours of 
development. ........................................................................................................... 48 
Figure 5 - ep300 RNA abundance in the first 23.5 hours of development. ............. 50 
Figure 6 – Time series collection diagram. .............................................................. 66 
Figure 7 – Pilot p300 ChIP-seq time series. ............................................................ 70 
Figure 8 – Pilot p300 ChIP-seq time series correlation. .......................................... 73 
Figure 9 – p300 ChIP-seq long time series. ............................................................ 81 
Figure 10 – Enrichment vs number of peaks called by MACS2 for p300 ChIP-seq 
long time series samples. ........................................................................................ 83 
Figure 11 – Scatter plots of normalised p300 reads for pairs of pilot and long p300 
ChIP-seq samples at equivalent times and their correlation. .................................. 85 
Figure 12 – p300 ChIP-seq long time series samples’ correlation. ......................... 87 
Figure 13 – Gaussian process method results. ....................................................... 89 
Figure 14 – Examples of p300 binding dynamics and corresponding SNRs. ......... 91 
Figure 15 – p300’s vs random region’s genomic distribution. ................................. 92 
Figure 16 – Intergenic p300 vs intergenic random regions’ distance to closest TSS.
 ................................................................................................................................. 93 
Figure 17 – p300 binding dynamics. ........................................................................ 95 
Figure 18 – Cluster p300 dynamics. ........................................................................ 96 
Figure 19 – Heatmaps of p300 and RNAPII binding and several histone 
modifications in p300 binding regions. .................................................................. 102 
Figure 20 - Heatmap of H3K4me1 in p300 binding regions. ................................. 103 
Figure 21 – All p300 regions’ vs p300 regions with high H3K4me3’s genomic 
distribution. ............................................................................................................ 104 
Figure 22 – p300 genomic annotation vs dynamics. ............................................. 105 
Figure 23 – p300 binding fold change. .................................................................. 106 
Figure 24 - p300 normalised peak height distribution. .......................................... 107 
Figure 25 - p300 fold change in regions with low or high p300 binding. ............... 108 
 12 
 
Figure 26 – p300 occupancy at proximal promoters of genes with different 
transcriptional states. ............................................................................................. 117 
Figure 27 – Net transcription rate. ......................................................................... 119 
Figure 28 – p300 and transcription dynamics. ...................................................... 123 
Figure 29 – Euclidean distances between p300 binding at proximal promoters and 
nearby p300 regions. ............................................................................................. 125 
Figure 30 – Example of correlated p300 dynamics. .............................................. 126 
Figure 31 – Euclidean distances between p300 binding at proximal promoters and 
gene transcription levels/net transcription rate. ..................................................... 128 
Figure 32 – Highly correlated p300 binding at proximal promoter and gene 
transcript levels. ..................................................................................................... 130 
Figure 33 – Candidate enhancer-gene prediction over different genomic distances.
 ............................................................................................................................... 134 
Figure 34 – Candidate enhancer-gene method testing. ........................................ 139 
Figure 35 – Euclidean distances between eRNA expression and p300 binding/gene 
expression. ............................................................................................................ 141 
Figure 36 – eRNA and p300 binding dynamics. .................................................... 143 
Figure 37 – eRNA and nearby gene expression. .................................................. 144 
Figure 38 - p300 differential motif binding at different developmental stages. ...... 156 
Figure 39 – Foxh1 and foxh1.2 RNA abundance and their motif association with 
p300 over time. ...................................................................................................... 158 
Figure 40 – Pou RNA abundance and their three motifs’ association with p300 over 
time. ....................................................................................................................... 161 
Figure 41 – Sox RNA abundance and their motif association with p300 over time.
 ............................................................................................................................... 163 
Figure 42 – Zic RNA abundance and their motif association with p300 over time.
 ............................................................................................................................... 164 
Figure 43 – Tcf/lef RNA abundance and their motif association with p300 over time.
 ............................................................................................................................... 165 
Figure 44 – Gata and lmo RNA abundance and their motif association with p300 
over time. ............................................................................................................... 168 
Figure 45 – Grhl1 RNA abundance and its motif association with p300 over time.
 ............................................................................................................................... 169 
Figure 46 – Cdk9 genomic locus. .......................................................................... 173 
 13 
 
Figure 47 – Foxh1 and candidate target gene cdk9. ............................................. 174 
Figure 48 – Histogram of SEDs for Foxh1 candidate gene targets. ...................... 175 
 14 
 
List of tables 
 
Table 1 – Time and number of X. tropicalis embryos collected from a single 
synchronous clutch, for a pilot p300 ChIP-seq time series. .................................... 67 
Table 2 – Number of sequencing and uniquely mapped read pairs in pilot p300 
ChIP-seq time series. .............................................................................................. 68 
Table 3 – Pilot p300 ChIP-seq time series peak calling results. ............................. 71 
Table 4 – Embryo collection for p300 ChIP-seq long time series. ........................... 76 
Table 5 – p300 ChIP-seq long time series sequencing. .......................................... 78 
Table 6 – p300 ChIP-seq long time series samples’ enrichment. ........................... 82 
Table 7 – Pearson correlation coefficient between pilot and long p300 ChIP-seq 
time series. .............................................................................................................. 84 
Table 8 - Go term enrichment in genes near early, mid, late and constant p300 
regions ..................................................................................................................... 99 
Table 9 – p300 at proximal promoters or nearby genes with different transcriptional 
states. .................................................................................................................... 116 
Table 10 – Regions for candidate enhancer-gene pairing method testing. ........... 137 
Table 11 – Motifs with highest differential association with p300 binding. ............ 156 
 
 15 
 
 Abbreviations 
3C Chromosome conformation capture 
ac Acetylation 
ar  ADP ribosylation 
ATAC-seq Assay for Transposase-Accessible Chromatin with sequencing 
BMP Bone morphogenetic protein 
bp Base pair 
CAGE Cap analysis of gene expression 
CBP CREB-binding protein 
CE Candidate enhancer 
ChIP Chromatin Immunoprecipitation 
CTCF CCCTC-binding protein 
DHS DNaseI hypersensitive 
DNA Deoxyribonucleic acid 
E Glutamic acid 
ED Euclidean Distance 
ENCODE ENCyclopedia Of DNA Elements 
EST Expressed sequence tag 
Fast Forkhead activin signal transducer 
Foxh Forkhead box H 
Grhl Grainyhead-like 
GWAS Genome-wide association studies 
H3 Histone 3 
H4 Histone 4 
K Lysine 
Hi-C Chromosome conformation capture with high-throughput sequencing 
hiNOS Human inducible nitric oxide synthase 
HMG High mobility group 
HP1 Heterochromatin Protein 1 
hpf Hours post fertilisation 
Lef Lymphoid enhancer factor 
Lmo LIM domain only 
MBT Mid-blastula transition 
 16 
 
Me1/2/3 Mono, di, trimethylation 
mRNA Messenger RNA 
MZT Maternal-to-zygotic transition 
PIC Preinitiation complex 
ph Phosphorylation 
PRC2 Polycomb repressive complex 2 
R Arginine 
RNA Ribonucleic acid 
RNAPII RNA polymerase II 
S  Serines 
SED Sum of Euclidean Distances 
shh sonic hedgehog 
SNP Single-nucleotide polymorphism 
Sox SRY-box 
su  Sumoylation 
T Threonines 
TADs Topologically associated domains 
TAF1 TBP-associated factor 1 
Tcf T-cell factor 
TSS Transcription start site 
ub Ubiquitylation 
 
Chapter 1 Introduction 
17 
 
Chapter 1. Introduction 
1.1 Transcription and its Regulation 
All cells of an organism contain virtually the same DNA sequence so, in 
order for cells to differentiate and perform the stereotypical functions of their 
specific cell type, spatio-temporal patterns of gene expression need to be tightly 
regulated. This is primarily achieved through the regulation of the production of 
transcripts. Transcriptional regulation is achieved through highly complex 
regulatory networks that exert control through several different mechanisms, such 
as modulation of chromatin structure, protein availability, transcription initiation, 
elongation and mRNA splicing (reviewed in Maston et al., 2006). 
 
A key step in transcriptional regulation is the modulation of the initiation 
phase, which involves different DNA elements, epigenetic modifications and the 
recruitment of general and sequence-specific transcription factors to their target 
sites on DNA. The DNA sequences involved are the promoter, adjacent to the 
transcription start site (TSS), and distal elements such as enhancers and insulators 
(Figure 1) (reviewed in Maston et al., 2006, Spitz and Furlong, 2012). 
Chapter 1 Introduction 
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Figure 1 - Model of eukaryotic gene regulation.  
Sequence-specific transcription factors bind to their motifs in enhancer regions 
(purple) and recruit coactivators (blue), such as p300, which mediate 
enhancer-promoter loop formation, histone remodelling and/or RNAPII recruitment. 
The preinitiation complex (PIC) (green) assemble in the promoter region (light 
green), containing the TSS, where transcription starts. Insulators (orange) are 
bound by CTCF (yellow) and form a loop to prevent incorrect enhancer-gene 
pairings. 
 
The promoter is where the preinitiation complex (PIC) is assembled before 
initiating transcription. The PIC is formed by RNAPII, general transcription factors, 
such as the TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH, and the Mediator 
(reviewed in Maston et al., 2006). The Mediator, a large protein complex, interacts 
with sequence specific transcription factors, transmitting its signals to RNAPII, 
modulating its function, e.g. by phosphorylating it, leading to the release from the 
PIC. The Mediator is involved in transcriptional regulation by altering chromatin 
organisation and modulating enhancer-promoter looping and transcription initiation 
and elongation (reviewed in Allen and Taatjes, 2015). 
Transcription initiation can be modulated by the combinatorial binding of 
sequence-specific transcription factors to enhancer sequences (reviewed in 
Chapter 1 Introduction 
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Kadonaga, 2004). Coactivators, in turn, modulate transcription by binding to 
sequence-specific transcription factors and to the PIC, creating a DNA-loop 
structure. Coactivators can also promote PIC assembly, modify the chromatin 
structure and/or mediate DNA unwinding (reviewed in Spiegelman and Heinrich, 
2004, Maston et al., 2006). 
The ENCODE (ENCyclopedia Of DNA Elements) Project set out to identify 
and explain how all the different types of functional sequences act together and 
lead to all the different cellular processes (Encode, 2004). They first analysed 1% 
of the human genome and detected that most base pairs are transcribed; identified 
previously unknown TSSs and non-coding transcripts; and identified several 
chromatin modifications which are characteristic of different types of functional 
elements (Encode et al., 2007), which will be explored below (1.1.4.2 – Histone 
modifications). The Encode Project has helped further the knowledge of how 
transcription is regulated and their studies will be mentioned throughout this 
introduction. 
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1.1.1 Enhancers 
Banerji and colleagues first used the term “enhancer” to describe how 
fragments of SV40 viral DNA were able to increase transcription of the transfected 
rabbit β-globin gene in HeLa cells by 200 times (Banerji et al., 1981). The authors 
also showed how enhancers are effective in both orientations and both upstream 
and downstream of the gene promoter. Two years later the same team identified 
the first eukaryotic enhancer, for the mouse β-globin gene (Banerji et al., 1983). 
Usually enhancers act on the closest gene (de Villiers et al., 1983, Wasylyk 
et al., 1983, Dillon et al., 1997) however there are multiple exceptions, with 
enhancers acting on genes further away (de Laat and Grosveld, 2003, Spitz et al., 
2003, Shi et al., 2013), as in the classical example of the sonic hedgehog (shh) 
enhancer, which is located 1 Mb away from the gene’s TSS, inside an intron of 
another gene (Lettice et al., 2003). A recent study reported that 10% of promoter 
interactions were with regions more than 1 Mb away and some interactions are 
even interchromosomal (Javierre et al., 2016). Not all of these interactions are 
expected to be functional, however, at least some are likely to be, which shows that 
gene regulation can be achieved over extremely long distances. 
Enhancers usually contain the binding site sequences for several 
transcription factors (Zeitlinger et al., 2003, Mullen et al., 2011, Trompouki et al., 
2011). Genes may also have multiple enhancers, each being active at different 
developmental stages and/or at different cell types, or they may act synergistically 
to drive gene expression (reviewed in Maston et al., 2006, Shlyueva et al., 2014).  
O’Kane and Gehring developed a method to systematically identify 
enhancer regions in Drosophila, the enhancer trap. This method uses transposable 
elements with a reporter gene, which randomly integrates in the genome, and the 
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reporter gene’s expression is then analysed and the flanking regions sequenced to 
identify the regulatory region (O'Kane and Gehring, 1987). Ruf and colleagues 
developed a similar method to probe regulatory elements in mouse embryos, also 
by using a transposon system (Ruf et al., 2011). A reporter gene, with a minimal 
promoter unable to drive gene expression, is inserted in random regions and their 
expression, driven by endogenous enhancers, is analysed. They showed that most 
insertions had very restricted tissue expression, indicating that the majority of 
enhancers regulate gene expression in a tissue-specific way; even genes 
ubiquitously expressed will likely have different enhancers driving expression in 
different tissues. 
Enhancer regions contain clusters of motif sequences, usually 6 to 12 bp 
long, to which transcription factors bind, usually in a combinatorial and synergistic 
way (reviewed in Kadonaga, 2004, Shlyueva et al., 2014). However, the majority of 
transcription factor binding events in the genome do not seem to lead to expression 
of neighbouring genes; in yeast it has been estimated that only 50% of binding is 
functional (Gao et al., 2004, Ucar et al., 2009), with the number for higher 
eukaryotes being reduced to around 20% (Vokes et al., 2008, Krejci et al., 2009). 
There may be several reasons behind the low percentage of transcription factor 
binding events leading to gene transcription: transcription factor redundancy; 
random binding events in areas of open chromatin; the need for additional 
cofactors; or the binding may be achieving other functions other than directly 
regulating transcription, such as chromatin remodelling (reviewed in Spitz and 
Furlong, 2012). 
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1.1.1.1 Enhancers and disease 
Studying enhancer regions and how they are involved in transcriptional 
regulation is essential to understanding development, but also because mutations 
in enhancer regions have been identified as the cause of several disorders in 
humans. Mutations in a shh enhancer (1 Mb away from the gene’s TSS) cause 
preaxial polydactyly (Lettice et al., 2003); individuals with a common variant in an 
enhancer for the RET gene have 20-fold increased risk for Hirschsprung’s disease 
(Emison et al., 2005); and a single-nucleotide polymorphism (SNP) on an enhancer 
300 kb upstream of the MYC oncogene leads to increased cancer risk (Sur et al., 
2012), among many other examples (reviewed in Iyer et al., 2004). 
More than one third of SNPs identified in genome-wide association studies 
(GWAS) do not overlap known exons, suggesting that a high proportion of altered 
phenotypes are caused by mutations in non-coding sequences (Visel et al., 2009b). 
The ENCODE Project reported an even higher value in their dataset of functional 
human elements, with 88% of disease associated SNPs being present in 
non-coding regions of the genome (Encode, 2012). 
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1.1.2 Insulators 
Insulators, first described in the early 90s in D. melanogaster (Holdridge and 
Dorsett, 1991, Kellum and Schedl, 1991, Kellum and Schedl, 1992), are DNA 
sequences that prevent contacts between enhancers and promoters on opposite 
sides of the insulator, inhibiting inappropriate gene activation. Insulators can also 
separate regions with different levels of chromatin condensation (Donze et al., 
1999, Prioleau et al., 1999) (Insulators reviewed in West et al., 2002). It was later 
found that CCCTC-binding factor (CTCF) binds insulators (Chung et al., 1993, Bell 
et al., 1999) and that CTCF sites can contact each other creating a chromatin loop 
(Splinter et al., 2006). Insulators are outside of the scope of this thesis, but for an 
excellent review, I would direct the reader to (Gaszner and Felsenfeld, 2006). 
 
1.1.3 Enhancer-promoter looping 
Enhancers and promoters can physically interact through chromatin looping, 
first shown in the repression of bacterial genes (Ptashne, 1986) and later in the 
mice β-globin locus (Carter et al., 2002, Tolhuis et al., 2002). Palstra and 
colleagues then showed that, for that same locus, during development, the 
topology of the loop changes depending on which genes are being expressed 
(Palstra et al., 2003). Several studies have identified PIC proteins, such as 
Mediator subunits and general transcription factors, at enhancers (Lin et al., 2013, 
Zhou et al., 2013), suggesting that the enhancer and the promoter are at very close 
proximity during transcription initiation (reviewed in Levine et al., 2014). The 
enhancer-promoter loop structure and how it is formed is still not fully understood, 
however there is evidence that the two regions are linked by Mediator-cohesin 
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protein complexes, which form rings around the DNA (Kagey et al., 2010, Phillips-
Cremins et al., 2013). 
About half of enhancer regions interact with multiple promoters and most 
promoters interact with multiple enhancers (Thurman et al., 2012, Javierre et al., 
2016). It was proposed that enhancers contact multiple promoters in the same cell 
through a “flip-flop” mechanism, with the enhancer looping to one promoter and 
then another (Wijgerde et al., 1995). However, Fukaya and colleagues have 
recently shown that an enhancer can contact and activate multiple gene promoters 
simultaneously, in the same cell, instead of only one at a time (Fukaya et al., 2016). 
In 2002, Dekker and colleagues developed a technique that allowed the 
identification of spatial colocalisation between two chromosomally distant 
sequences – Chromosome conformation capture, or 3C (Dekker et al., 2002). 
Several improvements have been made to this technique, leading to the 
development of 3C-based methods like 4C, 5C and Hi-C, allowing the probing of 
more and more genomic regions (reviewed in de Wit and de Laat, 2012, Denker 
and de Laat, 2016). These advances allowed the discovery that chromosomes are 
divided into topologically associated domains (TADs), with DNA sequences being 
more likely to contact sequences inside the same TAD. These domains tend to be 
maintained between different tissues (Dixon et al., 2012, Nora et al., 2012, Sexton 
et al., 2012), however, these boundaries are not absolute, and it has been reported 
that about 30% of promoter-enhancer interactions are across TAD boundaries 
(Javierre et al., 2016). 
TAD boundaries are enriched in CTCF (Dixon et al., 2012) and when 
disrupted, gene promoters start interacting with different enhancers, which can lead 
to altered gene expression and consequent disorders (Lupianez et al., 2015). 
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Ghavi-Helm and colleagues performed 4C-seq experiments in Drosophila 
embryos at two developmental stages and in mesoderm cells versus whole 
embryos (Ghavi-Helm et al., 2014). They reported that most enhancer-promoter 
loops are stable and do not change between different stages and tissues, even 
when expression of genes within those TADs varies. The authors suggest that 
when the enhancer loops to interact with the promoter, RNAPII is recruited but 
remains paused; later on, at the time of gene activation, transcription factors and/or 
other enhancer regions may be recruited leading to the release of RNAPII pausing, 
activating transcription. Despite this study suggesting enhancer-promoter loops are 
maintained, several other studies report changes in looping and enhancer states 
during development (Tolhuis et al., 2002, Simonis et al., 2006, Heintzman et al., 
2009). Ji and colleagues have recently reported that TADs are maintained in 
different cell types, but the contacts inside them vary depending on the cell type 
and the genes expressed (Ji et al., 2016). 3C-based methods are based on 
average interactions in thousands or millions of cells; more stable and long-lasting 
interactions will be identified more often, which may bias the data and 
underestimate the number of fast and dynamic loop structures and their importance 
in transcriptional regulation. 
Further evidence that enhancer-promoter looping is a dynamic process that 
varies depending on whether a gene is being expressed was given by a recent 
study by Javierre and colleagues (Javierre et al., 2016). They performed promoter 
capture Hi-C (a 3C-based method applied genome-wide), in which Hi-C fragments 
are pulled down if they contain promoter regions. This study showed that 
promoter-enhancer interactions are highly specific, depending on the celltype and 
on the gene’s activation state.  
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1.1.4 Chromatin structure 
The chromatin structure surrounding promoters and enhancers is also 
essential for transcriptional regulation. It can facilitate or preclude access to DNA 
binding motifs, modulating where the different proteins involved are able to bind. 
DNA is packaged in the cell in the form of chromatin, a DNA-protein 
complex. Its basic unit is the nucleosome consisting of 147 bp of DNA wrapped 
around an octamer of histones – two H2A, two H2B, two H3 and two H4 (reviewed 
in Kouzarides, 2007).  
 
1.1.4.1 Accessible chromatin regions 
Active enhancers, as well as promoters and other regulatory regions, are 
nucleosome-depleted, in order to increase DNA accessibility. Wu first described 
DNase I hypersensitivity in D. melanogaster gene promoters and recognised that 
those areas would allow for easier protein binding (Wu, 1980). DNase I 
hypersensitive (DHS) sites can now be determined genome-wide by DNase I-seq; 
this method uses DNases, nucleases which preferentially fragment areas of the 
chromatin which are less condensed, and the fragments are then sequenced and 
mapped to the genome (Boyle et al., 2008, Song and Crawford, 2010). 
The ENCODE Project showed that TSS sequences have high DNAse I 
hypersensitivity and that 98.5% of transcription factor bindings in the genome occur 
within DHS sites (Encode et al., 2007, Encode, 2012). Lu and colleagues 
performed DNAse I-seq and showed that in mouse embryo development the 
genome is increasingly more accessible, with promoter regions being accessible 
before enhancers (Lu et al., 2016). 
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Although DNAse I-seq has allowed us to gain insights into the chromatin 
structure, it requires a very high number of cells and the optimization of the 
experimental conditions is not always straightforward. To overcome these 
limitations, Buenrostro and colleagues developed a technique called Assay for 
Transposase-Accessible Chromatin with sequencing (ATAC-seq) (Buenrostro et al., 
2013). ATAC-seq is able to detect open chromatin in as few as 500 cells, through 
the use of Tn5 transposase and sequencing adaptors. In one single step the Tn5 
fragments and tags the genome with adaptors, being more likely to do this in 
regions of open chromatin. These fragments are then amplified and sequenced 
(Buenrostro et al., 2013, Buenrostro et al., 2015). The authors also reasoned that 
DNA bound by other proteins, such as transcription factors, would be transposed 
less frequently, making it possible to detect discrete footprints (Buenrostro et al., 
2013). This method is now widely used to detect open chromatin areas and DNA 
binding protein footprints (Davie et al., 2015, Wu et al., 2016, Jorstad et al., 2017, 
Younger and Rinn, 2017). 
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1.1.4.2 Histone modifications 
Histones have N-terminal tails that can be modified leading to alterations in 
the nucleosome structure and, consequently, in DNA accessibility. There are 
several different types of chemical modifications, namely, acetylation (ac), 
methylation (me), ubiquitylation (ub) and sumoylation (su) of lysines (K), 
methylation of arginines (R), phosphorylation (ph) of serines (S) and threonines (T), 
ADP ribosylation (ar) of glutamic acid (E), deamination (conversion of arginine to 
citruline) and proline isomerisation. Methylation of lysines can be mono-, di- or 
trimethylation (me1, me2, me3) (reviewed in Kouzarides, 2007). Dozens of 
enzymes that mediate these modifications have been identified, however this is out 
of the scope of this thesis, Kouzarides, 2007 is an excellent review of all the 
identified enzymes and the mechanisms involved. 
There are dozens of different histone modifications, here I will review the 
ones more relevant in transcriptional regulation. 
 
1.1.4.2.1 H3K4me 
H3K4me3 (histone 3, lysine 4 trimethylated) was shown to mark active 
promoters (Santos-Rosa et al., 2002), while H3K4me2 seemed to be present on 
both active and inactive genes (Schneider et al., 2004). In a study of 1% of the 
human genome, all three methylation forms of H3K4 were shown to be highly 
enriched in TSSs of active genes (Koch et al., 2007). H3K4me1, but not H3K4me3, 
is also enriched in enhancer regions, thus enhancers can be identified by a higher 
ratio of the monomethylated vs trimethylated modification, compared to promoter 
regions (Encode et al., 2007, Heintzman et al., 2007). Recently, Rickels and 
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colleagues reported that Drosophila embryos with reduced H3K4me1 develop 
normally and that gene expression is only minimally affected by the presence of 
H3K4me2/3 at enhancers, instead of H3K4me1. The authors suggest that 
H3K4me1 is only involved in the fine-tuning of transcription in specific situations, 
such as stress response (Rickels et al., 2017). 
 
1.1.4.2.2 H3K36me 
Strahl and colleagues reported that H3K36me at promoters is correlated 
with gene repression (Strahl et al., 2002). However, several groups have shown 
that H3K36me is correlated with active gene elongation, being deposited by the 
passage of the RNAPII (Krogan et al., 2003, Xiao et al., 2003, Mikkelsen et al., 
2007). Inactive genes are associated with deacetylated histones and there is 
evidence that Rpd3, a histone deacetylase, is recruited by H3K36me in transcribed 
gene bodies and deacetylates the histones in order to repress incorrect initiation of 
transcription away from the TSS. This action is enriched at the 3’ end of gene 
bodies, therefore the promoters maintain their acetylation, allowing gene 
transcription to be initiated at the correct site (Carrozza et al., 2005, Joshi and 
Struhl, 2005, Keogh et al., 2005). 
 
1.1.4.2.3 H3K27me 
H3K27me is present in the inactivated X chromosome (Plath et al., 2003, 
Silva et al., 2003) and is involved in gene repression by the Polycomb group 
(Kuzmichev et al., 2002). H3K27me3 is deposited by EZH2, part of the Polycomb 
repressive complex 2 (PRC2), which is known to repress developmental genes 
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(Boyer et al., 2006, Bracken et al., 2006). The monomethylated form of this histone 
tail is present in active genes, promoting their transcription; 70% of nucleosomes 
have the dymethylated form, inhibiting incorrect enhancer usage; while the 
trimethylated form is highly associated with gene repression (Barski et al., 2007, 
Ferrari et al., 2014). It has now been shown that all three methylation states of this 
histone tail are regulated by PRC2 (Ferrari et al., 2014). 
1.1.4.2.4 H3K9me 
H3K9me marks constitutive heterochromatin, due to its ability to recruit 
Heterochromatin Protein 1 (HP1) (Bannister et al., 2001, Lachner et al., 2001, 
Nakayama et al., 2001, Noma et al., 2001). H3K9me is also present in facultative 
heterochromatin in imprinted loci and is involved in X inactivation (Peters et al., 
2002, Silva et al., 2003). H3K9me is also involved in silencing euchromatic regions, 
repressing gene transcription (Tachibana et al., 2002, Ayyanathan et al., 2003). 
Vakoc and colleagues detected that, surprisingly, H3K9 di- and trimethylation and 
HP1 are dynamically associated with active gene bodies, with both marks being 
quickly lost with the end of transcription (Vakoc et al., 2005). The authors blocked 
transcription elongation and H3K9me and HP1 levels decreased dramatically in 
gene bodies, while being maintained in heterochromatic regions, showing their 
deposition is correlated with transcriptional elongation. Wang and colleagues 
reported H3K9 di- and trimethylation in repressed areas, consistent with the early 
reports that this histone modification is present in inactive regions (Wang et al., 
2008). H3K9me may activate gene transcription when present in gene bodies and 
be repressive when present at promoter regions (Kouzarides, 2007). 
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H3K4me and H3K9me3 are antagonistic, the former facilitates the action of 
p300, a transcriptional coactivator with histone acetyltransferase (HAT) activity, 
while the latter inhibits it (Wang et al., 2001, Nishioka et al., 2002a).  
 
1.1.4.2.5 H3K20me 
Nishioka and colleagues reported that H4K20me marks heterochromatin 
(Nishioka et al., 2002b). Later, the monomethylated version of that histone tail was 
found to be enriched in active genes (Talasz et al., 2005, Barski et al., 2007) and 
the trimethylated version in heterochromatic and repressed regions (Schotta et al., 
2004, Wang et al., 2008). 
 
1.1.4.2.6 Histone acetylation 
Acetylation of lysines neutralises its charge, leading to an increase in 
chromatin flexibility and accessibility. Wang and colleagues studied the genomic 
distribution of 18 different histone acetylations and found they were all associated 
with gene activation, however some, including H3K18/27, are more prevalent in 
non-coding and non-promoter regions (Wang et al., 2008). As previously 
mentioned, enhancers are enriched with H3K4me1; Creyghton and colleagues 
found that H3K4me1 enhancers can either be active, inactive or poised and that 
the presence of H3K27ac is able to discriminate the active ones (Creyghton et al., 
2010). 
H3K9ac marks active regulatory elements, mainly promoters but also 
enhancers (Roh et al., 2005, Roh et al., 2007, Karmodiya et al., 2012). It has 
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recently been shown that H3K9ac is necessary for the release of paused RNAPII, 
stimulating elongation (Gates et al., 2017). 
 
 
 
 
 
Figure 2 – Histone modifications and transcriptional regulation.  
Histone modifications associated with active vs inactive gene transcription. 
H3K4me1 and H3K27ac are predictive of active enhancer regions (star); 
H3K4me1/3 and H3K9ac of active gene promoters (pentagon); H3K27me3 of 
repressed enhancers (circle); H3K9me2/3 and H3K27me3 of repressed gene 
promoters (triangles). (Adapted from Baldwin et al., 2013). 
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1.1.5 Enhancer RNAs 
Kim and colleagues showed that 25% of neuronal enhancers, defined by the 
presence of CBP (a transcriptional coactivator) and H3K4me1, were transcribed by 
RNAPII (Kim et al., 2010). These enhancer-RNAs – or eRNAs - were found to be 
relatively short (<2kb), bi-directional, likely not polyadenylated and their expression 
levels correlated with the mRNA levels of nearby genes. The authors also 
suggested that eRNA synthesis may require an enhancer-promoter interaction; 
when the Arc gene (including its promoter) was deleted, RNAPII was still able to 
bind to the Arc enhancer but no eRNA was detected. Since then, many studies 
have reported these RNAs and have further increased our understanding of these 
molecules: eRNAs may be required for their associated gene’s transcription 
(Mousavi et al., 2013, Iott et al., 2014, Schaukowitch et al., 2014); may be involved 
in regulating chromatin accessibility (Mousavi et al., 2013); in promoting and 
stabilising enhancer-promoter loops (Li et al., 2013) and in facilitating transcription 
elongation (Schaukowitch et al., 2014). eRNAs are also more likely to be produced 
in enhancers involved in promoter looping (Lin et al., 2012). 
The knowledge that enhancers may be transcribed was used to predict 
enhancer regions, using CAGE (cap analysis of gene expression) which detects 
nascent transcripts (Andersson et al., 2014). This study predicted more than 
40,000 enhancer regions based on the presence of bi-directional short eRNAs and 
reported that enhancer activity correlates highly with it. The authors also showed 
that 95% of eRNAs where unspliced, 80% were located in the nucleus, 90% were 
not polyadenylated and that they had a median length of 346 bp. 
  
Chapter 1 Introduction 
34 
 
1.1.6 Transcriptional adaptor p300 
p300 was first identified as an interaction partner of adenovirus E1A proteins, 
proteins which are able to regulate transcription of several genes (Harlow et al., 
1986). Eckner and colleagues cloned and characterized it, describing it for the first 
time as a transcriptional adaptor (Eckner et al., 1994) and the same team later 
showed that it can stimulate transcription (Arany et al., 1995). 
 
 
Figure 3 – CBP and p300 protein domains.  
Percentages represent amino acid identity between the different domains, with the 
coloured areas representing areas with high identity. C/H – cysteine histidine rich 
zinc finger motifs; Bromo – bromodomain (Adapted from Giles et al., 1998). 
 
CREB-binding protein (CBP) is a highly homologous protein to p300, with 
their known functional domains having more than 90% sequence identity. Their 
functional domains are conserved and they seem redundant in most functions 
(Arany et al., 1995, Lundblad et al., 1995) (reviewed in Roth et al., 2001). Figure 3 
shows CBP and p300 protein domains and the regions of high identity. Both 
proteins are histone acetyltransferases (HATs), with their main targets being 
H3K18 and H3K27 (Jin et al., 2011), which are mainly present in non-coding, non-
promoter regions, as mentioned above (1.1.4.2.6 – Histone acetylation). 
p300 and CBP have multiple domains and numerous known interacting 
partners, including several transcription factors (Goodman and Smolik, 2000). 
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Being able to interact with a range of different proteins, p300 and CBP take part in 
several cellular processes, such as the previously mentioned transcriptional 
adaptor and histone acetyltransferase function, however, they are also involved in 
regulating the cell cycle (Yaciuk and Moran, 1991), growth (Howe et al., 1990, 
Wang et al., 1995), differentiation (Akimaru et al., 1997), apoptosis (Shikama et al., 
1999) and DNA damage repair (Liu et al., 1999) (reviewed in Giles et al., 1998). In 
fibroblasts, p300 and/or CBP are required for the activation of some genes, while 
for others they are needed only to get maximal gene expression (Kasper et al., 
2014). 
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1.1.6.1 p300 and transcriptional regulation 
The role of p300 in transcriptional regulation is not yet fully understood. As 
mentioned above, p300 has affinity for several proteins; one example is the 
transcriptional coactivator ASC-2, which interacts with p300 as well as with 
sequence-specific transcription factors and with components of the promoter 
complex (Lee et al., 1999). It has also been recently shown that in human 
hepatocytes p300 binds RNAPII, at the hiNOS (human inducible nitric oxide 
synthase) promoter, and AP1, at the hiNOS enhancer, creating an 
enhancer-promoter loop (Guo et al., 2016). p300 knockdown led to the 
disappearance of this loop and decreased hiNOS expression by 50%. These 
interactions may help create the bridge between the sequence-specific 
transcription factors located at enhancers and the basal transcription machinery at 
promoters.  
p300 may regulate transcription through a combination of the following 
mechanisms: the previously mentioned role in enhancer-promoter looping and its 
HAT activity; its ability to recruit (Janknecht and Hunter, 1996a, Janknecht and 
Hunter, 1996b, Kee et al., 1996, Cho et al., 1998) and acetylate RNAPII, which 
leads to its release from a paused state (Schroder et al., 2013); and its ability to 
acetylate and stimulate P-TEFb (a protein involved in transcription elongation) (Fu 
et al., 2007, Cho et al., 2009) (reviewed in Holmqvist and Mannervik, 2013). It has 
also been shown that p300 HAT activity alone can lead to gene activation; Hilton 
and colleagues used nuclease deficient Cas9 to guide p300’s HAT domain to 
enhancer regions and saw an increased expression of the associated genes (Hilton 
et al., 2015). It has been shown that p300/CBP knockdown disrupts enhancer-
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promoter looping, but not insulator looping (Kim and Kim, 2013), indicating that 
p300/CBP are involved in the former but not the latter type of looping. 
In the same study in which eRNAs were first identified, the authors studied 
how CBP binding in primary neuronal cultures changed in response to high-level 
exposure to potassium chloride – which is known to activate calcium-dependent 
signalling pathways and change downstream gene expression (Kim et al., 2010). 
The number of CBP binding sites in the genome increased from 1,000 to 28,000 
upon stimulation, suggesting that CBP is involved in the observed changes in gene 
expression. Furthermore, they analysed the binding of three transcription factors 
known to be involved in neuronal processes – CREB, SRF and NPAS4 – and found 
that they colocalise with CBP in a 200 bp region in the centre of the enhancer (Kim 
et al., 2010). 
It has recently been shown that CBP binds eRNAs transcribed from 
CBP-bound enhancers, which stimulates its acetyltransferase activity, essential for 
gene regulation (Bose et al., 2017). The eRNAs bind to the CBP’s HAT domain, 
which is highly conserved with p300’s, thus, the same is expected to occur with the 
latter. The knockdown of CBP led to an 89% decrease in expression of the tested 
mRNAs and 50% of the tested eRNAs. This suggests that eRNAs are involved in 
stimulating CBP’s HAT activity, but that CBP binding is needed for eRNA 
production, implying that the eRNAs are not involved in guiding or attracting CBP to 
the locus. Indeed, when eRNAs were depleted, CBP was still able to bind 
enhancers but enhancer and target promoter acetylation was significantly reduced. 
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1.1.6.2 p300/CBP and disease 
Gayther and colleagues identified somatic mutations in the EP300 gene 
(which encodes p300) in several cancer samples and described it as a 
tumour-suppressor gene for the first time (Gayther et al., 2000). Since then, several 
studies have identified somatic mutations in the EP300 and CBP genes in cancer 
samples, which may be due to their interaction with proteins like p53, TGF-β and 
Rb, involved in tumorigenic pathways (reviewed in Iyer et al., 2004). The feasibility 
of targeting p300 for prostate cancer treatment was studied and showed promising 
results: p300 knockdown led to an increase in apoptosis and decrease in cell 
invasion (Santer et al., 2011). 
Roelfsema and colleagues identified for the first time mutations in the EP300 
gene in a congenital disease, Rubinstein-Taybi syndrome (Roelfsema et al., 2005). 
This syndrome causes mental and growth retardation and increased childhood 
tumour risk. This syndrome is more usually caused by mutations in the CBP gene, 
however, due to their high level of homology, the authors screened patients for 
mutations in the EP300 gene and found 3 inactivating mutations. 
p300 or CBP homozygous and double heterozygous mouse knockouts are 
early embryonic lethal and p300 heterozygous knockouts had low survival rates; 
indicating that normal levels of these two proteins are essential for correct 
embryonic development (Yao et al., 1998, Oike et al., 1999a, Oike et al., 1999b). 
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1.1.6.3 p300 and enhancer prediction 
In 2005, Wang and colleagues reported p300 binding to an androgen 
receptor gene enhancer, 4 kb away from the gene’s TSS (Wang et al., 2005) and 
since then p300 has been widely used to predict enhancer regions. 
Heintzman and colleagues performed Chromatin Immunoprecipitation 
(ChIP) analysis for p300, core histone H3, H4K5/8/12/16ac, H3K9/14ac, 
H3K4me1/2/3, RNAPII and TBP-associated factor 1 (TAF1), part of the basal 
transcriptional machinery, in 1% of the human genome selected by the ENCODE 
project. They found 70% of p300 binding sites were also DHS sites. More than 75% 
of p300 positive regions were located more than 2.5 kb away from known TSSs, 
60% were conserved regions and 44% of sites coincided with previously described 
regulatory modules. p300 positive sites showed H3K4me1 enrichment, however 
this histone modification has a broader peak than p300. H3K4me3 was not found to 
be enriched at these sites. There was also a modest enrichment for RNAPII and 
TAF1 at enhancers, which may be an indication of a physical interaction with 
promoter regions (Heintzman et al., 2007). 
Wang and colleagues compared p300 and CBP binding in human CD4+ T 
cells and showed that p300 is enriched in promoters and in candidate enhancers, 
with CBP having a very similar distribution (Wang et al., 2009). 
Visel and colleagues predicted enhancer regions using p300 ChIP-seq data 
for forebrain, midbrain and limbs of mouse embryos. They then tested 86 of those 
regions for enhancer activity using transgenic mice, with 87% of sequences leading 
to reproducible expression patterns. This represented a 5 to 16-fold increased 
success rate when compared to studies which used sequence conservation to 
predict enhancers (Visel et al., 2009a). 
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In another study by Heintzman and colleagues, p300 and CTCF binding and 
histone modifications were analysed in 1% of the human genome, in five cell lines. 
They observed that promoters and insulators mostly have a constant chromatin 
state between cell types, unlike enhancers, whereas p300 binding and histone 
modifications change significantly depending on the cell type. About 80% of the 
identified enhancers were cell type specific, however, 85% of the active genes 
were common between the cell lines (Heintzman et al., 2009). This is consistent 
with what was reported by Ruf and colleagues (previously mentioned in section 
1.1.1 – Enhancers), that even ubiquitously expressed genes are controlled by 
different enhancers in different cell types (Ruf et al., 2011). In the human genome, 
most of the ubiquitous DHS sites are at promoter or insulator regions, while cell 
type specific DHS sites are mainly in enhancer regions (Xi et al., 2007). All of these 
results show how dynamic enhancers’ states are, particularly when compared to 
more stable elements, such as promoters and insulators. This indicates that 
enhancers are likely essential for cell type-specific gene expression.  
In a study focusing on mouse embryonic heart tissue, more than 3,000 heart 
enhancers were predicted using p300 ChIP-seq data (Blow et al., 2010). The 
authors then tested 130 of the predicted sequences by transgenesis and 75% of 
those showed tissue-specific activity, a 29-fold increase in positive signals 
compared to studies using evolutionary conservation. The same team then 
predicted more than 6,000 heart enhancers in human fetal and adult heart tissue 
and 66% of the sequences tested by transgenesis drove expression in the heart. 
The two studies were compared and only 21% of fetal human heart enhancers 
overlapped with mouse heart enhancers, indicating a low evolutionary conservation 
of heart enhancers (May et al., 2011). 
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Attanasio and colleagues performed p300 ChIP-seq on facial tissue from 
mouse embryos in order to study craniofacial development and identified more than 
4,000 enhancers. Transgenic mice assays were used to test 206 candidate regions 
and 60% showed activity in craniofacial tissues (Attanasio et al., 2013). 
As mentioned above (1.1.4.2.6 – Histone acetylation), Creyghton and 
colleagues had shown that H3K27ac could distinguish active from poised/inactive 
enhancers (Creyghton et al., 2010). Rada-Iglesias and colleagues also found that 
p300-bound enhancers could be distinguished between active or poised based on 
the presence or absence of H3K27ac, respectively (Rada-Iglesias et al., 2011). 
They also tested non-conserved human embryonic stem cells’ poised enhancers in 
zebrafish and they were able to drive expression in a time and cell type specific 
pattern.  
Based on these studies, p300 binding would appear to be a good enhancer 
predictor, with 60-87% of p300 binding regions seeming to behave as enhancers in 
transgenic assays. Active enhancers can be predicted by the presence of p300, 
H3K4me1 and H3K27ac. Enhancer state seems to be particularly dynamic, 
compared to promoters and insulators, reinforcing the importance of these 
sequences for transcriptional regulation. 
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1.1.7 Sequence conservation 
Sequence conservation is widely used to predict enhancer regions, however 
evidence is gathering for this not being the most reliable method. By comparing 
transcription binding sites in human and mouse hepatocytes, it was found that 
41-89% of regions were species specific (Odom et al., 2007). In a study comparing 
human, mouse and dog CEBPA and HNF4A genomic distribution, only 10-22% of 
binding sites were conserved (Schmidt et al., 2010). It was also shown that the 
most commonly used metrics to detect evolutionary constraint were only able to 
detect 29-61% of known regulatory sequences (McGaughey et al., 2008, Bulger 
and Groudine, 2011) and this number may be an overestimate, due to many known 
regulatory regions having been identified based on sequence conservation. 
As mentioned above (1.1.6.3 – p300 and enhancer prediction), studies 
which used p300 to identify enhancers regions found that only a small percentage 
of those were conserved amongst different species and that predicting enhancers 
by p300 binding increased the efficacy when compared to predicting enhancers 
only by sequence conservation (Visel et al., 2009b, Blow et al., 2010, May et al., 
2011). 
These findings are consistent with a model of enhancers being less 
conserved than promoters (Villar et al., 2015). This shows that enhancer prediction 
should not be performed solely by analysing sequence conservation and that 
analysing p300 binding and histone modifications can be more efficient. 
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1.1.8 Enhancer validation 
The most common approach to test a candidate enhancer is by placing its 
sequence in a plasmid with a minimal promoter and a reporter gene and delivering 
the plasmid to cell lines or embryos. The reporter gene’s activity is then assessed 
by, for example, microscopy (for fluorescent proteins), in situ hybridisation or by 
measuring enzymatic activity (e.g. luciferase assays). However, these approaches 
do not allow for genome-wide screening, due to the time required to test each 
sequence (reviewed in Shlyueva et al., 2014). 
Several groups have used a barcode-based technique which allows for the 
testing of multiple sequences simultaneously, in which candidate enhancers are 
cloned upstream of a minimal promoter and a reporter gene containing a unique 
barcode. RNA-seq is performed on cells with the plasmid and, with the different 
barcode for each candidate sequence, quantitative analysis can be performed to 
determine the level of expression driven by each candidate enhancer (Nam and 
Davidson, 2012, Patwardhan et al., 2012). However, this technique only allows the 
testing of hundreds or a few thousand sequences, due to the need to synthesise 
and clone all the different barcodes. 
Arnold and colleagues developed a genome-wide enhancer screen, by 
placing the candidate sequences downstream of the minimal promoter. With this 
configuration, a functional enhancer will enhance its own expression, and it can be 
quantitatively measured by RNA-seq. This approach does not require different 
barcodes and has a simplified cloning step, allowing for the testing of millions of 
sequences (Arnold et al., 2013). The setback of approaches like these is that they 
can only be done in cell types which can be transduced, limiting its use in living 
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organisms, where developmental processes may alter the functionality of an 
enhancer (reviewed in Shlyueva et al., 2014). 
To assess the possible enhancer activity of predicted sequences in Xenopus 
or zebrafish embryos, several groups have used Tol2-mediated transgenesis 
(Kawakami et al., 2004, Allende et al., 2006, Fisher et al., 2006, Hamlet et al., 2006, 
Kawakami, 2007, Bessa et al., 2009, Loots et al., 2013). In Tol2 transgenesis 
experiments, the predicted enhancer sequence is cloned upstream of a minimal 
promoter driving expression of, for example, GFP. The construct is then co-injected 
with Tol2 transposase mRNA, which will facilitate integration in the genome and, if 
the sequence is actually an enhancer, GFP expression should be observed in the 
same tissues and at the same stages as the gene that the enhancer endogenously 
regulates.  
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1.1.9 ChIP-seq 
ChIP is a technique used to detect DNA-protein interactions in vivo and can 
be applied to, for example, determine protein and histone modification distribution 
across the genome, to then predict enhancer regions (as described extensively in 
the previous sections). It was first performed by Gilmour and Lis in E.coli to detect 
which genes were bound by RNA polymerase in E.coli (Gilmour and Lis, 1984). 
Cells were irradiated with UV light to covalently link DNA to bound RNA 
polymerase and an anti-RNA polymerase antibody was used to pull down 
DNA-protein complexes. This DNA could then be purified and used in hybridisation 
assays, to determine which sequences were bound by RNA polymerase. Currently, 
the most common crosslinking agent is formaldehyde, first used by Solomon and 
colleagues in D. melanogaster (Solomon et al., 1988). 
ChIP-on-chip (or ChIP-chip) was first developed by Blat and Kleckner to 
study cohesin-bound locations in the yeast chromosome III (Blat and Kleckner, 
1999), closely followed by three different groups which applied the technique to 
genome-wide microarrays (Ren et al., 2000, Iyer et al., 2001, Lieb et al., 2001). 
With the advent of next-generation sequencing, ChIP-sequencing 
(ChIP-seq) was developed, allowing to determine the DNA sequence of the pulled 
down fragment with five groups publishing the method within four months of each 
other (Albert et al., 2007, Barski et al., 2007, Johnson et al., 2007, Mikkelsen et al., 
2007, Robertson et al., 2007). Several methods have been developed based on 
ChIP-seq, such as ChIP-exo, which increases the experiment’s resolution. This 
method, developed by Rhee and Pugh, uses an exonuclease to degrade the DNA 
up to the protein binding site, enabling the identification of the exact DNA sequence 
to which the protein of interest binds (Rhee and Pugh, 2012). 
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1.2 Xenopus tropicalis 
In the rapidly developing embryo gene regulation is extremely dynamic, with 
diverse sets of genes being activated in different cells-types, so to allow 
differentiation into the multiple tissues which will give rise to the adult animal. This 
makes it an optimal system to study transcriptional regulation. 
Xenopus tropicalis is being increasingly used in developmental biology 
studies, due to being diploid (compared with the allo-tetraploid Xenopus laevis), the 
ease of embryo handling and because most techniques used in X. laevis can be 
easily adapted for X. tropicalis use (Showell and Conlon, 2009). Xenopus has the 
advantage of producing large synchronously fertilized clutches with extrauterine 
development (Wheeler and Brandli, 2009) that allow microinjections and other 
physical manipulations to be performed at early cleavage stages, all year round. 
Having large numbers of synchronised cells allows the study of time-dependent 
processes, like transcriptional regulation, by next-generation techniques which 
require large quantities of starting material. The X. tropicalis genome is almost fully 
sequenced and research also benefits from the extensive expressed sequence tag 
(EST) libraries available (Showell and Conlon, 2009, Hellsten et al., 2010). 
The first 12 divisions in X. tropicalis embryos are rapid and synchronous and 
all cellular processes are regulated by maternally deposited mRNAs and proteins. 
After the 12th division the mid-blastula transition (MBT) occurs and the embryonic 
control shifts to the zygotic genes with the first wave of zygotic transcription, as part 
of the maternal-to-zygotic transition (MZT) (Tadros and Lipshitz, 2009). At the MBT, 
as well as the activation of the zygotic genome, there is desynchronisation of the 
cell cycles, which become much longer, and cells become motile (Newport and 
Kirschner, 1982a). All these changes are believed to be triggered by the titration 
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relative to DNA of a maternally deposited component in the embryo (Newport and 
Kirschner, 1982b). Collart and colleagues reported four DNA replication factors, 
Drf1, Cut5, RecQ4 and Teslin, as being these hypothesised titrated proteins 
(Collart et al., 2013). The authors showed that these proteins are essential for MBT 
to occur and that their overexpression leads to a delayed MBT. 
 
1.2.1 Dynamics of early transcription in Xenopus tropicalis 
It is already known that zygotic transcription starts before the MBT (Yang et 
al., 2002, Skirkanich et al., 2011, Tan et al., 2013). Owens and colleagues 
measured the mRNA expression profiles from fertilisation until 66 hours post 
fertilisation (hpf) at 30-minute intervals (Collart et al., 2014, Owens et al., 2016). 
Importantly, in this study a method was developed to perform absolute 
normalisation on RNA-seq data, allowing the calculation of absolute transcript 
numbers in an embryo. This, in turn, allows the calculation of each gene’s net 
transcription rate (Owens et al., 2016). 
Both of these studies showed how dynamic transcription is in the developing 
embryo (Figure 4), which raises the question of what are the mechanisms that 
regulate this dynamic process. 
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Figure 4 - Example of genes’ transcription profiles in the first 23.5 hours of 
development. 
(Data from Owens et al., 2016). The y-axis represents the absolute number of 
transcripts per embryo and the x-axis the hours post fertilization. The pink bar 
marks the MBT; shaded area represents 95% confidence interval. 
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1.2.2 Enhancers and histone modifications in Xenopus tropicalis embryos 
Hontelez and colleagues created epigenome maps at five developmental 
stages (Stages 9, 10.5, 12, 16 and 30) in X. tropicalis, for H3K27me3, H3K4me1/3, 
H3K9ac, H3K36me3, H3K9me2/3 and H4K20me3, plus binding maps for RNAPII 
and p300 and a DNA methylome map. p300 binding appears to vary between the 
assessed time points and different families of transcription factors associate with 
p300 at different developmental stages. They showed that most histone 
modifications are maternally defined and that p300 binding requires zygotic 
transcription – they blocked transcription by using α-amanitin and 85% of p300 
regions disappeared (Hontelez et al., 2015). Even though they sampled five 
separate time points, the time intervals are too long to calculate dynamics. For 
example, for very dynamic genes, such as cxcr4 or ventx3.2 (Figure 4), if only 
those time points had been sampled we would not have a full correct picture of 
gene’s transcription dynamics. 
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1.2.3 p300 in Xenopus embryos 
p300 protein is present in X. laevis eggs (Wuhr et al., 2014), but its levels 
have not been determined in X. tropicalis. We do know its mRNA is maternally 
deposited. Figure 5 shows the expression profile for ep300, the gene that encodes 
p300, in absolute transcript numbers per embryo (Data from Owens et al., 2016). 
ep300 mRNA is present in the oocyte, its levels start increasing at around 4 hpf 
and it has a second wave of activation at around 13 hpf. 
 
 
Figure 5 - ep300 RNA abundance in the first 23.5 hours of development. 
(Data from Owens et al., 2016). The y-axis represents the absolute number of 
transcripts per embryo and the x-axis the hours post fertilization. The pink bar 
marks the MBT; shaded area represents 95% confidence interval. 
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1.3 Thesis Aim 
The main aim of this project is to understand the dynamics of enhancer 
usage and how they relate to the dynamics of gene transcription, using the early 
developmental stages of Xenopus tropicalis as a model and p300 as an indicator 
molecule. 
Data from the lab (Collart et al., 2014, Owens et al., 2016) showed how 
dynamic early transcription is, with genes being activated and deactivated in short 
time windows. This suggests that the mechanisms actually regulating transcription 
should display similar dynamic behaviour. As transcription is proposed to be, in part, 
regulated via enhancers, I hypothesised that these dynamics should be detectable 
in data associated with the enhancer regions. p300 has been widely used to predict 
enhancers (Wang et al., 2005, Heintzman et al., 2007, Heintzman et al., 2009, 
Visel et al., 2009a, Wang et al., 2009, Blow et al., 2010, May et al., 2011, Rada-
Iglesias et al., 2011, Attanasio et al., 2013, Hontelez et al., 2015) and there were 
indications from p300 ChIP-seq sparse time series data from the Veenstra lab 
(Hontelez et al., 2015) that p300 binding is dynamic in early development. However, 
this data is too coarse grained to match up effectively with the observed 
transcriptional dynamics. Consequently, this project focused on generating high 
resolution temporal data to gain knowledge of the dynamic patterns of enhancer 
usage, which is essential to understanding how gene regulation is achieved. 
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Chapter 2. Materials & Methods 
2.1 Embryo in vitro fertilisation 
Animals were housed and all procedures performed according to the 
Animals (Scientific Procedures) Act 1986 (UK). 
 
2.1.1 Oocyte collection 
Adult X. tropicalis females were primed 24 hours before use with a 
subcutaneous injection into the dorsal lymph sac of 10 units of human chorionic 
gonadotropin (hCG, Sigma-Aldrich) in 100µL sterile water. Three to four hours 
before use, females were boosted in order to induce ovulation, with an injection of 
200 units of the same hormone in 100µL sterile water. Oocytes were then collected 
from the female by gently pressuring the lower area of the abdomen, into a petri 
dish with one drop of 1x Marc’s modified Ringers (MMR). 
 
2.1.2 Sperm collection 
Two males were killed by immersion in an overdose of Ethyl 
3-aminobenzoate methanesulfonate (0.2%, MS222, Sigma-Aldrich) for at least 
15 min at room temperature, followed by decapitation and destruction of the brain 
and spinal cord by double-pithing, as required by the schedule 1 guidelines. Testes 
were isolated through an incision in the abdominal wall and macerated in 
Leibovitz’s L-15 medium (Sigma-Aldrich) with 10% fetal bovine serum (FBS, 
Sigma-Aldrich). 
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2.1.3 Fertilisation and embryo development 
The testes suspension was used to fertilize the eggs from one female. After 
4 to 5 min the eggs were flooded with 0.05x MMR. 10 min later, embryos were 
de-jellied with 2% cysteine hydrochloride (Sigma-Aldrich) in 0.05x MMR, pH8, for 
approximately 5 min and then washed in 0.05x MMR. Embryos were cultured at 
26oC in 0.05% MMR with gentamycin (100µL/mL, Sigma-Aldrich) until appropriate 
Niewkoop and Faber stage. For time series experiments, division times were 
recorded for at least the first 4 divisions, as well as approximate stage at time of 
collection. 
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2.2 Chromatin Immunoprecipitation (ChIP) 
For ChIP the protocol by Gentsch and colleagues was followed, with some 
alterations (Gentsch and Smith, 2014, Gentsch et al., 2015). Recipes for solutions 
used are presented at 2.5 – Solutions. 
 
2.2.1 Chromatin cross-linking 
An appropriate amount of embryos (depending on the developmental stage) 
was collected, washed twice in 0.05x MMR and fixed in 1% formaldehyde (freshly 
opened capsule, Sigma-Aldrich) in 0.05x MMR for 25 minutes at room temperature. 
Fixed embryos were washed three times with ice cold 0.05x MMR and batches of 
less than 250 embryos were transferred to 2mL tubes and snap-frozen in liquid 
nitrogen. Embryos were stored at -80oC for future use. For time series experiments 
with 30-minute time intervals, this procedure was performed with the assistance of 
Brook Cooper and Elena De Domenico due to time overlaps between performing 
the washes and the next time point embryo collection. 
 
2.2.2 Chromatin extraction 
Nuclei isolation and chromatin extraction was performed in batches of no 
more than 50-80 embryos. Fixed embryos were homogenised in E1 and 
centrifuged at 1000g for 2 minutes at 4oC. The supernatant and lipids attached to 
the wall were discarded. The pellet was resuspended in E1 and incubated on ice 
for 10 min, followed by centrifugation and discarding of supernatant as before. The 
previous two steps were repeated twice with E2 and once with E3. 
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2.2.3 Chromatin fragmentation 
At this point the pellet is formed of cross-linked nuclei, which were 
resuspended in 150µL of E3. Chromatin was fragmented by sonication in a 
Bioruptor® Plus (Diagenode) for 30 cycles, with 30/30 sec On/Off times. 
Fragmented chromatin was transferred into pre-chilled tubes, centrifuged at 
15,000g for 5 min at 4oC and the clear supernatant was transferred to a clean 
pre-chilled tube. 3-5% of the shredded chromatin was collected to use as input 
(non-immunoprecipitated chromatin) and stored at 4oC. 
 
2.2.4 Chromatin immunoprecipitation 
13 µg p300 antibody (Santa Cruz Biotechnology, catalog number: sc-585) 
were added to the chromatin and the mixture was incubated overnight on a rotator 
(10 rpm) at 4oC. 120 µL Dynabeads® Protein G (Invitrogen) per sample were 
washed for 5 min in E3, at 4oC. The washed beads were added to the chromatin 
and antibody mixture and incubated for 4 hours on a rotator (10 rpm) at 4oC. 
From this point onward, a magnetic rack was used to assemble the 
beads/antibody/chromatin complexes at the bottom of the tubes before discarding 
the supernatant. Samples were washed 10 times with pre-chilled RIPA buffer, with 
5 min incubations on a rotator (10 rpm) at 4oC in between washes. Samples were 
washed once more, this time in pre-chilled TEN buffer for 5 min on a rotator 
(10 rpm) at 4oC. Pellets were resuspended in 50µL of TEN buffer and the 
suspension was transferred to a new tube. Samples were centrifuged at 1000g for 
1min at 4oC and the supernatant was discarded. 100µL SDS elution buffer was 
added to the beads and the mixture was shaken for 15 min in a thermomixer set to 
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1000 rpm and 65oC. Samples were centrifuged at 15,000g for 30 sec at room 
temperature. Supernatants were transferred to a new tube. Last three steps were 
repeated. ChIP samples had 200 µL by the end of these steps. 
 
2.2.5 Reverse cross-linking 
SDS elution buffer were added to input samples to 200 µL. ChIP and input 
samples were supplemented with 20 µL 5M NaCl and were incubated overnight at 
65oC. 200 µL TE buffer and 8 µL RNAse A (final concentration 200 µg/mL, 
Invitrogen) were added and incubated for 1 hr at 37oC. 4 µL proteinase K (final 
concentration 200 µg/mL, Ambion) were added and incubated for 2 to 4 hours at 
55oC. 
 
2.2.6 DNA purification and sequencing 
DNA was purified using the MinElute PCR Purification Kit (Qiagen) 
according to the manufacturer’s protocol and eluted in ~20 µL. 
The library preparation step and sequencing was performed by GATC 
Biotech or the High-Throughput Sequencing team at The Francis Crick Institute/Mill 
Hill Lab. 
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2.3 Pilot p300 ChIP-seq time series collection 
X. tropicalis embryos were generated as described in section 2.1. Fertilized 
embryos were allowed to develop for 7 hours and were then collected every 
30 minutes, until 10.5 hours post fertilization, with the help from Brook Cooper. 
Embryos were processed as described in section 2.2. 
 
2.4 Long p300 ChIP-seq time series collection 
X. tropicalis embryos were generated as described in section 2.1. Fertilized 
embryos were allowed to develop for 5 hours and were then collected every 
30 minutes, until 17.5 hours post fertilization, with the help of Elena De Domenico. 
Embryos were processed as described in section 2.2. 
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2.5 Solutions 
Most solutions were prepared by The Francis Crick Institute/Mill Hill Lab 
services, including 50 mM HEPES (pH 7.5), 1 mM EDTA, 50 mM Tris-HCl (pH 8.0). 
 
10x Marc’s Modified Ringers MMR 
1 M NaCl 
20 mM KCl 
20 mM CaCl2 
10 mM MgSO4 
50 mM HEPES (pH 7.5) 
pH adjusted to 7.5 and solution sterilised by autoclaving. 
 
E1 
50 mM HEPES (pH 7.5) 
150 mM NaCl 
1 mM EDTA 
10% glycerol 
0.5% Igepal CA-630 
0.25% Triton X-100 
0.2mM PMSF in 100% EtOH 
1mM DTT 
1 protease inhibitor tablet (Roche) per 10mL  
(PMSF, DTT and protease inhibitor should only be added right before use) 
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E2 
10 mM Tris-HCl (pH 8.0) 
150 mM NaCl 
1 mM EDTA 
0.5 mM EGTA 
0.2mM PMSF in 100% EtOH 
1mM DTT 
1 protease inhibitor tablet (Roche)  per 10mL) 
(PMSF, DTT and protease inhibitor should only be added right before use) 
 
E3 
10 mM Tris-HCl (pH 8.0) 
150 mM NaCl 
1 mM EDTA 
1% Igepal CA-630 
0.25% Na-Deoxycholate 
0.1% SDS 
0.2mM PMSF in 100% EtOH 
1mM DTT 
1 protease inhibitor tablet (Roche)  per 10mL) 
(PMSF, DTT and protease inhibitor should only be added right before use) 
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RIPA buffer 
50 mM HEPES  (pH 7.5) 
500 mM LiCl 
1 mM EDTA (pH 8.0) 
1% Igepal CA-630 
0.7% Na-deoxycholate 
 
SDS elution buffer 
50 mM Tris-HCl (pH 8.0) 
1 mM EDTA 
1% SDS 
 
TEN buffer 
10 mM Tris-HCl (pH 8.0) 
1 mM EDTA (pH 8.0) 
150 mM NaCl 
 
All solutions were prepared in double-distilled water 
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2.6 ChIP-seq analysis 
Unless otherwise stated, data analysis was done using command line and 
Python 3.5 (www.python.org) and all graphs were produced with python packages 
matplotlib (Hunter, 2007) and seaborn (seaborn.pydata.org). 
 
2.6.1 Sequencing reads analysis 
Raw sequencing files were first analysed using FastQC software 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) to determine the quality 
of the sequencing reads. They were then mapped to the X. tropicalis genome 
assembly 7.1 (Hellsten et al., 2010, Karpinka et al., 2015) using bowtie2 
(Langmead and Salzberg, 2012) using default parameters (used -X 700 to align 
paired-end reads). 
For paired-end sequencing, reads not mapped to proper pair were removed 
(samtools view -f 2) (Li et al., 2009). Non-unique reads were filtered out by using 
grep -v XS:i. Bedtools (Quinlan and Hall, 2010) bamtobed was used to convert the 
BAM files to BED files (or BEDPE for paired-end sequencing) and genomecov was 
used to generate the BEDGRAPH files and normalise reads by total number of 
mapped reads. wigToBigWig was used to convert the BEDGRAPH file to bigwig 
(https://genome.ucsc.edu/goldenpath/help/bigWig.html), to be displayed in a 
genome browser. 
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2.6.2 Peak calling 
MACS2 (Model based analysis of ChIP-seq 2) (Zhang et al., 2008) was 
used to perform peak calling, to identify regions with enriched p300 binding over 
background, with an FDR of 0.1% and the following parameters: --SPMR -q 
0.001 --call-summits (-f BAM for single-end and -f BAMPE for paired-end data). 
 
2.6.3 p300 region-Gene assignment 
p300 regions were assigned to their closest gene using annotatePeaks.pl 
from HomerTools (Heinz et al., 2010) 
 
2.6.4 p300 region clustering 
p300 regions were clustered using the python package scipy 
(https://www.scipy.org) clustering. Data was kmeans clustered, with the k value 
being heuristically determined, by testing several values and determining which 
one led to the best region separation, without overclustering. The average time 
point at which the cluster reached its maximum expression was calculated and 
clusters were ordered by that value. Clusters with identical maxima were manually 
ordered. 
 
2.6.5 Random region generation 
Random regions were generated using bedtools random, with the 
appropriate number of required regions. Random regions were then annotated as 
mentioned on section 2.7.3.  
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2.6.6 Genome browser and heatmaps 
Genome browser profiles were generated with fluff (Georgiou and van 
Heeringen, 2016). Read density heatmaps were generated using deepTools 
(Ramirez et al., 2016), computeMatrix reference-point with 
parameters --referencePoint center -a 5000 -b 5000 in order to centre heatmaps 
around the middle of the p300 region and to count reads in a 10 kb area around it. 
Heatmap was then plotted using plotHeatmap --sortRegions no, so regions 
maintained the clustering ordering. 
 
 
 
  
Chapter 3 Results 
 
64 
 
Chapter 3. Identification of Candidate Enhancers 
and p300 Dynamics  
3.1 Introduction  
Creating a dataset of candidate enhancer regions is an essential tool in the 
genetic and epigenetic study of any model organism. Having such a tool allows 
further study on how specific enhancer mutations may lead to a disorder and also 
opens the possibility to modulate gene expression by modifying enhancers of 
interest. p300 has been used extensively to predict active enhancer regions in 
different model organisms (Wang et al., 2005, Heintzman et al., 2007, Heintzman 
et al., 2009, Visel et al., 2009a, Wang et al., 2009, Blow et al., 2010, May et al., 
2011, Rada-Iglesias et al., 2011, Attanasio et al., 2013), including Xenopus 
tropicalis (Hontelez et al., 2015). 
To understand transcriptional regulation – which underpins much of 
development – it is important to understand the temporal dynamics of enhancer 
behaviour. p300 has been assayed at different developmental stages; however, to 
date, no experiment has been performed to determine how p300 binding changes 
during short time intervals. Currently, the most frequently sampled p300 datasets 
have been assayed at developmental stages several hours apart. Having high 
resolution time data would allow the determination of the fast dynamics that may be 
involved in the fine-tuning of gene expression in the early embryo. 
Work presented in this chapter aimed to create a dataset of candidate 
enhancer regions in early Xenopus tropicalis development, determine their usage 
dynamics, using p300 as a proxy for this, and compare the identified regions with 
previously published histone modifications and RNAPII data. In order to achieve 
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this, a pilot p300 ChIP-seq time series was performed in Xenopus tropicalis 
embryos, from 7 to 10.5 hpf, at 30 min time intervals, followed by a longer 
experiment, from 5 to 17.5 hpf, also at 30 min time intervals (Figure 6). 
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3.2 p300 ChIP-seq 
3.2.1 p300 ChIP-seq pilot time series 
3.2.1.1 Embryo Collection 
Xenopus tropicalis embryos were collected with the help from Brook Cooper, 
for a pilot p300 ChIP-seq time series. Embryos were collected as described in 
Materials and Methods, at the times shown on Figure 6 (green), from 7 to 10.5 hpf, 
with the number of embryos per sample described on Table 1. The number of 
embryos needed for the ChIP-seq decreases with the increasing cell number per 
embryo. This clutch had a division time during the cleavage stages of 17 minutes. 
Samples will be referred to by their time (e.g. Sample collected at 7.5 hpf will be 
referred to as Sample 7.5). 
 
Hours post fertilisation 
(hpf) 
Number of embryos 
7 75 
7.5 74 
8 75 
8.5 57 
9 55 
9.5 53 
10 53 
10.5 55 
 
Table 1 – Time and number of X. tropicalis embryos collected from a single 
synchronous clutch, for a pilot p300 ChIP-seq time series. 
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3.2.1.2 Sequencing results 
p300 ChIP was performed on all samples as described in Materials and 
Methods. All samples were sent to GATC Biotech for library preparation and 
paired-end (51 bp) sequencing in an Illumina HiSeq. It was requested that they first 
sequenced samples 7.5, 8.5, 9.5 and 10.5 hpf and the matched inputs, to avoid 
sequencing all samples if the quality of the experiment was not sufficient. After 
receiving positive results from that set of samples, it was requested that they 
sequenced the rest of the samples and inputs, however GATC Biotech reported 
that they were not able to perform library preparation on samples 7, 8, 9 and 10 hpf. 
Therefore, the pilot time series was analysed with a 1 hour time interval. 
ChIP-seq analysis was performed as described in Materials and Methods. 
FastQC analysis was performed to determine the quality of the sequencing reads 
and all samples had very high quality. After read alignment, about 60% of read 
pairs in each sample mapped uniquely. Table 2 summarises sequencing results. 
 
Samples 
Number of read pairs 
(Millions) 
Uniquely mapped pairs 
(Millions) 
7.5 41.9 25.6 (61.0%) 
8.5 22.5 13.7 (61.0%) 
9.5 26 15.9 (61.2%) 
10.5 30.7 18.8 (61.5%) 
Input 7.5 47.5 28.6 (60.2%) 
Input 8.5 46.3 29.6 (63.8%) 
Input 9.5 44.5 27.7 (62.3%) 
Input 10.5 49.1 27.6 (56.2%) 
 
Table 2 – Number of sequencing and uniquely mapped read pairs in pilot p300 
ChIP-seq time series. 
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Figure 7 represents the ChIP-seq data normalised by total number of 
uniquely aligned reads, per sample, in two loci with different p300 binding dynamics. 
The mix1/mixer locus has p300 binding at early time points, with that binding 
disappearing towards later development. The lrrk1 locus shows one p300 region 
with maximum binding at 8.5 hpf and regions with later p300 binding. 
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3.2.1.3 Peak calling 
Peak calling was then performed using MACS2, as described in Materials 
and Methods, with a false discovery rate of 0.1%. An example of the peak regions 
called in one or more samples can be seen on Figure 7. 
The majority of ChIP-seq experiments are done with single-end sequencing; 
in order to determine if paired-end sequencing has advantages, peak calling was 
performed both on the paired-end data and on the corresponding single-end data. 
 
Samples 
Peaks in 
Paired-end 
Peaks in 
Single-end 
Overlap paired 
vs single-end 
Overlap top paired 
vs single-end 
7.5h 12516 8344 65.9% 91.6% 
8.5h 10657 6918 64.8% 92.2% 
9.5h 8044 4738 58.0% 85.3% 
10.5h 11570 6716 58.9% 85.8% 
 
Table 3 – Pilot p300 ChIP-seq time series peak calling results. 
Numbers of peaks called per sample and how the ones in the single-end data 
compare with the ones called in the paired-end data. Overlap represents the 
percentage of paired-end peaks also present in the single-end data. 
 
Table 3 shows the number of peaks called for each sample in the 
paired-end and in the single-end data and the percentage of peaks called in the 
paired-end that are also called in the single-end data (overlap paired vs single-end). 
About 40% of peaks are lost in the single-end data, most likely due to the actual 
fragment size in single-end data being unknown, leading to a worse performance 
from MACS2. To determine how the highest scored peaks behaved, peaks were 
sorted by their MACS2 score and the top half were selected. These were then 
compared to the peaks called in the single-end data, with the results described on 
Table 3. About 90% of the highest scored peaks are maintained when analysing 
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only single-end data, therefore, the majority of peaks missed in the single-end data 
have a low score and are more likely to be false positives. 
 
With the goal of performing a longer p300 ChIP-seq time series, it was 
important to determine if input samples for every time point needed to be 
sequenced in order to have reliable peak calling. To address this, peaks in sample 
7.5 were called using input 10.5, instead of input 7.5 (the input initially used); 
92.5% of the peaks were maintained and, looking only at the top half of the peaks, 
this number increased to 98.7%. This indicates that it is not essential to have input 
samples for all time points because the vast majority of peaks are maintained when 
an input from embryos 3 hours later is used. Therefore, I decided not to sequence 
all input samples in subsequent experiments. 
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3.2.1.4 Pilot time series correlation 
Figure 8 represents the Pearson correlation coefficient between pairs of 
samples in the pilot time series. As expected, samples are more closely correlated 
with the adjacent sample than to samples further away in time, which shows the 
high quality of the data and also that time dynamics are present in the data – 
because neighbouring time points are better correlated, if there were no time 
dynamics this effect would not be present. 
 
 
Figure 8 – Pilot p300 ChIP-seq time series correlation. 
Pearson correlation between pairs of pilot p300 ChIP-seq time series samples. 
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3.2.1.5 Conclusions from pilot p300 ChIP-seq time series 
The pilot p300 ChIP-seq time series showed how, even with only 4 time 
points over 3 hours, it is possible to see dynamic p300 binding (Figure 7 and Figure 
8). Paired-end sequencing yields higher peak numbers, however most of the highly 
scored peaks are maintained in single-end sequencing (Table 3). Given that 
paired-end sequencing costs nearly twice as much as single-end, subsequent 
ChIP-seq experiments were performed with single-end sequencing. Peak calling 
does not seem to be affected by using input from samples three hours apart, 
therefore, in subsquent ChIP-seq experiments, not all input samples were 
sequenced. 
  
Chapter 3 Results 
 
75 
 
3.2.2 p300 ChIP-seq long time series 
3.2.2.1 Embryo Collection 
A much longer time series was collected, as shown on Figure 6 (blue), from 
5 to 17.5 hpf, at 30 min time intervals, with the help from Elena De Domenico. 
Embryos were collected as described in Materials and Methods, with the number of 
embryos per sample described on Table 4. Sample 6 was lost during the ChIP 
experiment. As previously mentioned, earlier time points require a higher number of 
embryos due to the lower cell number per embryo. Approximate developmental 
stage was recorded during collection. This clutch had a division time of 18 minutes 
during the cleavage stages.  
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Hours post 
fertilisation 
Number of 
embryos 
Approximate 
Stage 
5 100 9 
5.5 100 9 
6 90 9 
6.5 90 10 
7 75 10 
7.5 74 11 
8 70 11 
8.5 60 11 
9 55 11 
9.5 55 11 
10 55 12 
10.5 55 12 
11 50 12 
11.5 50 12 
12 50 12 
12.5 50 13 
13 40 13 
13.5 40 14 
14 40 14 
14.5 40 15 
15 40 16 
15.5 40 16 
16 40 17 
16.5 35 17 
17 35 18 
17.5 35 19 
 
Table 4 – Embryo collection for p300 ChIP-seq long time series. 
Time, number of embryos and approximate developmental stage of X. tropicalis 
embryos collected for the p300 ChIP-seq long time series. 
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3.2.2.2 Sequencing results 
p300 ChIP was performed on all samples as described in Materials and 
Methods. The High-Throughput Sequencing team at The Francis Crick Institute/Mill 
Hill Lab performed library preparation and single-end (51bp) sequencing in an 
Illumina HiSeq. Input samples were produced for all time points, however, due to 
cost considerations and given that it was shown in the pilot project that most peaks 
(~90%) are maintained when using inputs for other samples, only inputs 5, 7, 9, 11, 
13, 15 and 17 were sequenced. 
FastQC analysis showed that all samples had high-quality sequencing reads. 
Table 5 summarises sequencing results, showing about 50% of reads mapped 
uniquely in each sample. 
Peak calling was then performed as described in Materials and Methods, 
with a false discovery rate of 0.1%.  
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Samples 
Number of 
reads (Millions) 
Uniquely mapped 
reads (Millions) 
Number of 
peaks 
Input sample 
used 
5 50.9 22.9 (44.9%) 7152 5 
5.5 61 30 (49.1%) 1256 5 
6.5 67.5 33.9 (50.2%) 53 7 
7 65.9 32.5 (49.3%) 297 7 
7.5 66.9 33.7 (50.3%) 186 7 
8 54.7 28 (51.3%) 68 9 
8.5 46.2 22.9 (49.7%) 2086 9 
9 54.3 27.6 (50.8%) 2721 9 
9.5 53.1 27.1 (51.0%) 3980 9 
10 61 31.8 (52.1%) 2173 11 
10.5 41.9 19.5 (46.5%) 8238 11 
11 37.5 18.7 (49.7%) 3349 11 
11.5 46.9 23.9 (50.9%) 5965 11 
12 51.7 26.4 (51.1%) 2167 13 
12.5 62.5 32.7 (52.3%) 2479 13 
13 50.2 26 (51.7%) 2166 13 
13.5 35.2 19.2 (54.8%) 1384 13 
14 46.2 25.1 (54.4%) 3181 15 
14.5 57 30.8 (52.9%) 1364 15 
15 37.8 20.2 (53.5%) 2786 15 
15.5 42 23.6 (56.2%) 2049 15 
16 43.5 24.3 (56%) 3633 17 
16.5 45.8 25.7 (56.3%) 809 17 
17 35.9 14.9 (41.6%) 2784 17 
17.5 51.7 23.4 (45.3%) 242 17 
Input 5 82.1 43.5 (53%)   
Input 7 67.9 37 (54.6%)   
Input 9 44.9 24.9 (55.5%)   
Input 11 41.2 22.5 (54.5%)   
Input 13 25.7 14.2 (55.4%)   
Input 15 37.7 20.4 (54.2%)   
Input 17 38.1 21.7 (56.7%)   
 
Table 5 – p300 ChIP-seq long time series sequencing. 
Sequencing and uniquely mapped reads in the p300 ChIP-seq long time series, 
number of peaks called and which input sample was used for peak calling. 
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3.2.2.3 ChIP-seq normalisation 
p300 ChIP-seq data normalised by the total number of uniquely mapped 
reads in each sample is represented on Figure 9A (using the ventx locus as an 
example). Samples 5.5 to 8 have generally lower peaks and less peaks called, 
compared to other samples (Table 5). This was visible across the whole genome 
(data not shown), showing it is not a region specific phenomenon. These samples 
appeared to have a higher percentage of background reads, i.e. reads which map 
apparently randomly across the genome. 
Samples with higher background levels will have their peaks’ read density 
underestimated because, all other things being equal, sequencing reads are 
spread all over the genome and not concentrated in binding regions, as they are in 
high quality samples. This would negatively impact quantitative analysis of the data. 
In order to overcome this issue, the data were normalised in a way that discounted 
background reads. 
The following normalisation method was developed: 
 Peak calling was performed as described above, giving a set of 
regions called in each sample. 
 A peak file was created, with all the peaks from all samples. Any 
overlapping peaks or peaks with edges less than 49 bp away from a 
nearby peak were merged (with 51 bp reads, a read could be 
counted as aligning to two different peaks if those were less than 
49 bp apart). Hereafter, this will be referred to as the set of p300 
regions. 
 For each sample, the number of reads aligning to the set of p300 
regions was counted, irrespectively of whether a specific peak was 
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called in any given sample or not. That number was then used to 
derive the normalisation factor for its corresponding sample. 
 In summary, each sample is normalised by the total number of reads 
that map to all peaks called in all samples (set of p300 regions). 
 
In total, 17,414 p300 regions were identified. 
Figure 9 shows a comparison of the data in the ventx locus: A representing 
the data normalised by total number of uniquely mapped reads, B representing the 
data normalised by total number of reads aligning to the set of p300 regions. 
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Figure 9 – p300 ChIP-seq long time series.  
A – Genome browser view of the ventx locus, with p300 ChIP-seq reads 
normalised by the total number of uniquely mapped reads. B – Genome browser 
view of the same locus, with p300 ChIP-seq reads normalised by the total number 
of reads aligning to the set of p300 regions. 
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Having a set of p300 regions also allows the calculation of a sample’s 
enrichment – which I define as the percentage of total mapped reads that align to 
the set of p300 regions. Table 6 summarises that data and samples 5.5 to 8, which 
seemed to have smaller peaks and higher background, do indeed have lower 
levels of enrichment. Figure 10 shows how the number of peaks called correlate 
with the sample’s enrichment; the higher the latter, the more peaks MACS2 is able 
to call. 
 
Samples Number of peaks 
Reads in set of p300 
regions (Thousands) 
Enrichment 
5 7152 680 2.98% 
5.5 1256 432 1.44% 
6.5 53 390 1.15% 
7 297 438 1.35% 
7.5 186 436 1.30% 
8 68 388 1.38% 
8.5 2086 461 2.01% 
9 2721 617 2.23% 
9.5 3980 707 2.61% 
10 2173 786 2.47% 
10.5 8238 717 3.68% 
11 3349 527 2.82% 
11.5 5965 748 3.13% 
12 2167 757 2.87% 
12.5 2479 972 2.97% 
13 2166 725 2.79% 
13.5 1384 445 2.31% 
14 3181 654 2.61% 
14.5 1364 711 2.36% 
15 2786 506 2.50% 
15.5 2049 522 2.21% 
16 3633 611 2.51% 
16.5 809 462 1.79% 
17 2784 465 3.12% 
17.5 242 497 2.12% 
Table 6 – p300 ChIP-seq long time series samples’ enrichment. 
Number of peaks called per sample, number of reads in the set of p300 regions 
and sample’s enrichment. 
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Figure 10 – Enrichment vs number of peaks called by MACS2 for p300 ChIP-seq 
long time series samples. 
 
By normalising the samples by the read count in the set of p300 regions, the 
subsequent analysis is not dependent on varying background levels and varying 
quality of peak calling. 
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3.2.2.4 Pilot and long time series show high replicability 
To determine how replicable p300 ChIP-seq is, the Pearson correlation 
coefficients between the pilot and long time series were calculated, at each time 
point in common. Clutch division times were slightly different (17 minutes in the 
pilot and 18 in the long time series), so all times had to be adjusted (Table 7). 
Samples correlated well between the two experiments, even though there is a 
slight time lag between the pairs (Table 7 and Figure 11). 
 
Time in pilot time 
series 
Adjusted time in 
long time series 
Pearson correlation 
coefficient 
7.5 7.94 ≈ 8 0.83 
8.5 9 0.89 
9.5 10.05 ≈ 10 0.9 
10.5 11.11 ≈ 11 0.82 
 
Table 7 – Pearson correlation coefficient between pilot and long p300 ChIP-seq 
time series. 
Chapter 3 Results 
 
85 
 
 
Figure 11 – Scatter plots of normalised p300 reads for pairs of pilot and long 
p300 ChIP-seq samples at equivalent times and their correlation. 
Each dot represents one peak region; the y-axes represent the number of 
normalised reads in samples of the long time series and the x-axes in samples of 
the pilot time series. The colour represents the dot density. Times have been 
adjusted due to different clutch division times (Table 7). TM – Time series. 
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3.2.2.5 Time series adjacent time points correlate better than biological 
replicates 
Pearson correlation coefficients were calculated between all pairs of 
samples in the long time series experiment (Figure 12). As expected, neighbouring 
samples are very highly correlated (>0.9), being even more correlated than 
biological replicates (from different clutches) (Table 7), which shows that the time 
interval is small enough for adjacent samples to function as biological replicates 
and to capture potentially important time dynamics. 
Figure 12 also shows that time dynamics are present in the data, with the 
correlation coefficient steadily decreasing with increased time distance between the 
samples (e.g: 5 hpf vs 17.5 hpf correlation coefficient is 0.17.) 
Sample 10.5 had a significantly lower correlation coefficient to adjacent time 
points so it was removed from further analysis. 
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Figure 12 – p300 ChIP-seq long time series samples’ correlation. 
Pearson correlation between all pairs of p300 ChIP-seq long time series samples. 
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3.2.2.6 Gaussian processes and data filtering 
Owens and colleagues (Owens et al., 2016) developed a method based on 
Gaussian processes to calculate a statistical model of time series data which, 
amongst other quantities, results in a median line of best fit for each RNA 
expression profile, and the corresponding 95% confidence intervals. This method 
estimates three parameters by maximising the marginal likelihood: 
 σf2, the signal variance, which measures the scale of the normalised read 
count for that region (how high are p300 levels at a given region). 
 τ, the timescale or length-scale, which indicates how fast the signal can 
change. It is calculated based on the times the line of best fit crosses a 
given threshold. 
 σn2, the noise variance, which measures the noise around the calculated line 
of best fit and influences the size of the confidence intervals. 
For further information on Gaussian processes and the equations used to 
calculate each parameter, I would direct the reader to section 3.3 (Gaussian 
Process Models of Gene Expression) of the Supplemental Information of Owens et 
al., 2016. 
 
In order to perform dynamic quantitative analysis, this algorithm was 
adapted to the p300 ChIP-seq data generated in this project. The normalised read 
count in individual p300 regions was calculated genome-wide, for each time point. 
These values were then used to fit Gaussian processes and so calculate the 
smooth line that best describes the p300 binding profile for each p300 region. 
Figure 13 shows the genome browser view of an example p300 region and the 
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resulting curve that best describes the data, with the corresponding 95% 
confidence interval. 
 
Figure 13 – Gaussian process method results. 
Example genome browser view with one p300 region highlighted (blue box) and the 
resulting Gaussian process graph. Points represent the normalised read count for 
the highlighted region at each time point; curve marks the median line of best fit for 
that region and the shaded area is the 95% confidence interval. 
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Figure 14 shows some of the different profiles obtained, with some regions 
having maximum p300 binding at earlier stages and then decreasing during 
development; regions where binding increases during the time series; regions with 
more dynamic behaviours, with p300 binding increasing and decreasing during this 
time interval; and regions which are almost constant. 
In order to remove regions with no obvious time signal, where reads vary 
significantly between adjacent samples, the signal-to-noise ratio (SNR) was 
calculated for each p300 region. The SNR was calculated using the Gaussian 
process parameters described above, with SNR = log(σf2/σn2). The filtering 
threshold was heuristically determined and was set at SNR > 3.8, which excluded 
4842 regions (28%) (for example, the lower two profiles in Figure 14). All further 
analysis was done with the filtered set of p300 regions. 
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Figure 14 – Examples of p300 binding dynamics and corresponding SNRs. 
The y-axis represents the number of normalised p300 reads in a given p300 region. 
The filtering threshold was set at SNR = 3.8. 
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3.2.2.7 p300 regions are mainly distal, however there is more promoter-p300 
binding than expected for random sequences 
To assess where p300 tends to bind in relation to genes, its genomic 
distribution was calculated. p300 regions were assigned to their closest gene 
(using HomerTools, as described in Materials and Methods) and given a genomic 
annotation – intergenic, promoter (for genomic annotation purposes, promoter is 
defined as the region up to 1kb upstream of the actual TSS), exon or intron. For 
each p300 region, the distance to the closest TSS was also calculated. In order to 
compare this data with randomly distributed regions, a random set of regions was 
created as described in the Materials and Methods. 
Figure 15 shows the genomic distribution of p300 regions and compares it 
with the distribution of a set of random genomic regions. 
 
 
Figure 15 – p300’s vs random region’s genomic distribution. 
Vertical axis represents percentage of p300/random regions with a specific 
genomic annotation. 
 
Chapter 3 Results 
 
93 
 
 
Figure 16 – Intergenic p300 vs intergenic random regions’ distance to closest 
TSS. 
Vertical axis represents percentage of intergenic p300/random regions at different 
distances to the nearest TSS. 
 
Figure 16 shows the distribution of intergenic p300 and random regions, by 
their distance to the closest TSS. These two figures show that p300 regions tend to 
be closer to genes than it would be expected for a set of random regions, with 
Figure 15 showing that p300 regions are 6 times more likely than a random set of 
regions to be in the gene promoter and Figure 16 showing higher percentages of 
p300 binding closer to the TSS compared with random regions and the reverse for 
farther away distances. 
From the 12,572 p300 regions, 9,807 are in intergenic or intron regions, 
therefore, those are the candidate enhancer regions predicted in this study. 
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3.2.2.8 p300 binding is highly dynamic in early development 
In order to determine p300 binding dynamics, the p300 regions were 
normalised to their maxima and filtered to remove non-dynamic regions - any 
region with less than a 2-fold change during the time series (excluded 3647 (29%) 
regions). p300 regions’ binding profiles were then clustered by k-means (k = 30), as 
described in the Materials and Methods, and the resulting clusters were ordered by 
their average profiles. Figure 17A shows the resulting ordering and Figure 17B 
shows the constant (< 2-fold change) regions. This figure confirms what Figure 14 
had already hinted at, there are very diverse p300 binding dynamics, with some 
regions having p300 binding only for very short periods. This highlights the 
importance of having high-resolution time series data; under-sampling would not 
detect such rapid alterations in binding. 
About 38% of p300 regions have their maximum binding at 5 hpf, the first 
time point, and 28% at 17.5 hpf, the last one. The dynamics of these regions 
cannot be fully understood because their actual maximum binding may be at any 
time before or after the time series. 45% of p300 regions have at least one peak in 
their binding dynamics during the time series (p300 binding profile which increases 
and then decreases, as the example on Figure 13), with regions being above 95% 
of maximum binding for, on average, 2.7 hours. 
Figure 18 shows the average number of normalised p300 reads in each 
cluster from Figure 17A. It shows the different types of p300 binding dynamics 
present in this time series, including some clusters with two distinct stages of high 
p300 binding. 
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Figure 17 – p300 binding dynamics. 
A - Heatmap showing all dynamic p300 regions, normalised by their maxima, 
kmeans clustered (k = 30) and ordered by cluster maximum time point. p300 
regions were divided into early, mid or late p300 binding. B – Heatmap showing all 
the non-dynamic (< 2-fold change during time series) p300 regions. 
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Figure 18 – Cluster p300 dynamics. 
Average number of normalised reads in p300 regions per time point in each cluster. 
Clusters ordered from left to right, then top to bottom. 
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The gene nearest to each p300 region was determined and GO term 
analysis was performed using GOstats, focusing on terms for biological processes 
(GO terms from Owens et al., 2016). Table 8 represents the 10 GO terms with 
highest enrichment for each group and the corresponding p-value. 
GO terms associated with early development, such as gastrulation and Wnt 
signalling-related terms, are highly enriched in the early p300 binding group. GO 
terms associated with the development of early tissues and pattern specification 
are enriched in the mid p300 binding group, while GO terms for specific organ 
development, particularly kidneys, are enriched in late p300 binding. Finally, GO 
terms associated with ubiquitous cellular functions, such as transcription, 
macromolecule biosynthesis and gene regulation are highly associated with genes 
near p300 regions with constant p300 binding. 
 
  
Chapter 3 Results 
 
98 
 
 
P-value 
Gene 
count 
GO term 
E
a
rl
y
 p
3
0
0
 g
e
n
e
s
 (
4
0
5
2
 g
e
n
e
s
) 4.16E-11 172 Cell surface receptor signalling pathway involved in cell-cell signalling 
3.24E-09 150 Cell-cell signalling by wnt 
3.68E-09 149 Wnt signalling pathway 
1.85E-08 117 Gastrulation 
2.35E-08 402 Regulation of multicellular organismal development 
4.13E-08 279 Positive regulation of developmental process 
5.05E-08 667 Anatomical structure morphogenesis 
8.68E-08 413 Locomotion 
1.07E-07 103 Regulation of Wnt signalling pathway 
1.55E-07 269 Tube development 
M
id
 p
3
0
0
 (
1
8
0
4
 g
e
n
e
s
) 
3.70E-25 272 Embryo development 
1.26E-22 234 Anatomical structure formation involved in morphogenesis 
1.58E-22 193 Tube development 
5.68E-22 193 Embryonic morphogenesis 
6.98E-22 310 Tissue development 
9.51E-21 244 Epithelium development 
1.63E-20 147 Embryonic organ development 
2.00E-20 186 Embryo development ending in birth or egg hatching 
2.40E-20 170 Pattern specification process 
3.68E-20 181 Chordate embryonic development 
L
a
te
 p
3
0
0
 (
2
9
9
7
 g
e
n
e
s
) 
9.24E-09 53 Nephron tubule development 
1.86E-08 56 Renal tubule development 
2.77E-08 58 Nephron epithelium development 
4.00E-08 313 Epithelium development 
6.17E-08 72 Kidney epithelium development 
1.62E-07 68 Nephron development 
1.72E-07 205 Morphogenesis of an epithelium 
2.52E-07 171 Tube morphogenesis 
3.13E-07 46 Renal tubule morphogenesis 
3.68E-07 34 Negative regulation of developmental growth 
C
o
n
s
ta
n
t 
p
3
0
0
 (
3
6
1
7
 g
e
n
e
s
) 
1.81E-22 904 Cellular macromolecule biosynthetic process 
6.59E-22 915 Macromolecule biosynthetic process 
1.70E-21 755 RNA biosynthetic process 
2.42E-21 746 Nucleic acid-templated transcription 
2.42E-21 746 Transcription, DNA-templated 
4.92E-21 841 RNA metabolic process 
1.29E-20 759 Regulation of cellular macromolecule biosynthetic process 
1.44E-20 893 Nucleic acid metabolic process 
2.70E-20 809 Regulation of gene expression 
5.36E-20 923 Gene expression 
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Table 8 - GO term enrichment in genes near early, mid, late and constant p300 
regions 
p300 regions were divided into early, mid, late and constant, based on their binding 
dynamics, and each region was assigned to the closest gene. GO terms associated 
with genes in each group were analysed and the p-value of a hypergeometric test 
between genes on each condition and all Xenopus genes is presented for each 
term. 
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3.2.2.9 p300 is highly correlated to the less dynamic H3K4me1 mark 
The p300 dataset was compared to published ChIP-seq data (Hontelez et 
al., 2015). As previously mentioned, H3K4me1 is usually found at promoters and 
active or poised enhancers, H3K4me3 and H3K9ac at promoters, H3K36me3 in 
active gene bodies and H3K27me3, H4K20me3, H3K9me2 and H3K9me3 in 
heterochromatin or repressed regions. 
p300 regions were divided into early, mid, late or constant based on their 
binding dynamics. The first three groups correspond to the sections on Figure 17A 
and the constant group corresponds to Figure 17B. 
The ChIP-seq read density of each of the published histone modifications 
and of RNAPII in the set of p300 regions – divided into early, mid, late and constant 
– were visualised together in order to determine which histone modifications 
correlate with p300 binding (Figure 19). p300’s read density was also plotted for 
four time points across the time series for reference. Graphs show read count for a 
10 kb area centred on the p300 regions. This analysis was performed using 
DeepTools, as described in Materials and Methods. 
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Figure 19 – Heatmaps of p300 and RNAPII binding and several histone 
modifications in p300 binding regions. 
Regions were ordered by p300 binding dynamics, with the first group being regions 
with high p300 binding in the beginning of the time series, the second, in the 
middle, the third in the end of the time series and the last group being regions 
which p300 binding changes less than 2-fold during the whole time series. p300 
data for 5, 9, 13 and 17 hpf are shown for reference. RNAPII and histone 
modifications data from Hontelez et al., 2015. 
 
 
As expected, p300’s read density is higher at 5 hpf for the early regions, and 
the read density shifts to the later regions during the time series. Also as expected, 
the p300 binding in the constant regions (less than 2-fold change) is maintained. 
H3K4me1 is present in the majority of p300 regions, which would be 
expected due to both being present in enhancer regions. H3K4me1 does not 
appear to be as dynamic as p300, however, the data was independently clustered 
(Figure 20) in order to determine whether it is indeed less dynamic or if the 
apparent lower dynamics are due to the temporal profiles not being well correlated. 
Through hierarchically clustering H3K4me1 in p300 regions, dynamics can be 
detected, however, p300 binding seems to appear and disappear faster than 
H3K4me1. This is expected due to this modification being present in both poised 
and active enhancers. 
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Figure 20 - Heatmap of H3K4me1 in p300 binding regions. 
p300 binding regions were hierarchically clustered based on the binding dynamics 
of H3K4me1. Data from Hontelez et al., 2015. 
 
Overall, H3K4me3, and to a lesser extent H3K9ac and RNAPII, show low 
levels of colocalisation with p300. However, for the constant p300 regions and for a 
small cluster of late regions, there seems to be a high H3K4me3, H3K9ac and 
RNAPII read density. The genomic annotation of those high H3K4me3 regions was 
analysed and a third of those regions are in promoters, compared to only 16% of 
the overall p300 regions being in promoters (Figure 21). This would be expected, 
given that H3K4me3, H3K9ac and RNAPII are present in promoter regions. 
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Figure 21 – All p300 regions’ vs p300 regions with high H3K4me3’s genomic 
distribution. 
Vertical axis represents percentage of all p300 regions/p300 regions with high 
H3K4me3 with a specific genomic annotation. 
 
H3K36me3, H3K27me3, H4K20me3, H3K9me2 and H3K9me3 do not 
colocalise with p300 binding, which was also expected, due to these marks 
typically being present in non-regulatory or repressed regions. 
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3.2.2.10 p300 binding in promoter and exonic regions is less dynamic 
Next, I analysed if p300 regions with a specific genomic annotation 
(Intergenic, Promoter, Exon or Intron) were more likely to have one of the four 
different binding dynamics: early, mid, late or constant (divided as described 
above). The percentage of p300 intergenic regions that have each of the above 
dynamics was calculated. The same was done for p300 promoter, exonic and 
intronic regions, as well as for all p300 regions for comparison. 
 
 
Figure 22 – p300 genomic annotation vs dynamics. 
p300 regions were divided based on their genomic annotation (intergenic, 
promoter, exon, intron or all p300 regions) and then based on their dynamics, if 
they are active in early, mid or late time points, or if they are not dynamic 
(constant). Graph shows the percentage of each dynamic in each genomic 
annotation group. Groups of bars for the same genomic annotation add up to 
100%. 
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Figure 22 shows the results of this analysis, and shows that promoter, and 
to a lesser extent exonic regions, are much more likely to have constant 
(non-dynamic) p300 binding. Intergenic and intronic regions have a similar 
dynamics’ distribution as “All p300 regions”. 
 
The average fold-change in p300 binding for each genomic annotation 
group was calculated to determine if p300 binding in promoter regions is indeed 
less dynamic. Figure 23 shows the distribution of fold change in p300 binding for 
regions in each of the genomic annotation groups. Promoters do indeed have less 
dynamic p300 binding than intergenic regions (66% decrease in mean fold change, 
p-value = 2.73e-235, Mann-Whitney U test). p300 binding at exonic regions is also 
significantly lower than at intergenic regions (33% decrease, p-value = 1.24e-37, 
Mann-Whitney U test). 
 
 
Figure 23 – p300 binding fold change. 
Fold change in p300 binding in p300 regions with the different genomic 
annotations. 
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In order to determine if different distribution of read densities in promoters 
and intergenic regions are a confounding factor in the analysis of the dynamic 
behaviour between the different regions, their distribution was determined (Figure 
24). 
 
 
Figure 24 - p300 normalised peak height distribution. 
Histogram of p300 normalised peak heights in promoter (red) and intergenic (blue) 
regions. 
 
To confirm if p300 binding in promoter regions is indeed less dynamic, 
regions with similar distributions were compared; for this, data was split into high 
and low p300 binding regions (>150 normalised reads vs <100 normalised reads). 
Regardless of read density, promoter regions do indeed have lower fold change 
than intergenic regions (65% and 48% decrease in low and high p300 binding 
regions, respectively. p-value = 1.37e-153 and 3.54e-21, Mann-Whitney U test) 
(Figure 25). 
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Figure 25 - p300 fold change in regions with low or high p300 binding. 
Fold change in p300 binding in intergenic and promoter regions with either low 
(<100 normalised reads) or high (>150 normalised reads) p300 binding. 
 
Intergenic and promoter p300 regions corresponding to the same nearest 
gene were paired and their fold changes were analysed. In 74% of the pairs, the 
p300 binding varied more in the intergenic than in the promoter region, with 
intergenic regions having, on average, a fold change almost two times higher than 
the promoter regions. 
The expression of the corresponding genes will be analysed in the next 
chapter, to investigate the relationship between p300 binding at promoters and 
distal regions with the gene’s transcription dynamics. 
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3.3 Discussion 
3.3.1 Pilot time series 
In this chapter I described the creation of two p300 ChIP-seq time series. 
The first of these was a pilot time series which allowed me to test the approach. 
Despite spanning only 3 hours, it resolved some p300 binding dynamics, and 
justified the production of a second, longer time series.  
The pilot time series confirmed two technical aspects of the approach: firstly, 
that single-end sequencing is appropriate for ChIP-seq and that little is gained in 
performing paired-end sequencing; and secondly, for closely spaced time series 
not all inputs need to be sequenced. These two points translate into worthwhile 
cost savings, an important consideration when performing high-throughput time 
series experiments. 
 
3.3.2 Long time series 
Next, I performed a long p300 ChIP-seq time series, which showed there is 
a very high correlation coefficient between adjacent time points and between the 
two time series. This is important to show that the results obtained are reproducible. 
A novel ChIP-seq normalisation method was developed, allowing the 
comparison of samples with different levels of background signal. This, together 
with the algorithm adapted from Owens et al., 2016 to generate the curves of best 
fit for each p300 region, allowed quantitative downstream analysis to be performed. 
After filtering out regions with low signal-to-noise ratio, 12,581 p300 regions 
were found. Importantly, the high-resolution time series allowed the calculation of a 
temporal signal-to-noise ratio, which allowed the identification of robust p300 
binding regions exhibiting consistent temporal dynamics. Additionally, with a lower 
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temporal resolution I would require replicates of individual time points to predict 
high confidence p300 regions. Given that I showed that adjacent time points 
correlate better than biological replicates, they can serve as internal replicates with 
the application of a framework like Gaussian processes. 
Approximately 50% of the p300 regions are intergenic, however, p300 
regions tend to be closer to TSSs than expected for a set of random regions, with 
six times more binding within the 1 kb promoter region. This 50% value is lower 
than the one reported by Heintzman and colleagues (75% at >2.5 kb) (Heintzman 
et al., 2007). That study was done in humans, with a genome roughly twice as 
large as X.tropicalis (Hellsten et al., 2010), which may explain the difference. 
p300 regions were clustered according to their binding dynamics (early, mid, 
late or constant binding), which showed that p300 binding in early development is 
highly dynamic, with more than two thirds of the p300 regions varying more than 
2-fold during this time series.  
GO analysis was performed on genes near p300 regions in each of the 
above mentioned groups (early, mid, late and constant p300). Even though not all 
genes are regulated by their closest enhancer, the enriched GO terms for each 
category matched well with the developmental processes at each stage. Early p300 
regions are present near genes associated with early development and gastrulation, 
while genes associated with tissue patterning and organ development are near mid 
and late p300 regions, respectively. Most interestingly, genes involved in ubiquitous 
cellular functions were highly enriched near p300 regions which have constant 
binding. These results reinforce that p300 binding is regulating expression of 
different genes at different stages of development. 
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When comparing the generated data with previously published data on 
histone modifications, I found good agreement with the literature. p300 and 
H3K4me1 colocalise well, however p300 appears more dynamic than this histone 
modification. Overall, p300 and H3K4me3/H3K9ac/RNAPII do not correlate well, 
except for the constant p300 regions, and a subset of the late p300 regions. These 
regions were analysed and, unsurprisingly, a much higher percentage of these are 
in promoter regions, when compared to the overall p300 binding. This was also 
expected due to these three marks being present in active promoter regions. 
Finally, 56% of p300 binding to promoters is not dynamic, changing less 
than 2-fold during the 12.5 hours of this time series, compared to only 21% of p300 
binding in intergenic regions being constant. This indicates that p300 binding is 
much less dynamic in promoters than in distal enhancers. The average fold change 
in p300 binding in the different genomic annotation groups was calculated and the 
p300 binding at promoter regions does indeed vary significantly less than at 
intergenic regions. The analysis of intergenic and promoter regions close to the 
same gene showed that intergenic p300 binding varies almost twice as much as 
the p300 binding in the nearest gene’s promoter. These values are likely to be 
underestimated, due to the existence of unannotated promoters in the X. tropicalis 
genome. As mentioned in the Introduction, p300 is implicated in enhancer-promoter 
looping. If one promoter interacted with only one enhancer, it would be expected 
that they would have very similar p300 binding dynamics. However, different 
enhancers regulate gene expression in different cell types and at different 
developmental stages, thus, promoters may be involved in looping, with different 
enhancers, for longer periods of time. The observation that p300 binding in distal 
candidate enhancers is more dynamic than in promoter regions is then a 
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reinforcement of the model of a promoter binding different enhancers in different 
tissues at specific time periods. 
 
In this chapter I described the creation of a set of 9,807 candidate enhancer 
regions in early X. tropicalis development, showed that p300 binding is extremely 
dynamic and that p300 binding in promoter regions is less dynamic than in distal 
candidate enhancers. In the next chapter I will describe the analysis performed in 
order to understand how p300 binding correlates with gene transcription and how it 
may be used to predict enhancer-gene pairs. 
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Chapter 4. p300 and Gene Transcription 
4.1 Introduction 
The aim of the analysis described in this chapter was to investigate the 
temporal relationship between p300 binding and gene transcription, in order to 
detect potential correlations and to assess if they can be used to predict 
enhancer-gene pairings. 
p300 may regulate transcription through various mechanisms, with one of 
the most prominent being a proposed role in enhancer-promoter looping (Kim and 
Kim, 2013, Guo et al., 2016). If p300 is involved in activating transcription, and not 
only establishing a poised transcriptional state which lasts several hours until 
transcription actually starts, the dynamics of p300 binding should correlate with 
transcription dynamics. 
 
Based on this, I set out to answer the following questions: 
1. Are active genes (genes with increasing number of transcripts) more 
likely to have p300 binding at their promoter and/or nearby candidate 
regions? If p300 binding is indeed involved in transcription regulation, 
it would be expected that active genes are more likely to have nearby 
p300 binding than inactive genes. 
2. Do p300 binding dynamics at promoters correlate with the binding 
dynamics at nearby enhancers? If p300 is involved in 
enhancer-promoter looping, it would be expected that the binding 
dynamics in an enhancer and corresponding promoter to be similar, 
as the same molecule is in proximity to both regions. 
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3. Do p300 binding dynamics in a gene promoter correlate with the 
transcription rate of that gene? If p300-mediated looping leads to 
transcription initiation and the loop is maintained during transcription, 
it would be expected that the more cells have p300 binding in a given 
promoter, the more that gene would be expressed. 
4. Can enhancer-gene pairs be predicted based on the two previous 
hypotheses and what can be said about conventional enhancer-gene 
pairing approaches, such as pairing an enhancer to the closest gene, 
in light of this data? 
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4.2 Active genes are more likely to have p300 binding nearby 
I first set out to assess if active genes are more likely than inactive ones to 
have p300 binding in their promoter regions and/or in nearby candidate enhancers. 
A list of 1677 genes activated between 6 and 19 hpf and their fold change 
(between activation and their peak) was generated by Michael Gilchrist. Briefly, a 
gene is described as active if its expression levels rise sharply over consecutive 
time points (method described in Collart et al., 2014). 
These genes were sorted by their fold change and divided into three groups: 
top 33%, middle 33% and bottom 33% (559 genes in each group) of active genes. 
The percentage of genes within each category, as well as in all inactive genes (all 
genes not considered active by the above method, which may include some genes 
with low activation - 26,713 genes), with a p300 region in the 100 bp upstream or 
downstream of the TSS (hereafter referred to as proximal promoter) or in the 20 kb 
surrounding region was determined. The 200 bp region around the promoter was 
removed from the 20 kb region. As described in the previous chapter, a p300 
region is any region detected by the peak caller in any sample and merged, 
followed by SNR filtering.  
Table 9 summarises the results. Genes in the top 33% set are almost 
6 times more likely to have a p300 region in the proximal promoter than inactive 
genes (p-value = 8.56e-65, Fisher Exact test), and almost 2 times as likely as the 
middle and bottom 33% active genes (p-value = 3.34e-08 and 2.33e-06, 
respectively, Fisher Exact test). Regarding the 20 kb surrounding region, the top 
33% active genes are almost 4 times more likely than inactive genes to have a 
p300 region within this region (p-value = 2.01e-102, Fisher Exact test), and 1.4 
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times more likely than the bottom and middle 33% of active genes 
(p-value = 2.46e-07 and 8.93e-09, respectively, Fisher Exact test). 
 
 Proximal Promoter 20kb region 
Inactive Genes 1385 (5%) 4208 (16%) 
Bottom 33% active genes 97 (17%) 237 (42%) 
Middle 33% active genes 87 (16%) 227 (41%) 
Top 33% active genes 155 (28%) 327 (59%) 
Table 9 – p300 at proximal promoters or nearby genes with different 
transcriptional states. 
Percentage of inactive (26,713 genes), bottom (559 genes), middle (559 genes) 
and top (559 genes) 33% of active genes that have p300 binding in their proximal 
promoter (±100bp) or in the 20 kb surrounding region. Active genes were divided 
based on their expression fold change. 
 
To determine if there was more p300 binding (i.e. more normalised p300 
reads) in proximal promoters of active genes, the maximum p300 binding during 
the time series in the regions in the four categories was determined (Figure 26). 
Proximal promoters of the top 33% active genes have a maximum p300 binding 
45% higher than proximal promoters of inactive genes (p-value = 9.22e-12, 
Mann-Whitney U test). The difference between the three sets of active genes is 
small, with top vs middle 33% not being statistically significant and top vs bottom 
33% only representing a 6% increase in maximum p300 binding (p-value = 0.0045, 
Mann-Whitney U test). 
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Figure 26 – p300 occupancy at proximal promoters of genes with different 
transcriptional states. 
Boxplots of maximum p300 binding at proximal promoter regions of inactive, 
bottom, middle and top 33% active genes. *: p-value < 0.05; **: p-value < 0.01; 
***: p-value < 0.001. 
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4.3 p300 dynamics and nearest gene’s expression 
Pairing genes with their corresponding enhancers is a challenge, with 
numerous genes known to be regulated by enhancers at extremely long distances 
(e.g. shh enhancer 1 Mb away from the gene promoter (Lettice et al., 2003)). In this 
section, I describe an initial analysis by pairing p300 regions with their closest gene, 
to determine if there is any overall correlation. 
 
Genes were divided into three groups: genes with early (4052 p300 regions), 
mid (1804 p300 regions) or late (2997 p300 regions) p300 binding (based on the 
p300 dynamics calculated in the previous chapter – 3.2.2.8 – p300 binding is highly 
dynamic in early development). 
I set out to determine if a gene close to a region which is bound by p300 
during early time points is transcribed at early time points, and the same for genes 
near mid and late p300 regions. To analyse this, I first needed to calculate the net 
transcription rate for each gene from the Owens et al., 2016 data. 
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4.3.1 Net transcription rate 
As mentioned in this thesis Introduction, Owens and colleagues developed a 
method to calculate the absolute normalisation of the RNA-seq data (Owens et al., 
2016). This absolute normalised data then allows the calculation of net transcription 
rates, which represent the rate of active transcription minus the rate of transcript 
degradation (expressed in transcripts/min/embryo) using: 
𝑛𝑒𝑡 𝑡𝑟𝑎𝑛𝑠𝑐𝑟𝑖𝑝𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒 =
𝑑𝑔(𝑡)
𝑑𝑡
 
 
with g(t) describing the expression level of a gene at time t (calculated using 
the Gaussian process method described in the previous chapter). Figure 27 shows 
an example of a gene’s expression (nodal3.1) and its net transcription rate. 
 
 
Figure 27 – Net transcription rate. 
Nodal3.1 absolute transcript levels (red) and its net transcription rate (green). 
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The RNA-seq experiment described in Owens et al., 2016 was performed in 
a clutch with a division time during the cleavage stages of 20 minutes, while the 
long p300 ChIP-seq time series’ embryos had a division time of 18 minutes. To 
perform comparative analysis between these two time series, the times on the 
p300 data were adjusted by multiplying each time by 20/18 (a procedure used and 
validated in Collart et al, 2014 to align RNA-seq time series developing at different 
rates), e.g. the first time point was adjusted from 5 hpf to 5.56 hpf and the final time 
point from 17.5 hpf to 19.44 hpf. 
 
4.3.2 Active genes near early p300 binding are transcribed early on in the 
time series 
In order to determine if the presence of early, mid or late p300 binding 
determined the timing of the closest gene’s expression, I calculated the average 
normalised transcript level and the average net transcription rate, over the p300 
ChIP-seq time series period, of the genes closest to the p300 regions in each 
group of p300 binding dynamics – early, mid or late. This was done considering 1) 
top 33% active genes (186 early, 151 mid and 144 late); 2) middle 33% active 
genes (111 early, 107 mid and 112 late); 3) bottom 33% active genes (119 early, 
75 mid and 129 late); 4) inactive genes (2251 early, 884 mid and 1692 late). The 
number of genes in each group is lower than the total number of active/inactive 
genes as some are not the closest gene to any p300 region. 
The results are summarised on Figure 28. It first shows the average p300 
dynamics in the early, mid and late groups, for comparison. The top 33% active 
genes near p300 regions with early dynamics reach their maximum (plateau) 
earlier than genes near mid and late p300. This becomes more obvious when 
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analysing the net transcription rate: genes near early p300 regions have their 
maximum net transcription rate at around 6 hpf, while for genes near mid p300 
regions it peaks at around 10 hpf and for genes near late p300 regions at 15 hpf. 
This difference is less pronounced when analysing the middle 33% active genes 
and it is almost non-existent in the bottom 33% active genes. There is no significant 
difference for inactive genes, except that genes near late p300 regions have a 
higher net transcription rate at later time points. A possibility is that a subset of 
these genes are activated just after the end of the p300 time series and their net 
transcription rate is already increasing during those time points. 
 
Even with a naïve enhancer-gene pairing method, based only on genomic 
distance, it is possible to observe a relationship between p300 binding dynamics 
and gene expression, particularly for highly active genes. 
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Figure 28 – p300 and transcription dynamics. 
Average number of p300 normalised reads in early, mid and late p300 regions 
(normalised to 1). Average transcript levels (normalised to 1) and net transcription 
rates for top, middle and bottom 33% active genes, as well as for inactive genes, 
divided based on the dynamics of p300 binding to nearby candidate enhancers. 
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4.4 Promoter vs distal p300 
p300 is known to be involved in enhancer-promoter looping (Kim and Kim, 
2013, Guo et al., 2016), thus, I hypothesised that the dynamics of p300 binding to a 
promoter and to its corresponding enhancers should be similar, given that for an 
individual loop, the same p300 molecule will be localised close to both the 
enhancer and the promoter for the duration of the loop. 
In order to determine if p300 binding dynamics at proximal promoters and 
nearby candidate enhancers are similar, the Euclidean distance between the two 
curves was calculated. Euclidean distance (ED) represents the distance between 
the points of two curves, represented by the following equation: 
||𝑢 − 𝑣|| =  √(𝑢1 − 𝑣1)2 + (𝑢2 − 𝑣2)2 + ⋯ + (𝑢𝑛 − 𝑣𝑛)2 
with u and v representing each curve (normalised to their maxima) and n 
representing the number of points in each curve. The lower the ED, the more 
similar the two curves are. 
 
The ED between the p300 binding at proximal promoter regions and in every 
non-promoter p300 region in the surrounding 20 kb region (nearby p300 regions) 
was calculated, as well as between each proximal promoter region and random 
p300 regions (in a different chromosome) for comparison. As previously mentioned, 
enhancer-promoter looping can occur at much larger distances, however, using a 
20 kb region allows for an initial, less noisy, analysis. 
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The mean ED between p300 binding at proximal promoters of active genes 
and at nearby p300 regions is 3.51, 17% lower than the distance between random 
pairs (p-value = 3.08e-14, Mann-Whitney U test) (Figure 29).  
 
 
Figure 29 – Euclidean distances between p300 binding at proximal promoters 
and nearby p300 regions. 
Histograms and distribution curves representing the EDs between p300 binding at 
proximal promoters of active genes vs nearby candidate enhancers (blue) or 
random candidate enhancers from a different chromosome (red). 
 
These results show that p300 binding dynamics at proximal promoter 
regions are significantly more similar to the binding dynamics in nearby p300 
regions than to random candidate enhancers (on a different chromosome). Some 
of the random pairings also have low ED, thus they have similar dynamics. This will 
be addressed in this chapter’s discussion. 
Figure 30 shows an example of p300 binding at a proximal promoter region 
(green) and at three nearby candidate enhancers (in blue) with low ED, 
demonstrating how similar the dynamics are. It is also interesting to note how the 
four regions show the same p300 binding dynamics. 
  
Chapter 4 Results 
 
126 
 
 
Figure 30 – Example of correlated p300 dynamics. 
Example of p300 binding at a proximal promoter (P – green) and three nearby 
candidate enhancers (1, 2, 3 – blue). Genome browser view of the four regions and 
graphs of the p300 binding dynamics of each pair, with the corresponding ED. 
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4.5 p300 binding at promoters, transcript levels and net 
transcription rate 
In the previous section I have shown that p300 binding at proximal 
promoters correlates more closely with nearby candidate enhancers than with 
random p300 regions. Whereas enhancers do not always regulate the closest gene, 
the p300 binding in a gene’s promoter is likely to be involved in regulating that 
gene’s transcription. This allows the analysis of whether and how p300 binding 
correlates with transcription, without the confounding issues associated with pairing 
enhancers and genes. 
ChIP-seq measures how many cells in the embryo have a particular protein 
bound to a DNA sequence relative to all other DNA sequences. I hypothesised that 
the more cells have p300 involved in a specific enhancer-promoter looping, the 
more its target gene is expressed and therefore, the gene’s transcription rate 
should correlate with the p300 binding dynamics at the gene’s promoter. For 
sharply increasing active genes, the net transcription rate, described in section 
4.3.1 - Net transcription rate, should provide a reasonable approximation for the 
actual transcription rate. Moreover, I calculated a scale normalised Euclidean 
Distance between p300 regions and genes, asking whether to what extent the 
shapes of the curves match; this should partly abrogate the effect of not accounting 
for transcript degradation. 
To assess how similar p300 and transcription dynamics are, I calculated the 
ED between p300 binding at proximal promoters and both that gene’s absolute 
transcript levels over time and net transcription rate. 
p300 binding at active genes’ proximal promoters correlates better with 
genes’ transcript levels than expected at random (mean ED = 4.74, 22% lower than 
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for random pairs, p-value = 3.30e-28, Mann-Whitney U test) (Figure 31A), however 
the same is not the case for the genes’ net transcription rate (p-value = 0.075, 
Mann-Whitney U test) (Figure 31B). Furthermore, proximal promoter vs gene 
transcript levels ED is 54% lower than proximal promoter vs net transcription rate 
ED (mean ED = 4.74 vs 10.30, respectively, p-value = 2.91e-107, Mann-Whitney U 
test), demonstrating that proximal promoter p300 binding profiles correlates better 
with gene transcript levels than with net transcription rates. 
 
 
Figure 31 – Euclidean distances between p300 binding at proximal promoters 
and gene transcription levels/net transcription rate. 
Histograms and distribution curves representing the ED between p300 binding at 
proximal promoters vs A – Gene’s absolute transcript levels over time (blue), or B – 
Gene’s net transcription rate (blue). Comparison with p300 binding at random 
proximal promoters in a different chromosome are represented in red. 
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These results fail to support the initial hypothesis that p300 binding at 
proximal promoters should correlate with the net transcription rate of the 
corresponding gene.  
Figure 32 shows examples of p300 binding in proximal promoters (green) 
and the corresponding gene’s transcript levels over time (red) with low ED, showing 
how similar their profiles are. 
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Figure 32 – Highly correlated p300 binding at proximal promoter and gene 
transcript levels. 
Examples of p300 binding at a proximal promoter (green), the corresponding 
gene’s transcript levels (red) and the pair’s ED. 
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4.6 Candidate enhancers – gene pairing 
In the previous two sections it was shown that there is correlation between 
both the dynamics of p300 binding at proximal promoters and nearby candidate 
enhancers and the dynamics of p300 binding at proximal promoters and the 
corresponding gene’s transcript levels over time. The promoter-candidate enhancer 
analysis alone cannot predict candidate enhancer-gene pairings, as there may be 
cases where that correlation is high but that the p300 promoter-gene correlation is 
not. In such cases, it is possible that those genes are either not regulated by 
p300-mediated looping or that other events must occur before transcription begins. 
I hypothesised that enhancer-gene pairs could be predicted based on both 
analyses: If the p300 binding at a candidate enhancer correlates well with the 
binding at a gene promoter and the binding at a gene promoter correlates well with 
the gene’s transcript levels, I would predict that that candidate enhancer has a 
higher likelihood of regulating that gene. 
To this end, I developed a method to predict candidate enhancer-gene pairs, 
by calculating the Sum of Euclidean Distances (SED). The EDs calculated in the 
two previous sections (candidate enhancer-proximal promoter and proximal 
promoter-gene) were added, to reach a SED score for each candidate 
enhancer-gene pair in a 200 kb region (distance can be adjusted). In summary: 
𝑆𝑢𝑚 𝐸𝑢𝑐𝑙𝑖𝑑𝑒𝑎𝑛 𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒𝑠(𝑆𝐸𝐷)𝐸−𝐺 = 𝐸𝐷𝑃−𝐸 + 𝐸𝐷𝑃−𝐺 
with ED representing Euclidean distance, P the p300 binding at the proximal 
promoter of active genes, E the p300 binding at candidate enhancers and G the 
corresponding gene’s transcript levels. Lower SED scores indicate higher 
correlation. 
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For each active gene with p300 binding in its proximal promoter (311 genes), 
the candidate enhancer with the lowest SED score was predicted as the gene’s 
corresponding enhancer (7.1 – Appendix 1 – Predicted enhancer-gene pairs). This 
method can also be used to predict several enhancers for the same gene and order 
them by their score. 
 
From these 311 active genes with p300 binding in their proximal promoter, 
242 have three or more candidate enhancer regions in the 200 kb surrounding 
region. The closest candidate enhancer is the best match only for 25% of these 
genes, while 28% of the genes have their best match on the 2nd or 3rd closest 
candidate enhancer. This means that for almost half of the genes (47%) their best 
candidate enhancer match is the 4th closest or further.  
As an example of this, Xetro.A01863 and the six candidate enhancer 
regions in a 170 kb region are shown on Figure 33, as well as the gene’s RNA 
abundance, the p300 binding dynamics in its proximal promoter and in the six 
candidate enhancers. The most well correlated region is the 5th one (ordered by 
increasing distance), located at 43 kb, in an intron of a nearby gene. 
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Figure 33 – Candidate enhancer-gene prediction over different genomic 
distances. 
Example of a distant p300 region correlating better with a gene transcription that 
nearby ones. Schematic representation of the locus, with the several genes and 
candidate enhancers. Graphs with Xetro.A01563’s expression, p300 binding in its 
proximal promoter and in six candidate enhancers (CE), with the SED score for 
each trio. Graphs ordered by increasing SED. Candidate enhancers ordered by 
increasing distance to the Xetro.A01563 proximal promoter. 
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4.6.1 Method testing 
Nakamura and colleagues identified Wnt8a enhancers (enhancers bound by 
Wnt8a) and their target genes, in gastrula X. tropicalis embryos, by a combination 
of β-catenin ChIP-seq and Wnt8a morpholino knockdown, followed by RNA-seq 
(Nakamura et al., 2016). They tested the ability of seven of these predicted 
enhancer regions to drive gene expression by luciferase assay; four of the regions 
were positive and three were negative. This provided a small set of regions to 
validate the corresponding candidate enhancer-gene prediction method described 
in the previous section. 
Table 10 summarises the tested regions and the results. The target genes 
for these candidate enhancers were cdx2, cdx4, hoxa1, hoxd1 and msx1. Hoxa1 
(region 4) and hoxd1 (regions 8 and 9) do not have detectable p300 binding at their 
proximal promoter regions, therefore they could not be analysed with the SED 
method, which requires p300 binding at the proximal promoter. Two of the seven 
tested regions were composed of two β-catenin ChIP-seq peaks (2 + 3 and 5 + 6); 
region 6 did not have a corresponding p300 region, therefore it was not analysed. 
After excluding those regions, the SED was calculated for regions 1, 2, 3, 5 and 7. 
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Table 10 – Regions for candidate enhancer-gene pairing method testing. 
Nine β-catenin regions from Nakamura et al., 2016 tested as Wnt8a target 
enhancers, their genomic location, distance to target gene and luciferase assay 
result. These regions were searched for corresponding p300 regions and the SED 
score between the p300 binding dynamics at those enhancers and the target 
promoter and the corresponding gene’s expression was calculated. Regions 
without p300 binding or that the corresponding promoter does not have p300 
binding were excluded from the analysis. 
 
Regions 1 and 5, which tested positive in the luciferase assay, had the 
lowest SED of the five regions (5.48 and 4.28 respectively, compared to 8.79, 8.94 
and 5.79 for 2, 3 and 7, respectively, which tested negative). 
Figure 34 shows the p300 binding profile at each of the five regions as well 
as the p300 binding at the target proximal promoter and the target gene’s RNA 
abundance. The three profiles (gene, proximal promoter and candidate enhancer) 
are very similar for 1 and 5 (positive regions), as well as for 7, which tested 
negative in the luciferase assay, however it had a relatively low SED (high 
correlation). For both regions with high SED (2 and 3 – negative regions), the p300 
binding dynamics at the candidate enhancer region are actually similar to the 
gene’s expression dynamics. What increases the SED is the p300 binding at the 
proximal promoter, which is not similar to either the p300 at candidate enhancer or 
to the gene’s expression. Given that these regions tested negative in the luciferase 
assay, it reflects the importance of including the dynamics in enhancers, promoters 
and genes in their method, to exclude candidates in cases where one of the 
dynamics does not match. At least in these examples, if the proximal promoter 
dynamics were not included, these candidate enhancers would correlate well with 
the gene, however it was experimentally demonstrated that these are likely not 
enhancer regions. 
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Even though five regions are a very small sample, the method yields lower 
scores for the two positive regions and higher scores for the three negative regions 
which is a positive indication that this method has good potential. It would be 
interesting to perform further testing to validate the method. 
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Figure 34 – Candidate enhancer-gene method testing. 
p300 binding dynamics (blue) at the five tested enhancers (from Nakamura et al., 
2016) and the binding in the corresponding proximal promoter (green) and target 
gene’s expression (red).  
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4.7 p300 and eRNA dynamics 
Enhancer RNAs were first discovered in 2010 (Kim et al., 2010) and since 
then several studies have showed that they are involved in transcriptional 
regulation (Mousavi et al., 2013, Iott et al., 2014, Schaukowitch et al., 2014). In this 
section I took advantage of the p300 and mRNA temporal data to evaluate eRNAs 
at the list of candidate enhancer regions generated in Chapter 3. 
 
A set of candidate enhancers was selected, by taking all intergenic p300 
regions (9,149 regions) and excluding those with H3K4me3 (based on the Hontelez 
et al., 2015 data), a promoter mark, to minimise the risk of including regions in 
unannotated promoters, leaving 5,847 regions (64%). The number of RNA-seq 
reads from the raw data from Owens et al., 2016, both from the ribosome-depleted 
and poly(A)-selected RNA-seq data, were counted and the previously described 
Gaussian process was applied to each region. To allow for detection of eRNAs 
independent of their polyadenylation status I focused on the ribosome-depleted 
data. Results were similar for the poly(A)-selected data (data not shown). 
Regions that had less than, on average, 1 read per time point were excluded, 
with 1625 regions remaining (18% of the p300 regions). Kim and colleagues 
reported that 25% of candidate enhancers are transcribed into eRNAs, therefore, 
the resulting number of regions from this project’s data is close to the expected. 
Hereafter, I will refer to RNAs expressed from candidate enhancer regions as 
eRNAs, however, some may actually represent unannotated gene regions. 
The ED between the eRNA expression profile and the p300 dynamics for 
each region was calculated, as well as between eRNA and a random p300 region. 
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The ED between eRNAs and nearby genes (between 1 and 20 kb away – ensuring 
that eRNAs did not overlap annotated gene regions) was also calculated. 
 
 
Figure 35 – Euclidean distances between eRNA expression and p300 
binding/gene expression. 
Histograms and distribution curves representing the EDs between 
ribosome-depleted RNA-seq reads in intergenic non-H3K4me3 p300 regions 
(eRNAs) and A – p300 binding at those same regions, B – Transcription levels for 
nearby genes. In red are the same comparisons but with random p300 
regions/genes from a different chromosome.  
 
eRNAs expression dynamics correlate well with both p300 binding dynamics 
in the same region (mean ED = 4.72) and with nearby gene expression 
(mean ED = 3.92) and, for both comparisons, it correlated better than with 
randomly assigned candidate enhancers/genes (27% decrease in mean ED for 
both, p-value = 6.46e-95 and 9.37e-82, respectively, Mann-Whitney U test). Figure 
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36 shows examples of four candidate enhancer regions, with the p300 binding and 
eRNA expression dynamics in each region. Regions 1 and 2 are 19 and 43 kb 
upstream of the nearest gene, respectively. Regions 3 and 4 are 267 and 25 kb 
downstream of the nearest gene, respectively. 
It is interesting to note that the eRNA in region 4 is present from fertilisation. 
This could indicate that there are maternally deposited eRNAs, or that these are 
either inside unannotated genes or that the nearest gene’s model is incorrect. The 
nearest gene to this region is prr16 (25kb upstream of the eRNA), which is not 
present at fertilisation, therefore, at least in this case, the latter is not a likely option. 
Overall, 9.5% (154 out of 1625) of eRNAs have their maximum at 
fertilisation. To my knowledge, maternally deposited eRNAs have never been 
reported, and it would be interesting to verify if these RNAs are indeed eRNAs. 
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Figure 36 – eRNA and p300 binding dynamics. 
Examples of p300 binding dynamics (blue) and eRNA expression (black) in four 
candidate enhancer regions, as well as each pair’s ED. 
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Figure 37 – eRNA and nearby gene expression. 
Examples of eRNAs (black) and nearby genes’ expression (red), as well as each 
pair’s ED and the genomic distance between the two regions.  
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Figure 37 shows examples of eRNAs and nearby genes’ expression. On 
average, eRNA expression correlates better with gene expression than with p300 
binding (17% decrease in mean ED, p-value = 6.34e-26, Mann-Whitney U test), 
which would make eRNA dynamics a very interesting method to explore 
enhancer-gene pairs. However, this analysis is beyond the scope of this thesis. 
There are several factors confounding that complicate this eRNA analysis, 
including unannotated genes and other non-coding RNAs, poor gene models or 
alternate promoters. 
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4.8 Discussion 
In this chapter I have described the relationship between p300 binding and 
gene transcription. I showed that the more transcriptionally active a gene is (higher 
expression level fold change), the more likely it is to have p300 binding nearby and 
that the binding itself is higher (more normalised ChIP-seq reads), showing a 
correlation between p300 binding and transcriptional activity.  
On average, the net transcription rates of active genes match the timing of 
nearby p300 dynamics, with genes near early p300 regions being active at early 
time points, near mid p300 regions at the middle of the time series and near late 
p300 regions at late time points. This shows that, on a genome-wide average, a 
gene’s transcription correlates with nearby p300 binding dynamics. 
I then set out to determine if p300 binding dynamics at promoters and 
nearby (<20 kb) candidate enhancers correlate. Not all possible enhancer-promoter 
combinations within a 20 kb region will be part of a DNA loop interaction. The 
hypothesis was that it would correlate better than random pairings, as 20 kb 
interactions will be considerably more likely than interchromosomal ones. Therefore, 
it was expected that several nearby candidate enhancer-proximal promoter pairs 
would have low correlation scores (high EDs), however that on average they would 
be more correlated than random pairs. The analysis showed that, indeed, p300 
binding dynamics at proximal promoters and at nearby candidate enhancers 
correlate well, and significantly better than if the proximal promoters are randomly 
paired with candidate enhancers in a different chromosome. This supports the 
model of p300 being involved in enhancer-promoter looping, due to the binding 
dynamics being similar on these paired regions. 
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Multiple candidate enhancers in the same loci may have the same p300 
binding dynamics. This may represent a complex DNA-loop structure, with multiple 
enhancers interacting with the same promoter simultaneously, or each enhancer 
may be responsible for regulating transcription in different tissues. My data cannot 
answer this, but it would be interesting to perform p300 ChIP-seq on different 
tissues to clarify which of the two are responsible for the overall result. 
I then set out to determine if p300 binding dynamics at proximal promoters 
also correlated well with the transcription of the corresponding gene. This would 
only be expected if looping is maintained during transcription, otherwise p300 
binding would only correlate with the timing of transcription activation. p300 binding 
dynamics at proximal promoters does correlate with transcript levels, however not 
with the gene’s net transcription rate. I had hypothesised that the more cells have 
p300 binding at a given promoter, the more that gene is transcribed (i.e. higher net 
transcription rate). p300 dynamics may not be an instantaneous indicator of 
transcription rate, due to the time required for, for example, RNAPII recruitment and 
release into the gene body. Another possible confounding factor is that net 
transcription rate describes active transcription rate minus mRNA degradation rate, 
however the ratio between the two is unknown and likely to vary between different 
genes and over time, as a gene is activated and builds up transcripts. Other 
methods which can be used to estimate transcription rates include measuring 
intronic reads in RNA-seq data (Madsen et al., 2015); RNAPII ChIP-seq time series 
(Maina et al., 2014); sequencing nascent RNA (GRO-seq) (Core et al., 2008, 
Jonkers et al., 2014); and sequencing chemically labelled RNA, for example with 
bromouridine (Veloso et al., 2014, Roberts et al., 2015). 
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Predicting which candidate enhancer regulates which gene’s expression is 
not a straightforward task. This can be done experimentally for a small number of 
pairs, for example by 3C or 4C, and then validating the predicted regions by 
deleting them, for example by CRISPR-Cas9, however, it is not feasible to attempt 
it genome-wide. Making use of the high-resolution p300 binding data and the 
previously published high-resolution absolute RNA-seq data (Owens et al., 2016), I 
attempted to computationally assign candidate enhancers to their corresponding 
genes. Having shown that p300 binding at proximal promoters and at nearby 
candidate enhancers and gene transcription correlate well, and importantly, better 
than randomly assigned pairs, I used this information to predict which candidate 
enhancer regulates which gene. 
The developed method – Sum of Euclidean Distances (SED) – adds the 
proximal promoter-candidate enhancer ED and the proximal promoter-gene ED, to 
generate a score for each candidate enhancer-gene pair within 100 kb of each 
other (the lower the score, the more correlated the pair is). 
This method can be applied to very large distances, to discover candidate 
enhancers with a high correlation with a specific gene. The downside of scanning 
large regions is that the number of false positives will likely increase. This tool can 
be used by investigators to filter which enhancers to test experimentally. 
According to this candidate enhancer-gene pairing prediction method, the 
closest candidate enhancer regulates only 25% of genes. Notably, this is in 
contrast to most annotation software that attributes candidate enhancer regions to 
the closest gene. 
This method was tested against a small set of published enhancer-gene 
pairs, with 100% accuracy. The set size (five pairs) was very small and further 
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testing is necessary, however hardly any enhancer targets have been validated in 
X. tropicalis so far. 
 
The SED method has some limitations, namely: 
1. In cases where more than one enhancer regulates one promoter at 
different time points, it would not be expected that their binding 
dynamics would match perfectly, due to each enhancer contributing 
to part of the p300 promoter binding. Each enhancer would seem to 
partially correlate with the promoter, however none would have a 
perfect score. This is consistent with the finding from the previous 
chapter that p300 binding at promoters is less dynamic than at 
candidate enhancers. If the p300 binding at a promoter is 
approximately the sum of the p300 binding at the different enhancers, 
the promoter would be bound for longer periods. This could be 
tackled by calculating the ED for shorter time intervals instead of 
calculating the score for the whole time series, or by searching for 
trios of enhancer-enhancer-promoter, where the sum of the two 
enhancers correlates with the promoter. 
2. Part of the random pairings are also well correlated (low ED), both 
when comparing promoter-candidate enhancer and promoter-gene. 
During early development, several genes and enhancers are 
activated by the same developmental processes, therefore it would 
be expected to find random pairs that correlate well, simply because 
the same cellular process is activating both at the same time. This 
will lead to some false positives, however this analyses showed that, 
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in general, the randomly generated pairs have significantly worse 
scores. 
3. A candidate enhancer with extremely low ED (well correlated) with a 
proximal promoter could potentially be predicted as regulating a gene 
even if the proximal promoter-gene ED was very high (not correlated), 
due to the former being so low that the sum would be a relatively low 
value. This issue could be tackled by setting a minimum threshold for 
both EDs (candidate enhancer-proximal promoter and proximal 
promoter-gene) in order to predict an enhancer-gene pair. 
4. Finally, only enhancer-gene pairs regulated by p300-mediated 
looping will be predicted with this method. As mentioned in the 
introduction, not all genes require p300 to be transcribed, therefore it 
would not be expected that all genes will correlate well with the p300 
at its promoter. 
 
I have also shown that RNA-seq reads from candidate enhancer regions, 
potential eRNAs, correlate well with both p300 binding in the same location and 
with nearby gene expression. If these RNAs are indeed eRNAs and not 
unannotated genes or due to incorrect gene models, this would be an interesting 
area to study further in an attempt to predict enhancer-gene pairs, by finding pairs 
with high eRNA-RNA correlation. 
To my knowledge, this is the first time potential eRNAs are reported in 
Xenopus. Almost 10% of these RNAs are present from fertilisation, suggesting that 
they may be maternally deposited. As previously mentioned, there are several 
confounding factors for this analysis, which could be resolved in future studies. 
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In summary, I showed that p300 binding at candidate enhancers and 
proximal promoters correlates well, in addition to p300 binding at proximal 
promoters and that gene’s expression. Using this information, I developed a 
candidate enhancer-gene pairing method and generated a list of most likely pairs 
for genes active during the times assayed in this work (7.1 – Appendix 1 – 
Predicted enhancer-gene pairs). 
Chapter 5. Results 
 
152 
 
Chapter 5. p300 in Xenopus development 
5.1 Introduction 
The aim of the analysis described in this chapter was to investigate p300 
binding in the context of X. tropicalis embryo development, to better understand the 
processes in which p300 is involved and to explore whether the dynamic data 
generated in this project can help predict candidate target genes for different 
transcription factors. I performed differential motif binding analysis, to determine 
which motifs are enriched in p300 regions active at different developmental stages. 
 
Xenopus development has been extensively reviewed (for example Hausen 
and Riebesell, 1991, Nieuwkoop and Faber, 1994, Wolpert, 2011). Very briefly, 
Xenopus development starts with external fertilisation followed by 12 rapid and 
synchronous cell divisions, with low levels of zygotic transcription. After the 12th cell 
division (between stage 8 and 9), the Mid-Blastula Transition (MBT) occurs: the cell 
cycle desynchronises and lengthens, and cells become motile. The blastula stages 
comprise the period before the MBT, as well as a short time period post-MBT prior 
to gastrulation. At around stage 10, gastrulation starts and cells reorganise to 
establish the animal body plan, giving rise to the three germ layers: 
1. Ectoderm – Precursor of the nervous system and epidermis 
2. Mesoderm – Precursor of tissues such as bone, gonads, kidney and 
muscle and the circulatory system 
3. Endoderm – Precursor of organs such as the digestive and 
respiratory systems organs 
At around stage 13 neurulation starts. Several tissues develop and 
differentiate during these stages, the most prominent of these developmental 
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processes being neurogenesis, ending with the closure of the neural tube at stage 
20. 
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5.2 p300 differential motif binding 
p300 interacts with multiple transcription factors at enhancers, therefore 
motif analysis on p300 binding regions should yield a variety of motifs. I 
hypothesised that at early time points p300 should associate with motifs for 
maternally deposited transcription factors and later in development with motifs for 
zygotically transcribed transcription factors. 
I performed differential motif analysis, to determine which transcription factor 
motifs are more associated with p300 occupancy at different developmental stages, 
using Gimmemotifs maelstrom (van Heeringen and Veenstra, 2011). This program 
combines the outcome of different statistical tests, regression and classification 
methods to calculate the association between transcription factor motifs and p300 
occupancy in each time point and the resulting values represent the –log10(p-value) 
of the rank aggregation. A high value means that the motif is predicted to be 
positively associated with p300 binding for that time point. For example, Figure 38 
shows high values for the Foxh motif in the first hour and a half of the time series, 
this means that p300 regions with this motif are more likely to have a high p300 
read count in early time points and low read count in late time points. 
Motifs for transcription factors not identified in Xenopus were excluded and 
the 10 transcription factor motifs with the highest differential association with p300 
were selected for further analysis (Table 11 and Figure 38). 
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 Motif Name 
Transcription 
factor family 
Motif 
1 Forkhead_M2151_1.01 Foxh 
 
2 
Homeodomain_POU 
Average_47 
Pou 
 
3 
Homeodomain_POU 
Average_43 
Pou 
 
4 
Homeodomain_POU 
Average_32 
Pou 
 
5 Sox_Average_66 Sox 
 
6 C2H2_ZF_Average_172 Zic 
 
7 Sox_Average_97 Tcf7/Lef 
 
8 GATA_Average_32 Gata 
 
9 Unknown_M3387_1.01 Lmo 
 
10 Grainyhead_M5316_1.01 Grhl 
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Table 11 – Motifs with highest differential association with p300 binding. 
Motif names, transcription factor family and motif logos from (Hontelez et al., 2015), 
based on (Weirauch et al., 2014). 
 
 
 
Figure 38 - p300 differential motif binding at different developmental stages. 
A high value (red) indicates that regions with that motif have higher than average 
p300 reads at that time point. 
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The three Pou motifs are very similar, although motif 2, which has the 
strongest association with p300 of the three, is also the more degenerate. The 
Gata and Lmo motif are nearly identical (Table 11). These two sets of motifs were 
then analysed as a whole (the three Pou motifs as one and the Gata and Lmo as 
another). 
In order to predict which transcription factors that bind to a given motif are 
more likely to be associated with p300, the time dependent behaviour of each motif 
was compared to the expression profile of the genes which encode the 
corresponding transcription factors, using the data from Owens et al., 2016. 
A transcription factor can be present in the embryo either by being 
maternally deposited in the form of mRNA and/or protein or by being zygotically 
transcribed. The Owens et al., 2016 data describes the mRNAs that are present in 
the embryo, however, to determine if a transcription factor protein is maternally 
deposited it is necessary to analyse proteome data. There is no available data on 
the X. tropicalis proteome, so I searched the closely related X. laevis proteome to 
determine whether a protein was likely to be present in the egg. The catalogue by 
Wuhr and colleagues is by far the most extensive dataset available, they identified 
more than 11,000 proteins in the X. laevis egg (Wuhr et al., 2014). Other studies 
have much lower yields – 5,800 (Smits et al., 2014), 4,000 (Sun et al., 2014) and 
1,400 (Sun et al., 2016) proteins. The absence of a protein in the Wuhr and 
colleagues data does not mean the protein is not present in the egg, only that it is 
under the detection limit. 
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5.2.1 Foxh motif 
Foxh (forkhead box H, or Fast – forkhead activin signal transducer) motif is 
highly positively associated with p300 binding for the first 1.5 hours of the time 
series, which corresponds to the end of the blastula stages. Foxh1 mRNA is 
maternally deposited and its zygotic transcription starts at around 3 hpf. Its 
expression starts decreasing sharply at around 5 hpf, with a second activation 
event at around 9 hpf. Foxh1.2 mRNA was not detected in the oocyte and starts 
being transcribed at 4 hpf, however its expression levels are almost 20 times lower 
than foxh1 (Figure 39). Foxh1 and Foxh1.2 were not detected in the X.laevis 
proteome data. Due to their expression profiles, Foxh1 is the most likely candidate 
to be associated with p300 at these early time points, given that foxh1.2 starts 
being transcribed just before the start of the p300 time series. Foxh motif-p300 
association has its maximum at the first time point of the time series, therefore they 
are likely associated for some time before that, even though the data cannot 
confirm that. 
 
Figure 39 – Foxh1 and foxh1.2 RNA abundance and their motif association with 
p300 over time. 
Dashed line indicates that that transcription factor is unlikely to be associated with 
p300, due to its RNA abundance over time not matching the p300 association 
timings. RNA abundance data from Owens et al., 2016. 
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Foxh1 is a member of the winged helix transcription factor family and it is 
necessary for the early stages of mesoderm specification and also to activate a 
number of endodermal genes (Chen et al., 1996, Watanabe and Whitman, 1999). 
Chen and colleagues identified Foxh1 as an interaction partner of Smads in 
Xenopus, being involved in TGFβ (Transforming growth factor β) signalling (Chen 
et al., 1996). Foxh1 is not able to drive transcription on its own (Chen et al., 1996), 
however, in the presence of TGFβ signalling, Smad2/Smad4 are translocated to 
the nucleus, binds Foxh1 and the complex is able to activate transcription (Chen et 
al., 1997, Liu et al., 1997). p300 is known to bind and acetylate Smads, which is 
required for Smad-mediated transcription (Ross et al., 2006, Inoue et al., 2007). 
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5.2.2 Pou motif 
Three Pou motifs are positively associated with p300 binding during the first 
2.5 hours of the p300 ChIP-seq time series, which corresponds to the end of the 
blastula stage and start of gastrulation. The three motifs are very similar, therefore 
they were analysed together. 
There are 18 pou genes identified in X. tropicalis, however the only with 
maternally deposited mRNA are pou2f1, pou5f3.2 and pou5f3.3 (Figure 40). In the 
X. laevis proteome data, only Pou2f1 was detected at fertilization. Pou5f3.1 is 
activated at 4 hpf, while the other members of the family are only expressed after 
around 10 hpf (Figure 40). 
Pou5f3.2 and Pou5f3.3 are the most likely candidates to be associated with 
p300 binding at these stages, due to their expression profiles matching the period 
of high association with p300. However, Pou5f3.1 and Pou2f1 cannot be excluded 
given that they are present in the embryo at those times. Their expression peaks at 
later time points (11 and 18 hpf, respectively), however they may still associate with 
p300 at earlier times and lose their association due to other factors, such as a 
potential loss of a necessary cofactor at later stages. 
Not much is known about Pou2f1 function in Xenopus development; there 
are indications that it may be involved in neural development (Veenstra et al., 
1995) and specifically in radial glia formation (Kiyota et al., 2008), however these 
cells are only identified after stage 23 (Messenger and Warner, 1989) and this 
protein is maternally deposited, thus it may have a still unknown role in the early 
stages of development. Pou5f3.1, Pou5f3.2 and Pou5f3.3 are involved in 
maintaining cell pluripotency during gastrulation (Cao et al., 2004, Cao et al., 2006, 
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Morrison and Brickman, 2006, Nishitani et al., 2015). p300 is known to colocalise 
with Pou5f3.1 in enhancer regions (Chen et al., 2008). 
 
 
Figure 40 – Pou RNA abundance and their three motifs’ association with p300 
over time. 
Dashed lines indicates that that transcription factor is unlikely to be associated with 
p300, due to its RNA abundance over time not matching the p300 association 
timings. Genes ordered by expression levels. RNA abundance data from Owens et 
al., 2016. 
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5.2.3 Sox motif 
The Sox (SRY-box) motif is associated with p300 binding during the first 3 
hours of the time series, corresponding to the end of the blastula stages and the 
start of gastrulation. From the Sox family of HMG (high mobility group)-box 
transcription factors, sox3, sox7, sox11 and sox13, and low levels of sox4 and sox9, 
mRNAs are maternally deposited, with some members of the family being 
transcriptionally activated before 5 hpf (Figure 41). Sox3 and Sox13 proteins are 
maternally deposited in X. laevis embryos.  
For the reasons explained in 5.2.2 – Pou motif, the most likely candidates to 
be associated with p300 binding in regions with the Sox motif at these stages are 
Sox3, Sox7, Sox11 and Sox17b, however Sox2, Sox13 and Sox17a cannot be 
excluded. 
Most Sox proteins are involved in neural development, however some 
members of the family are also involved in early embryo patterning and axis 
formation. Some examples are Sox3 and Sox7’s functions in early development. 
Sox3, the gene with the highest maternal contribution, regulates dorsal axis 
formation (Zhang et al., 2003) and activates sox2 transcription (Rogers et al., 2009). 
Sox7, also maternally deposited, is known to activate some of the earliest zygotic 
genes, such as the nodals and mixer, involved in mesoendoderm development 
(Zhang et al., 2005). At least Sox2 and Sox4 are known to interact with p300 to 
activate transcription (Nowling et al., 2003, Inoue et al., 2016). 
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Figure 41 – Sox RNA abundance and their motif association with p300 over time. 
Dashed lines indicates that that transcription factor is unlikely to be associated with 
p300, due to its RNA abundance over time not matching the p300 association 
timings. Genes ordered by expression levels. RNA abundance data from Owens et 
al., 2016. 
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5.2.4 Zic motif 
The Zic motif is associated with p300 binding during gastrulation, from about 
7 to 15 hpf, with a maximum association at around 10 hpf, which mainly 
corresponds to gastrulation. Zic2 mRNA is maternally deposited (as well as low 
levels of zic5), while the other members of the family are activated at around 4 hpf. 
Zic5 has a second wave of activation at about 8 hpf (Figure 42). No Zic proteins 
were found in the X. laevis egg.  
Zic1 and Zic3’s expression are the most consistent with the association with 
p300, making them the most likely candidates, however none of the other Zic 
proteins can be excluded. 
 
 
Figure 42 – Zic RNA abundance and their motif association with p300 over time. 
Genes ordered by RNA abundance. RNA abundance data from Owens et al., 2016. 
 
These proteins are involved in inducing neuroectoderm and in regulating 
neural crest formation during neurulation (Nakata et al., 1997, Kuo et al., 1998, 
Nakata et al., 1998, Kitaguchi et al., 2000, Fujimi et al., 2006). As far as I am aware, 
there are no reported studies showing Zic-p300 interactions.  
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5.2.5 Tcf7/Lef1 motif 
The Tcf7/Lef1 (T-cell factor/lymphoid enhancer factor) motif is positively 
associated with p300 binding for a short time window from 10 to 13 hpf, at the end 
of gastrulation. 
Tcf7l1 and tcf7 mRNAs are present in the oocyte, lef1 is activated very early, 
at about 3 hpf, and tcf7l2 at 13 hpf (Figure 43). Only Tcf7l1 protein was identified in 
the egg. Due to their presence in the embryo before 10 hpf, Tcf7, Tcf7l1 and Lef1 
are the most likely members of the family to be interacting with p300 during this 
time interval, however none of their expression profiles peak during the 
high-association period. There may be necessary cofactors which are only present 
in this short time window that leads to the high p300 interaction, however my data 
cannot answer this. 
 
 
Figure 43 – Tcf/lef RNA abundance and their motif association with p300 over 
time. 
Dashed line indicates that that transcription factor is unlikely to be associated with 
p300, due to its RNA abundance over time not matching the p300 association 
timings. Genes ordered by expression levels. RNA abundance data from Owens et 
al., 2016. 
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Tcf/Lef are HMG box transcription factors involved in Wnt signalling and can 
either activate or repress transcription. Lef1 is involved in mesoderm and ectoderm 
patterning during gastrulation (Roel et al., 2002, Roel et al., 2009); Tcf7 and Tcf7l1 
are necessary for mesoderm induction (Liu et al., 2005) and the latter is also 
involved in the establishment of the dorsal axis (Roel et al., 2002). These 
transcription factors activate gene transcription by interacting with β-catenin, which 
in turn recruits co-activators, such as p300/CBP (Sun et al., 2000, Wolf et al., 2002, 
Ma et al., 2005), which has also been shown in Xenopus (Hecht et al., 2000, 
Takemaru and Moon, 2000). 
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5.2.6 Gata/Lmo motif 
The Gata motif is associated with p300 binding during a short time window, 
between 11 and 13 hpf, corresponding to the end of gastrulation and beginning of 
neurulation. The Lmo (LIM domain only) motif is associated with p300 binding from 
10 to 18 hpf, with the maximum association occurring between 11 and 15 hpf, 
corresponding to the end of gastrulation and neurulation. The two motifs are 
extremely similar, however their p300 association times have interesting 
differences. They both peak at around 13 hpf, however the Lmo motif association is 
present during a longer time interval. 
Lmo4.1, lmo4.2 and lmo7 are maternally deposited, as well as gata5 and 
gata6, although at much lower levels. No Gata or Lmo protein was detected in the 
oocyte. From all the transcription factors in this families, only Gata1 can be 
excluded from interacting with p300 at these times, given that it is only activated at 
around 18 hpf, however the most likely candidates are Lmo2, Lmo4.1, Lmo4.2 and 
Gata2. 
Lmo4 has been shown to be a cofactor for GATA proteins, involved in 
ventral mesoderm specification (de la Calle-Mustienes et al., 2003), which gives 
rise to, among other tissues, hematopoietic cells (Davidson and Zon, 2000). 
Gata2 and Gata3 are involved in the segmentation of non-neural ectoderm  
(Read et al., 1998) and, as well as Lmo2, in early hematopoietic cells specification  
(Ting et al., 1996, Tsai and Orkin, 1997, Mead et al., 2001), which starts in the late 
gastrula/early nerula stages (Zon, 1995). Gata4, Gata5 and Gata6 are involved in 
heart (Jiang and Evans, 1996, Gove et al., 1997, Kuo et al., 1997, Nemer et al., 
1999) and gut development (Arceci et al., 1993, Gao et al., 1998, Weber et al., 
2000). Lmo7’s function has not been studied in Xenopus. 
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Figure 44 – Gata and lmo RNA abundance and their motif association with p300 
over time. 
Dashed line indicates that that transcription factor is unlikely to be associated with 
p300, due to its RNA abundance over time not matching the p300 association 
timings. Genes ordered by expression levels. RNA abundance data from Owens et 
al., 2016. 
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5.2.7 Grhl motif 
The Grhl (Grainyhead-like) motif is highly associated with p300 binding in 
the final 3.5 hours of the time series, already during neurulation. Grhl1 mRNA and 
protein is present in the fertilised oocyte, however its levels start decreasing 
immediately, with zygotic transcription of this gene starting at around 8 hpf. Grhl2 
and grhl3 are activated at around 8 and 4 hpf, respectively (Figure 45). None of 
these genes show a peak in expression during the timing of high p300-association, 
however the three mRNAs are present and are potential candidates for p300 
interaction. 
 
Figure 45 – Grhl1 RNA abundance and its motif association with p300 over time. 
RNA abundance data from Owens et al., 2016. 
 
Grhl1 and Grhl3 regulate epidermis differentiation as part of the BMP4 
(Bone morphogenetic protein 4) signalling pathway (Tao et al., 2005), which is 
known to be involved in stimulating epidermis differentiation and inhibiting neural 
specification (Wilson and Hemmati-Brivanlou, 1995). Grhl2’s function has not been 
assessed in Xenopus. 
Suprisingly, all members of this family have been reported as 
p300-inhibitors, by inhibiting its HAT activity and p300’s ability to interact with other 
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proteins (Pifer et al., 2016). Even though my data cannot shed light on this, it is 
possible that, given that these mRNAs are present at such high levels in early 
development, particularly grhl1, which is maternally deposited, their proteins may 
be inhibiting p300 from binding to these regions. An interesting possibility is that 
they may, then, not be bound at the later time points when p300 is recruited by 
another transcription factor present in the same enhancers. Further work would be 
required to evaluate this hypothesis. 
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5.2.8 p300 differential motif binding summary 
p300 appears to bind different transcription factors at different 
developmental stages and those transcription factors are involved in very diverse 
developmental processes. For most of the motifs associated with p300 binding, the 
association timings are highly concordant with the transcription dynamics of certain 
members of the corresponding transcription factor family. 
p300 appears likely to be involved in the early stages of mesoderm and 
endoderm specification, through its association with Foxh1 during the blastula 
stages; in pluripotency maintenance during gastrulation, by interaction with Pou 
proteins; in dorsal axis formation and activation of some of the earliest zygotic 
genes, such as sox2, nodals and mixer by interaction with Sox proteins; in 
neuroectoderm formation by interaction with Zic proteins; in germ layer induction 
and patterning in early Xenopus development, by interactions with β-catenin and 
Tcf/Lef proteins; and in hematopoietic cells differentiation and non-neural ectoderm 
patterning by interactions with Lmo and Gata proteins. Finally, p300 interacts with 
Grhl motifs during neurulation, however these protein have been reported as 
p300-inhibitors, by inhibiting its HAT activity and p300’s ability to interact with other 
proteins (Pifer et al., 2016). The differential motif analysis suggests that p300 is 
enriched in regions with the Grhl motif, at a time when these protein are involved in 
epidermis differentiation, however p300’s function may actually be inhibited in 
these regions. In light of this, it would be interesting to investigate if p300 is bound 
to these candidate enhancers at the same time and in the same tissues as the Grhl 
proteins. 
Importantly, p300 appears to mark enhancers involved in all of these 
developmental processes.  
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5.3 Predicting transcription factor candidate target genes 
I then sought to determine if the motif enriched candidate enhancers 
identified in this chapter can be combined with the enhancer-gene pairing method 
described in the previous chapter, to predict which transcription factors regulate 
which genes. 
As an example, I focused on p300 regions containing the Foxh motif as, 
unlike many of the other motif families studied, Foxh1 appears to be the sole 
transcription factor responsible for the positive association of p300 and Foxh motifs 
at early time points. The Foxh motif is also one of the most highly associated with 
p300 and Foxh1 has been extensively studied, allowing the comparison of the 
results with previously published data.  
The most representative regions of the p300-Foxh motif association were 
selected, by filtering the motif score from Gimmemotifs (hereafter called 
p300-Foxh1 candidate enhancers). Charney and colleagues performed Foxh1 
ChIP-seq on early X. tropicalis embryos (Charney et al., 2017). 99% of the 1324 
p300-Foxh1 candidate enhancer regions were detected by their study, showing that 
this method had a high specificity. Their study detected 40,884 Foxh1 regions, only 
a small fraction of that (3%) was detected with this method (low sensitivity). 
p300-Foxh candidate enhancers are 2.25 times more likely to have a Foxh1 
ChIP-seq peak than non-p300-Foxh candidate enhancers (p-value = 0.0, Fisher 
Exact test). 
The p300-Foxh1 candidate enhancers were analysed with the 
enhancer-gene prediction method described in the previous chapter, to determine 
which genes have the highest correlation (lowest SED) with those regions. The 
correlation between the p300-Foxh1 candidate enhancers and any gene within the 
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surrounding 1 Mb was calculated, given that there are examples of enhancers 
acting at those distances (Lettice et al., 2003). This distance can be adjusted to the 
characteristics of different experiments. 
 
5.3.1 Candidate Foxh1 target genes 
The top Foxh1 candidate target gene is cdk9 (SED = 2.68), which, to my 
knowledge, has not been reported as a Foxh1 target. Both foxh1 and cdk9 are 
present in the ectoderm and endoderm in early gastrulation (Howell et al., 2002, 
Zhu et al., 2009), making this transcription factor-target gene pair plausible. The 
highly associated p300-Foxh1 candidate enhancer is located nearly 10 kb away 
from the cdk9 promoter, in an intron of a nearby gene (Figure 46). 
 
 
Figure 46 – Cdk9 genomic locus. 
Genome browser view of the cdk9 and sh2d3c gene, with the two p300 regions 
predicted to be regulating cdk9 through p300-Foxh1 interaction. Cdk9 promoter 
region marked with a green box and p300-Foxh1 candidate enhancer with a blue 
box. 
 
Figure 47A shows the cdk9 expression profile (red) and the p300 binding 
dynamics at the gene promoter (green) and at the p300-Foxh1 candidate enhancer 
(blue). Figure 47B also shows the cdk9 expression profile (red), as well as the 
foxh1 gene expression profile (purple). All curves are normalised to their maxima. 
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Figure 47 – Foxh1 and candidate target gene cdk9. 
A – Cdk9 normalised expression profile (red) and normalised p300 binding 
dynamics in a p300-Foxh1 candidate enhancer (blue) and in the cdk9 promoter 
(green). B - Cdk9 (red) and foxh1 (purple) normalised expression profiles. 
 
Both the promoter and the p300-Foxh1 candidate enhancer were detected 
in a Foxh1 ChIP-seq experiment in early X. tropicalis embryos (Charney et al., 
2017). 
Chiu and colleagues performed a foxh1 morpholino knockdown on early 
gastrula embryos (Chiu et al., 2014) (slightly later than the p300-Foxh1 association 
described in this chapter). Cdk9 expression was not reduced by foxh1 knockdown. 
From the top 10 candidate target genes, only two had reduced expression, gdf3 
(SED = 3.19) and sds (SED = 3.75) (for scale of SED data, see Figure 48).  
 
To test the method with a known Foxh1 target, I analysed the results for 
mix1. Mix1 is a known Foxh1 target (Chen et al., 1996, Chen et al., 1997) and its 
expression was reduced in the previously mentioned morpholino knockdown study 
(Chiu et al., 2014). 
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Both the mix1 promoter and a candidate enhancer nearby contain the Foxh1 
motif (and are present in the published Foxh1 ChIP-seq data). The SED for this 
candidate enhancer-mix1 pair was low (5.95), being the 47th Foxh1 candidate 
target gene. Figure 48 shows the distribution of SED values for all p300-Foxh1 
candidate enhancers, with the value for the mix1 pair highlighted in red, showing it 
was one of the most correlated p300-Foxh1 candidate enhancer-gene pair. 
 
Figure 48 – Histogram of SEDs for Foxh1 candidate gene targets. 
Highlighted in red is the SED value for the correlation between mix1 expression 
and p300 binding dynamics at the gene’s promoter and at a nearby p300-Foxh1 
candidate enhancer. CE – Candidate enhancer. 
 
 
Candidate target genes with low SED values (lowest 30% SED values) are 
1.5 times more likely to have decreased expression (>50% fold change) in the 
FoxH1 morpholino knockdown study than genes with high SED values, however, 
this was not statistically significant (p-value = 0.12, Fisher Exact test). 
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5.4 Discussion 
p300 seems to be involved in the patterning of all germ layers and their 
development, by interacting with several essential transcription factors. Most of the 
identified transcription factor families were known to interact with p300, however, to 
my knowledge, there has not been any reports of p300-Zic interactions. It would be 
interesting to experimentally validate this and potentially expand the set of known 
p300 interaction partners. The differential motif binding analysis also provided an 
approach to predict enhancers involved in the different developmental processes. 
I then investigated the prediction of candidate gene targets for transcription 
factors, based on the p300 association with their motifs at different time points, 
using Foxh1 as proof of concept. 
Selecting p300-Foxh1 candidate enhancer regions yielded a set of 
sequences which matched extremely well with previously published Foxh1 
ChIP-seq data (99.5% of p300-Foxh1 regions were also detected in that study). 
However, only 3% of the previously published Foxh1 regions were detected using 
this method. A reason for this low number may be that not all Foxh1 binding in the 
genome are associated with p300. However, it is likely mainly due to the peak 
caller parameters, which in this study were set quite stringently, and have an 
extremely high impact on how many regions are called. In the present study, only 
17,414 p300 regions were detected, therefore the number of p300-Foxh regions 
would always be a small fraction of the total Foxh1 regions detected by Charney 
and colleagues (40,884). 
I then calculated the SED between each of the p300-Foxh1 candidate 
enhancers and any gene within 1 Mb, in order to predict candidate target genes. 
The top hit, cdk9, was not affected by foxh1 knockdown in previously published 
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data (Chiu et al., 2014), as well as seven of the top 10 hits. This study only had one 
replicate and imposed a fold change threshold of 1.5. Some of these candidate 
target genes may in fact be Foxh1 targets but having fold changes smaller than the 
applied threshold. In another ongoing study, Nick Owens reanalysed the Chiu et al., 
2014 data and cdk9 is indeed down regulated, with a sub-threshold fold change of 
1.25. A confounding factor is also that some transcription factors are redundant and 
their function can be in part replaced, therefore knockdown experiments have high 
percentages of false negatives (Dai et al., 2009, Gitter et al., 2009, Wu and Lai, 
2015). 
 
This analysis has allowed the investigation of many possible 
enhancer-transcription factor-gene trios with a single dataset. Whilst a specific 
transcription factor ChIP-seq combined with gene knockdown would be more 
accurate for a given transcription factor, this provides a much broader picture 
without the need to perform the experiments for every transcription factor of interest. 
This data can then be used by researchers to focus on a small number of 
candidate regions that can be validated by transcription factor specific ChIP-qPCR. 
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Chapter 6. Discussion 
With the advent of next-generation sequencing and with decreasing costs, 
genome-wide studies are now commonplace to elucidate many cellular processes, 
including, but not limited to, determining where specific proteins bind, where 
histone modifications are present, and what is the transcriptional state of cells. Few 
studies, however, have time-resolved data with more than two or three time points. 
These can be useful to study relatively static processes, however, as it was shown 
by Collart et al, 2014 and Owens et al, 2016, transcription in the early embryo is 
highly dynamic and analysis at sparse time points will not capture a full accurate 
picture of the process under study. 
Given the significant dynamics of transcription in the early embryo, the 
mechanisms regulating transcription should also display dynamic behaviours. p300 
is widely used to predict active enhancer (Wang et al., 2005, Heintzman et al., 
2007, Heintzman et al., 2009, Visel et al., 2009a, Wang et al., 2009, Blow et al., 
2010, May et al., 2011, Rada-Iglesias et al., 2011, Attanasio et al., 2013) and 
Hontelez et al., 2015 indicated that its binding changes during early X. tropicalis 
development, however that study only determined p300 binding at five time points 
over a period of about 24 hours. If p300 binding is as dynamic as transcription, 
those time intervals would be insufficient to correctly calculate enhancer usage 
dynamics, as determined by p300 binding. Therefore, in this project I set out to 
determine the dynamics of enhancer usage and if/how they correlate with gene 
transcription. 
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6.1  Candidate enhancers and p300 dynamics 
In the work presented in the third chapter of this thesis I aimed to create a 
dataset of candidate enhancers and determine how p300 binding dynamics change 
in these regions. This was achieved by generating and analysing two high 
resolution p300 ChIP-seq time series. 
 
6.1.1 p300 ChIP-seq analysis 
I started by optimising the p300 ChIP-seq protocol, particularly focusing on 
the details which can impact time series studies. This was discussed in Chapter 3, 
therefore I will only focus on the most important step in this optimisation process: 
The normalisation method. This was essential for a quantitative analysis of 
ChIP-seq time series data, not dependent on varying efficiencies in 
immunoprecipitation resulting in different levels of background signal between 
different samples. This normalisation implicitly assumes that total p300 binding 
remains constant in the embryo during the times sampled. Whilst this assumption is 
not ideal, it is the assumption used to normalise expression in most RNA-seq 
studies. Moreover, it should not affect the temporally local dynamics at a given 
enhancer, if the total level of p300 binding varies more slowly than that at a given 
enhancer. Given that all time points assayed are post-MBT, the relative stability of 
p300 mRNA (Figure 5), and that attention has been restricted to high SNR, variable 
(> 2-fold change in occupancy) p300 binding, this is not an unreasonable 
assumption and normalisation. 
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6.1.2 p300 binding dynamics 
A dataset of 12,572 p300 regions was created, with varied binding dynamics 
between 5 and 17.5 hpf, an interval which encompasses the end of the blastula 
stages, gastrulation and most of neurulation, some of the most important stages of 
development. From these, 9,807 are intergenic or intronic, being candidate 
enhancers. This is a useful tool for Xenopus researchers, allowing the fine-tuning of 
gene expression by disrupting enhancer regions and also to potentially study how 
mutations in non-coding regulatory regions can lead to diseases and altered 
phenotypes. 
I showed that p300 binding is extremely dynamic, which was an important 
finding, as the overall hypothesis of this project was that, given that transcription in 
the early embryo if highly dynamic, the underlying regulatory mechanisms should 
also present dynamic behaviours. With such a highly dynamic binding, this data 
also showed the importance of performing experiments at a high temporal 
resolution. By assaying development at lower resolution these fast dynamics would 
be lost. 
p300 binding at candidate enhancers was shown to be more dynamic than 
in promoters (discussed in 3.3.2 – Long time series). This finding reinforced the 
model of several enhancers regulating the same promoter, at different time points 
and different cell types. 
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6.2 p300 and transcription 
In the work presented in the fourth chapter of this thesis I aimed to 
understand how p300 binding and transcription dynamics correlate, by making use 
of the p300 data generated and published RNA-seq data. I specifically set out to 
determine if active genes are more likely to have p300 binding nearby; if the p300 
binding at promoters and nearby enhancers had similar dynamics; if p300 binding 
and gene transcription had similar dynamics; and finally, if an enhancer-gene 
pairing method could be developed. 
 
6.2.1 p300 and active genes 
I showed that active genes are more likely to have p300 binding in their 
promoter and nearby regions than inactive genes, and that p300 occupancy was 
higher in promoters of active than inactive genes, which is coherent with the model 
of p300 being involved in transcription activation. Furthermore, the more highly 
activated a gene is, the more likely it is to have p300 binding and the p300 
occupancy at its promoter is also higher, compared to less activated genes. 
 
6.2.2 p300 binding at promoters and candidate enhancers 
If p300 is indeed involved in enhancer-promoter looping, it would be 
expected that p300 binding dynamics in both regions involved in the same loop 
would be similar, given that the same molecule is in close proximity to both regions. 
As previously mentioned, it is challenging to predict which enhancer regulates 
which genes, therefore I initially restricted this analysis to small genomic distances 
(20 kb) and determined that p300 binding at candidate enhancers and promoters 
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was indeed more correlated than randomly generated pairs. This reinforces the 
model of p300 being involved in enhancer-promoter looping.  
 
6.2.3 p300 binding and gene transcription 
I also showed that p300 binding at proximal promoters correlates with gene 
transcription levels. This reinforces the model that enhancer-promoter looping is 
involved in transcriptional regulation and suggests that the loop is maintained for 
the duration of transcription, otherwise, p300 dynamics would only correlate with 
transcription activation, and not with the entire gene expression profile. 
 
6.2.4 Candidate enhancer-gene pairing 
Having shown that p300 binding dynamics at promoters correlates with both 
p300 dynamics at candidate enhancers and with gene expression, I set out to 
develop an enhancer-gene pairing method. 
Currently, there is no reliable way to determine which enhancer regulates 
which gene in a genome-wide manner. Chromatin conformation capture techniques 
can be useful to determine these enhancer-gene pairs for individual cases, but 
applications of these approaches on a genome-wide scale lack resolution 
(reviewed by de Wit and de Laat, 2012, Denker and de Laat, 2016). Several 
studies (for example, Ernst et al., 2011, Thurman et al., 2012, Corradin et al., 2014, 
Cao et al., 2017) have attempted to pair genes and their corresponding enhancers, 
mainly in human cells, assisted by the vast amounts of data generated for these 
cells. For example, Ernst and colleagues generated epigenome maps for nine 
histone marks in nine cell types (Ernst et al., 2011) and Cao and colleagues made 
use of published data on seven different histone modifications, DNAse I, DNA 
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methylation, eRNAs, ChIA-PET and Hi-C for 935 samples (Cao et al., 2017) to 
predict enhancer-gene pairs in human cells. 
Using such rich datasets are the ideal way to computationally predict 
enhancer-gene pairs, however, with the associated costs, these approaches are 
limited to genomes such as the human or mouse. Therefore, I developed a method 
– Sum of Euclidean Distances (SED) – to predict candidate enhancer-gene pairs 
based on p300 ChIP-seq and RNA-seq time series data. The advantages, 
limitations and possible solutions were discussed in 4.8 – Discussion. 
This method led to the prediction that only 25% of genes are regulated by 
the closest enhancer. As discussed previously, this is an important finding, given 
that most ChIP-seq regions annotation algorithms uses distance as their main or 
sole parameter. If this SED method is validated, it will in the least define error 
boundaries for the closest enhancer heuristic and it will also suggest ways in which 
these conventional approaches may be improved. 
 
6.2.5 Enhancer RNAs 
Taking advantage of the set of candidate enhancers generated in this study 
and the available RNA-seq data from Owens et al, 2016, I showed that potential 
eRNAs correlate well with p300 binding in the same region and with nearby gene 
expression. This was the first time potential eRNAs were reported in Xenopus and 
almost 10% of them may be maternally deposited. There are several confounding 
issues associated with eRNA analysis, discussed in Chapter 4, however it would be 
interesting to pursue further studies on this topic, particularly as it may provide an 
extra parameter to predict enhancer-gene pairs. 
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6.2.6 Genome annotation 
When filtering the p300 regions to analyse potential eRNAs, I realised that 
36% of regions annotated at intergenic had H3K4me3 peaks (as detected in 
Hontelez et al., 2015). This histone modification is extensively used to predict 
promoter regions (Encode et al., 2007, Heintzman et al., 2007). This high 
percentage of H3K4me3 in regions annotated as being intergenic may be due to 
either incorrect gene models/unannotated genes, or due to H3K4me3 not being 
exclusively present in promoter regions. The actual cause is likely a combination of 
the two, with some H3K4me3 representing alternative promoters or promoters of 
unannotated genes, and some representing non-promoter H3K4me3. H3K4me3 
ChIP-seq data should be combined with RNA-seq data to attempt to distinguish 
between the two, leading to a more accurate list of genes and their alternative 
promoters, which is an essential tool for Xenopus researchers in the genomic era. 
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6.3 p300 differential motif analysis 
In the work presented in Chapter 5 I aimed to investigate p300 binding in X. 
tropicalis development and to determine if the data generated in this project could 
be used to predict candidate target genes for a diverse set of transcription factors. 
I identified which DNA binding motifs were associated with p300 occupancy 
at different developmental stages and, for all motifs, at least some members of 
each transcription factor family had an expression profile highly concordant with the 
motif association with p300. These motifs are bound by transcription factors 
involved in very diverse developmental processes, indicating that p300 may also be 
involved in regulating those processes, however, even more important is the 
indication that p300 activity and motif analysis can be coupled to predict 
transcription factor binding and potential target genes. Therefore, I attempted to 
predict the target genes for a given transcription factor, based on the p300 binding 
association with its motif and the enhancer-gene pairing method.  
The method described on Chapter 5 allows the prediction of candidate 
target genes for multiple transcription factors with a single dataset. This allows 
researchers to then validate a small number of candidate enhancers by 
ChIP-qPCR for the transcription factor of interest, followed by reporter assays (e.g 
Tol2-mediated transgenesis) or enhancer mutation/deletion (e.g CRISPR-Cas9) to 
validate enhancer function and target gene. 
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6.4 Future work 
The following are the most interesting paths I believe should be followed as 
a continuation of the work described in this thesis: 
1. In this project I analysed p300 binding in whole embryos, thus, the 
obtained results represent averages of different processes and gene 
expression programs occurring in different tissues. It would be 
interesting to perform p300 ChIP-seq time series in specific tissues. 
This could be achieved, for example, by adapting BiTS-ChIP to 
Xenopus. Batch isolation of tissue-specific chromatin for 
Immunoprecipitation (BiTS-ChIP) was developed by Bonn and 
colleagues in D. melanogaster. In this technique embryos need to 
express a cell type specific marker to allow FACS sorting of the fixed 
nuclei, which are then processed with the standard ChIP-seq 
protocol (Bonn et al., 2012). 
2. Determine if there is a time delay between p300 binding and gene 
activation. This could be achieved by performing the ED analysis with 
the RNA-seq data delayed by X number of hours and determine if a 
given time delay led to a higher correlation. 
3. 3C or 4C to validate some of the predicted enhancer-promoter 
interactions. Low SED enhancer-promoter-gene would be the most 
interesting trios to test initially. 
4. CRISPR-mediated knockout of candidate enhancer regions in 
predicted enhancer-promoter pairs to determine if gene expression is 
reduced. 
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5. I showed that p300 binding at candidate enhancers is more dynamic 
than at promoters, likely due to genes being regulated by multiple 
enhancers. Therefore, it would be interesting to assess if it is 
possible to determine pairs of enhancers which together explain the 
dynamics of p300 binding at a given promoter. 
6. Further work on eRNAs, attempting to solve the confounding issues 
and potentially use eRNA data to improve the enhancer-gene 
predictions. 
7. An interesting extension to the analysis described in Chapter 5 would 
be to investigate the co-occurrence of motifs within a p300 region, to 
potentially uncover co-factors or synergistic partners. 
 
6.5 Conclusion 
In this thesis, I described the generation of a candidate enhancer dataset 
and their usage in early X. tropicalis development, using p300 as a proxy. I then 
showed that p300 binding at candidate enhancers and promoters correlate, as well 
as p300 binding in promoters and gene expression. This reinforced the model of 
p300-mediated looping being involved in gene transcription and indicated that the 
loop structure is likely maintained during transcription. Finally, I developed a 
method to predict enhancer-gene pairs and another to predict candidate target 
genes for a given transcription factor. 
These results and tools can be useful for researchers to further understand 
transcriptional regulation and regulatory networks. 
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Chapter 7. Appendix 
7.1 Appendix 1 – Predicted enhancer-gene pairs 
Gene Chromosome Start End Distance SED 
Xetro.A02181|mknk2 scaffold_1 123650317 123650643 -11266 2.24 
Xetro.J00801|gs17 scaffold_10 30778205 30778746 -2468 2.38 
Xetro.B02193|fzd4 scaffold_2 133845672 133845971 -19888 2.44 
Xetro.G00372| scaffold_7 16066598 16066914 1398 2.54 
Xetro.F00048|eif2c2 scaffold_6 1719646 1719990 70922 2.60 
Xetro.E00206|sox2 scaffold_5 12415547 12415804 -57322 2.67 
Xetro.H01485|pkdcc.1 scaffold_8 74627972 74628265 76492 2.69 
Xetro.H01348|meis3 scaffold_8 65765102 65765419 66936 2.76 
Xetro.I00911| scaffold_9 49357636 49358088 -8686 2.89 
Xetro.A01003|sds scaffold_1 61803635 61803947 -92287 2.89 
Xetro.G01863| scaffold_7 104717612 104717882 -70436 2.90 
Xetro.D02282|pim1 scaffold_4 121583870 121584267 67048 2.97 
Xetro.D00482|sall1 scaffold_4 22515068 22515221 -7842 3.14 
Xetro.I00092|mcm6.2 scaffold_9 3637092 3637359 -58685 3.15 
Xetro.J00216|arhgap39 scaffold_10 6161572 6161769 -4795 3.24 
Xetro.G01450|hes4 scaffold_7 82683994 82684282 15368 3.27 
Xetro.F01821|c3orf54 scaffold_6 137141745 137142166 35534 3.35 
Xetro.A01107|lpcat4 scaffold_1 64930391 64930730 -3302 3.41 
Xetro.E00971|dll1 scaffold_5 73327772 73328282 3950 3.45 
Xetro.B01595|unnamed scaffold_2 93984726 93985145 -59327 3.46 
Xetro.G00640|slc16a12 scaffold_7 32463266 32463558 1287 3.49 
Xetro.I02074|msgn1 scaffold_9 96845192 96845681 -10904 3.50 
Xetro.H01545|znf238.2 scaffold_8 78174109 78174427 -1680 3.52 
Xetro.K04987|vsig8 scaffold_8c 1233561 1234784 -14639 3.56 
Xetro.G01634|hes3.3 scaffold_7 94447157 94448064 -5844 3.62 
Xetro.H02244|plekho1 scaffold_8 105430922 105431167 75856 3.67 
Xetro.A02912| scaffold_1 173063869 173064439 12522 3.76 
Xetro.I00336|pdk1 scaffold_9 18587421 18587778 76966 3.83 
Xetro.F00500|cebpd scaffold_6 36715084 36715261 -65587 3.87 
Xetro.H00596|cdx4 scaffold_8 26394038 26394973 -96248 3.89 
Xetro.H01053|pbx2 scaffold_8 52222789 52222999 41968 3.91 
Xetro.D01106|foxa4 scaffold_4 61589850 61590377 11236 3.96 
Xetro.G01635|hes8 scaffold_7 94441545 94441986 10702 3.98 
Xetro.K00363|mef2d scaffold_27 100503 100684 32486 4.01 
Xetro.E01636|mixer scaffold_5 118173284 118173610 13120 4.02 
Xetro.B01852|tnfrsf19 scaffold_2 108191436 108191641 24984 4.03 
Xetro.A01563| scaffold_1 86445086 86445275 -43248 4.05 
Xetro.F00583|gata6 scaffold_6 41132586 41132959 -2993 4.05 
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Xetro.D01928|hpdl scaffold_4 102778658 102778965 70271 4.07 
Xetro.B01645|efnb2 scaffold_2 96714948 96715267 40670 4.08 
Xetro.G02292|mrto4 scaffold_7 123731987 123732226 -85314 4.20 
Xetro.H02253|nr2f5 scaffold_8 105875536 105875894 17801 4.28 
Xetro.A01542|efs scaffold_1 85947340 85947646 16445 4.32 
Xetro.A00551|znf608 scaffold_1 38115300 38115793 1688 4.33 
Xetro.C00582|myef2 scaffold_3 19938489 19938791 -8420 4.33 
Xetro.D01817| scaffold_4 94644338 94644672 9953 4.34 
Xetro.G01845|tead4 scaffold_7 104002689 104003619 36260 4.36 
Xetro.J00553|dlx3 scaffold_10 21491713 21491894 22952 4.37 
Xetro.A01061|aplnr scaffold_1 64036047 64036477 3885 4.38 
Xetro.I01918| scaffold_9 89274927 89275203 5838 4.39 
Xetro.F01630|fzd8 scaffold_6 124211435 124212040 2554 4.39 
Xetro.A01622|gas1 scaffold_1 90565037 90565940 -5466 4.42 
Xetro.G00717|admp2 scaffold_7 36586207 36586723 7626 4.43 
Xetro.B01266|rnd1 scaffold_2 77680506 77680725 -34916 4.44 
Xetro.C01640|btg1 scaffold_3 84535572 84535800 4506 4.45 
Xetro.C01899| scaffold_3 102962854 102963084 54094 4.47 
Xetro.I01389|unnamed scaffold_9 77936317 77936543 47902 4.48 
Xetro.K01603| scaffold_129 196861 197219 -14664 4.48 
Xetro.C00433|zmiz2 scaffold_3 11318934 11319570 30336 4.51 
Xetro.D01357|ptgs2 scaffold_4 75023843 75024324 -5130 4.52 
Xetro.A00935|mn1 scaffold_1 57936682 57937079 6947 4.53 
Xetro.E01089|hnrnpu scaffold_5 79663277 79663600 -1048 4.53 
Xetro.I01107|emp2 scaffold_9 62689798 62690207 -17126 4.55 
Xetro.B01215| scaffold_2 75288602 75289054 -44832 4.56 
Xetro.H01434|bmp4 scaffold_8 72120991 72121226 -1412 4.58 
Xetro.H00338|nr6a1 scaffold_8 15960873 15961329 -5053 4.59 
Xetro.G00035|rbm20 scaffold_7 1850461 1850948 54879 4.67 
Xetro.F01742|ngfr scaffold_6 133748766 133749077 6673 4.72 
Xetro.I02095|prss29 scaffold_9 97565341 97565658 -32338 4.73 
Xetro.F00346|unnamed scaffold_6 25828162 25828377 -94588 4.76 
Xetro.I00321|sp5 scaffold_9 17802012 17802348 6004 4.77 
Xetro.E01369|flrt3 scaffold_5 98375616 98376185 70605 4.77 
Xetro.K05077|anxa9 scaffold_8c 4142379 4142676 -8845 4.79 
Xetro.C01387|msx2 scaffold_3 70954158 70954516 71620 4.80 
Xetro.A00953|unnamed scaffold_1 59228944 59229330 20541 4.81 
Xetro.I02106|prss27 scaffold_9 97705804 97706130 33321 4.81 
Xetro.G01448|plekhn1 scaffold_7 82475104 82475331 -8270 4.85 
Xetro.A01113| scaffold_1 64930391 64930730 55042 4.87 
Xetro.D00417| scaffold_4 20092946 20093488 2317 4.88 
Xetro.J00830|rara scaffold_10 31996315 31996521 71264 4.89 
Xetro.K05138|gata4 scaffold_5b 1541015 1541460 -7060 4.91 
Xetro.D00195| scaffold_4 9574649 9575070 -2331 4.93 
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Xetro.E01541|atf3 scaffold_5 112283306 112283625 -99947 4.94 
Xetro.A02050|klb scaffold_1 119305852 119306066 98234 4.94 
Xetro.G00875| scaffold_7 46702957 46703221 11567 4.97 
Xetro.A00363|isl1 scaffold_1 22750517 22750847 -1797 4.98 
Xetro.C00277| scaffold_3 7849224 7849516 -17540 4.98 
Xetro.G01800|slc6a16 scaffold_7 102348618 102348950 83486 5.01 
Xetro.H00049| scaffold_8 2090074 2090296 -6681 5.03 
Xetro.A00602|xbp1 scaffold_1 42689082 42689305 86038 5.06 
Xetro.E00316|slc33a1 scaffold_5 20923348 20923573 -45134 5.10 
Xetro.H00248|znf750 scaffold_8 9906228 9906402 14815 5.12 
Xetro.K00691| scaffold_40 428625 428813 -4609 5.14 
Xetro.F00226|fzd6 scaffold_6 18333997 18334273 2108 5.15 
Xetro.A03177|msx1 scaffold_1 193646007 193646727 -5191 5.18 
Xetro.D01662| scaffold_4 85654012 85654311 23476 5.21 
Xetro.F00234|grhl2 scaffold_6 18937961 18938192 1904 5.23 
Xetro.D00899|cdh1 scaffold_4 52535949 52536239 13043 5.23 
Xetro.G00599|pcdh8l scaffold_7 30280138 30280795 -13206 5.25 
Xetro.D00013| scaffold_4 637801 638158 47903 5.26 
Xetro.A02603|tet2 scaffold_1 148894084 148894252 20634 5.26 
Xetro.J00920|cass4 scaffold_10 35377485 35377687 94683 5.27 
Xetro.F00849|foxc1 scaffold_6 63060924 63061147 -3010 5.33 
Xetro.C00618|gatm scaffold_3 21308488 21308700 -3152 5.39 
Xetro.A02254|cnn1 scaffold_1 126491892 126492134 -92205 5.39 
Xetro.K01222|xnf7 scaffold_83 382217 382460 -13346 5.39 
Xetro.C01366|afap1l1 scaffold_3 69115012 69115231 -75259 5.40 
Xetro.A01974|rod1 scaffold_1 116646417 116646710 41766 5.41 
Xetro.A01009|tbx3 scaffold_1 62144303 62144581 -1270 5.45 
Xetro.F01133|bmper scaffold_6 87720271 87720744 2470 5.45 
Xetro.D00701|kctd15 scaffold_4 38245268 38245657 36140 5.47 
Xetro.B01533|rarg scaffold_2 91515818 91516206 -5506 5.47 
Xetro.B00282|tceb3 scaffold_2 14054792 14055389 -31128 5.48 
Xetro.B00508|asb9 scaffold_2 26346879 26347298 -3929 5.50 
Xetro.B02279| scaffold_2 139170699 139170887 -38343 5.53 
Xetro.A01550|slc7a8 scaffold_1 86138288 86138554 -17177 5.53 
Xetro.D00441| scaffold_4 20886930 20887459 3206 5.55 
Xetro.C00514|tet3 scaffold_3 14213073 14213542 -8561 5.56 
Xetro.E00193|hes1 scaffold_5 11302709 11302907 1431 5.56 
Xetro.D01445|rbfox2 scaffold_4 79974701 79975104 8032 5.58 
Xetro.G01018|anxa2 scaffold_7 53249145 53249319 80976 5.63 
Xetro.I01474| scaffold_9 80330421 80330704 -2667 5.66 
Xetro.A03291|foxi4.2 scaffold_1 201659904 201660438 -10866 5.66 
Xetro.K01424|lpar2 scaffold_109 44823 45127 -31315 5.69 
Xetro.B00724|srsf1 scaffold_2 40724349 40724501 77330 5.69 
Xetro.D02243|gata2 scaffold_4 120113071 120113225 42082 5.70 
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Xetro.H01785|meis2 scaffold_8 90219071 90219299 -98555 5.70 
Xetro.D01086|tmed10 scaffold_4 60985721 60986011 -79031 5.70 
Xetro.J00091|srsf2 scaffold_10 3664309 3664592 -94667 5.72 
Xetro.E00553|ripply2.1 scaffold_5 40771280 40771569 -20420 5.75 
Xetro.J00381|snai1 scaffold_10 12981662 12981883 -1065 5.76 
Xetro.A00618| scaffold_1 43088040 43088184 15158 5.77 
Xetro.G01539| scaffold_7 88943004 88943216 -82740 5.80 
Xetro.I00468|fzd7 scaffold_9 27336503 27336905 -3082 5.82 
Xetro.B00654|spns2 scaffold_2 36468647 36469013 -4125 5.84 
Xetro.E00181|chrd scaffold_5 10692051 10692208 2218 5.85 
Xetro.C00636|mex3b scaffold_3 22486553 22486912 25166 5.88 
Xetro.A02274|loc388630 scaffold_1 127237573 127237925 15765 5.91 
Xetro.H00544|p2ry4 scaffold_8 24340264 24340496 -10470 5.93 
Xetro.C01869|szl scaffold_3 100190388 100190772 -5664 5.94 
Xetro.B02316|rps3 scaffold_2 140829491 140829751 19273 5.95 
Xetro.B01113|a2ld1 scaffold_2 64808938 64809143 76392 5.98 
Xetro.B01496|hnrnpa1 scaffold_2 89788156 89788319 -3724 5.98 
Xetro.E01129|akap12 scaffold_5 82206815 82206995 5649 6.01 
Xetro.F01555|spag6 scaffold_6 118702130 118702325 -35846 6.01 
Xetro.H01766|srsf5 scaffold_8 89005510 89005751 -2546 6.03 
Xetro.A02777|pcdh18 scaffold_1 162559481 162559769 6277 6.03 
Xetro.D00077|scube2 scaffold_4 3349289 3349814 -10469 6.07 
Xetro.F00764|rbm24 scaffold_6 57096034 57096331 61008 6.13 
Xetro.A01783|utp15 scaffold_1 101933202 101933429 49924 6.16 
Xetro.F01813|sema3f scaffold_6 136745058 136745490 2790 6.17 
Xetro.J00103|cygb scaffold_10 3766521 3766867 -8642 6.20 
Xetro.G00462|ventx3.2 scaffold_7 21504204 21504370 -54461 6.24 
Xetro.B00695|ksr1 scaffold_2 38542330 38542479 -70638 6.25 
Xetro.C00179|tacc1 scaffold_3 5761661 5761998 -6932 6.26 
Xetro.A00753|fzd10 scaffold_1 49748767 49748922 18821 6.27 
Xetro.H00800| scaffold_8 43654950 43655148 15035 6.29 
Xetro.K00983|ahnak scaffold_65 338506 338799 -49347 6.29 
Xetro.D01314|atf4 scaffold_4 73577515 73577750 -1072 6.29 
Xetro.K05002|tagln2 scaffold_8c 1464034 1464216 39825 6.29 
Xetro.D01032|prpf39.2 scaffold_4 58857552 58857832 81153 6.31 
Xetro.K00373|fkbp9 scaffold_27 340557 340961 18827 6.34 
Xetro.I00651|hes6.1 scaffold_9 35394488 35394987 6850 6.37 
Xetro.A02550|rasgef1b scaffold_1 144836022 144836203 -61922 6.38 
Xetro.H01321|axl scaffold_8 64902347 64902629 -29799 6.43 
Xetro.F00287| scaffold_6 21901715 21902064 63888 6.43 
Xetro.A03043|kit scaffold_1 183676655 183677109 -2465 6.43 
Xetro.J00905|bmp7.1 scaffold_10 34842324 34842935 -70130 6.46 
Xetro.C00970|cdx1 scaffold_3 44797719 44798183 -9311 6.46 
Xetro.I00194|zeb2 scaffold_9 7328087 7328488 67048 6.47 
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Xetro.K00372|rab25 scaffold_27 332361 332701 8228 6.47 
Xetro.G01640|hes3.1 scaffold_7 94488011 94488497 29486 6.48 
Xetro.H00955|degs3 scaffold_8 50045360 50045588 -84024 6.48 
Xetro.J00368|eya2 scaffold_10 11858258 11858640 -42497 6.54 
Xetro.I00863|arl4c scaffold_9 46888958 46889320 -9895 6.57 
Xetro.G00498|nt5c2 scaffold_7 23389749 23389913 -74311 6.58 
Xetro.A02917| scaffold_1 173393370 173393721 1920 6.59 
Xetro.E00432|fam83b scaffold_5 32172480 32172888 -4968 6.64 
Xetro.B01377|pcdh8.2 scaffold_2 83178240 83178723 -33523 6.65 
Xetro.K02114|cdh26 scaffold_217 44405 44676 -1522 6.66 
Xetro.H01276|serpina1 scaffold_8 62420822 62421193 -92840 6.70 
Xetro.F01674|ptprn2 scaffold_6 128512550 128512814 26022 6.70 
Xetro.C02032|gata3 scaffold_3 111971032 111971243 90060 6.74 
Xetro.I02069|nt5c1a scaffold_9 96604687 96604939 -21487 6.74 
Xetro.A01750|ccdc125 scaffold_1 100912509 100912816 71702 6.75 
Xetro.A01688|foxd4l1.1 scaffold_1 95945615 95945810 20956 6.76 
Xetro.A01618|fbp1 scaffold_1 90318546 90318896 -58879 6.77 
Xetro.F00798|tfap2a scaffold_6 59748726 59748889 16662 6.79 
Xetro.E00631|prdm1 scaffold_5 48169600 48170036 -1858 6.79 
Xetro.H00776|pou4f1.2 scaffold_8 42275685 42276076 40234 6.81 
Xetro.I00090|cxcr4 scaffold_9 3506700 3506936 -38208 6.87 
Xetro.A02297|slc25a42 scaffold_1 128242860 128243146 69043 6.87 
Xetro.C00695|mespb scaffold_3 25211058 25211457 -26774 6.90 
Xetro.D00916|nudt22 scaffold_4 53508614 53509057 -3316 6.92 
Xetro.K02331|ddr2 scaffold_266 79908 80646 -1873 6.92 
Xetro.E01382|sptlc3 scaffold_5 99150963 99151266 83238 6.95 
Xetro.K00375|ca14 scaffold_27 439106 439612 -8842 7.00 
Xetro.I00424|idh1 scaffold_9 24441640 24441906 73695 7.01 
Xetro.A02690|lef1 scaffold_1 155883080 155883362 -13429 7.04 
Xetro.B00284|eef1a1o scaffold_2 13978101 13978311 76884 7.08 
Xetro.E01547|vash2 scaffold_5 112283306 112283625 60021 7.10 
Xetro.C01646|angpt4 scaffold_3 84955772 84955929 13461 7.12 
Xetro.K00255|s1pr5 scaffold_24 267889 268320 -89132 7.14 
Xetro.B00797|gpr143 scaffold_2 45166838 45167226 -12160 7.17 
Xetro.B01816|cdx2 scaffold_2 106282766 106283241 9286 7.17 
Xetro.A00284|ankdd1b scaffold_1 17472707 17472984 3062 7.19 
Xetro.I01555|gng13 scaffold_9 83360861 83361207 36301 7.20 
Xetro.B02008|mmp3 scaffold_2 120686664 120686900 -29984 7.22 
Xetro.G01589|unnamed scaffold_7 91197760 91198088 76583 7.22 
Xetro.B00091|grhl3 scaffold_2 4077552 4077776 -80840 7.24 
Xetro.E00740|sgk1 scaffold_5 55823951 55824302 2368 7.32 
Xetro.H01277|gsc scaffold_8 62328059 62328276 92840 7.34 
Xetro.A00398|c9 scaffold_1 25871695 25872228 3069 7.34 
Xetro.A01289|unnamed scaffold_1 73734177 73734614 -44632 7.38 
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Xetro.B00414|upk3b scaffold_2 21245416 21245648 4046 7.39 
Xetro.H01281|clmn scaffold_8 62725770 62726111 -69797 7.39 
Xetro.D00831|chst6 scaffold_4 47969568 47969728 95652 7.40 
Xetro.G00241|ank3 scaffold_7 9449257 9450246 -14476 7.41 
Xetro.D01570| scaffold_4 82495772 82496206 18811 7.42 
Xetro.K02417|atp1b2 scaffold_297 2357 2688 28606 7.43 
Xetro.G01742|eps8l1 scaffold_7 99632946 99633184 -6793 7.44 
Xetro.H00296|unnamed scaffold_8 13300745 13300903 -81121 7.46 
Xetro.E01409|capn8 scaffold_5 101822720 101823049 -24432 7.47 
Xetro.D02572|fgd1 scaffold_4 139918482 139918847 84460 7.48 
Xetro.I00143|tuba3e scaffold_9 5275055 5275677 -15690 7.49 
Xetro.E00860|ezr scaffold_5 65035333 65035563 11062 7.50 
Xetro.H02267| scaffold_8 106743108 106743614 -28486 7.50 
Xetro.B01525|sp7 scaffold_2 91229553 91229811 5149 7.50 
Xetro.J00120|evpl scaffold_10 4064214 4064649 91942 7.50 
Xetro.D02526|hesx1 scaffold_4 137537006 137537356 -12651 7.50 
Xetro.C01851|atp6ap1 scaffold_3 98711128 98711441 7882 7.53 
Xetro.B01543|krt8 scaffold_2 91915507 91915812 58611 7.64 
Xetro.A02998|fat1 scaffold_1 180347698 180348340 6271 7.66 
Xetro.E00345|mycn scaffold_5 23536773 23536954 -54033 7.66 
Xetro.H00927|rtn2 scaffold_8 49191902 49192194 25935 7.75 
Xetro.F00785|dsp scaffold_6 58573329 58573515 -7374 7.76 
Xetro.A02845|rps3a scaffold_1 168147782 168148004 8778 7.79 
Xetro.D01614|adap1 scaffold_4 84164599 84164877 -1836 7.81 
Xetro.A00866|c22orf36 scaffold_1 55403032 55403245 -68890 7.84 
Xetro.G02071|trpm5 scaffold_7 115241191 115241517 -1086 7.84 
Xetro.D01090|efemp2 scaffold_4 60906709 60906961 79031 7.90 
Xetro.I02104| scaffold_9 97595993 97596291 97470 7.93 
Xetro.E01338|meis1 scaffold_5 95545302 95545551 11152 7.98 
Xetro.F00600|lpin2 scaffold_6 42936516 42936815 -32661 7.98 
Xetro.E00241|slc2a2 scaffold_5 15989746 15990126 -1859 8.03 
Xetro.F01109|gli3 scaffold_6 85801901 85802133 50856 8.04 
Xetro.B00360|rab34 scaffold_2 17784970 17785321 36154 8.06 
Xetro.I01508| scaffold_9 81281457 81281732 2352 8.07 
Xetro.D01275|cfh scaffold_4 71316373 71316644 98231 8.09 
Xetro.E00020|plod2 scaffold_5 1774690 1775021 -5848 8.14 
Xetro.K00087|p2ry11 scaffold_18 613045 613441 -3573 8.18 
Xetro.A02031|cpamd8 scaffold_1 118984582 118985031 -32491 8.19 
Xetro.E00325|p2ry1 scaffold_5 21617442 21617812 82946 8.19 
Xetro.E01282|foxa2 scaffold_5 91327181 91327633 4651 8.20 
Xetro.B01312|slc39a5 scaffold_2 80811164 80811418 -98307 8.21 
Xetro.B01556|krt5.7 scaffold_2 92300516 92300811 1695 8.24 
Xetro.F00712| scaffold_6 52193749 52194072 -7750 8.25 
Xetro.A01296|slc25a22 scaffold_1 73734177 73734614 98340 8.29 
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Xetro.D00746|aprt scaffold_4 43308227 43308434 43893 8.31 
Xetro.H00155|hmcn2 scaffold_8 6510319 6510517 6884 8.36 
Xetro.H01609|six1 scaffold_8 81400727 81401135 -5661 8.37 
Xetro.G02246|gramd1a scaffold_7 121659521 121659735 -41198 8.39 
Xetro.B00214|khdrbs1 scaffold_2 10623485 10623922 71143 8.39 
Xetro.A02002|hopx scaffold_1 117775731 117776029 78969 8.44 
Xetro.I01651|unnamed scaffold_9 85490140 85490608 18338 8.45 
Xetro.G02296|unnamed scaffold_7 123752790 123753095 -9986 8.50 
Xetro.B01904|pros1 scaffold_2 111316791 111317314 20812 8.52 
Xetro.B00098|sh3d21 scaffold_2 4299438 4299868 -77691 8.61 
Xetro.E00737|myb scaffold_5 55335772 55336021 -16246 8.66 
Xetro.I00787|ikzf2 scaffold_9 42791291 42791593 14709 8.68 
Xetro.D02416|unnamed scaffold_4 128375576 128375739 -80745 8.82 
Xetro.H00900|zic3 scaffold_8 48067925 48068342 -11143 8.82 
Xetro.A02236|lppr3 scaffold_1 125648871 125649026 40607 8.89 
Xetro.H01740|itpka scaffold_8 87387889 87388123 18082 8.93 
Xetro.E00176|ece2 scaffold_5 10497510 10497989 -59592 9.02 
Xetro.H00242|ribc1 scaffold_8 9711232 9711776 43188 9.03 
Xetro.D01422|pmm2 scaffold_4 78699509 78699787 12892 9.10 
Xetro.B01322|rps26 scaffold_2 80947060 80947224 97448 9.11 
Xetro.D00430|lsp1 scaffold_4 20383715 20384059 1477 9.17 
Xetro.A00337|rai14 scaffold_1 20365624 20365863 74316 9.18 
Xetro.E01625|lefty scaffold_5 117959395 117959550 -26368 9.36 
Xetro.E00199|atp13a-
like scaffold_5 11677579 11677862 4814 9.49 
Xetro.D01785|rpe65 scaffold_4 93175487 93175649 26078 9.57 
Xetro.A01017|rasal1 scaffold_1 62721533 62721722 24256 9.58 
Xetro.A02470|cldn23 scaffold_1 137869626 137869940 -37280 9.77 
Xetro.C00684|znf710 scaffold_3 24730708 24730967 13620 9.79 
Xetro.I01499|unnamed scaffold_9 80953646 80954051 22726 9.81 
Xetro.A00397|dab2 scaffold_1 25874928 25875134 -75483 9.85 
Xetro.D01232|unnamed scaffold_4 69348405 69348717 45247 9.99 
Xetro.G01769|loc388564 scaffold_7 101173028 101173329 3343 10.06 
Xetro.E01215|srsf7 scaffold_5 87845803 87846222 12071 10.27 
Xetro.A00390|c7 scaffold_1 25205653 25205853 -25966 10.35 
Xetro.A01497|hnrnpk scaffold_1 84974256 84974539 -16655 10.46 
Xetro.D00122|prr5l scaffold_4 6802289 6802513 99439 10.56 
Xetro.E00310|tiparp scaffold_5 20651293 20651571 -67214 10.62 
Xetro.J00233|rbl1 scaffold_10 6564844 6565099 69922 10.66 
Xetro.E00414|cep19 scaffold_5 30241556 30242103 3395 10.77 
Xetro.K00483|slc7a7 scaffold_35 122859 123045 48838 10.88 
Xetro.D00429|tnni2 scaffold_4 20248373 20248579 85176 10.89 
Xetro.D02419| scaffold_4 128375576 128375739 20654 10.94 
Xetro.D01308|slc25a24 scaffold_4 73108497 73108976 -17232 11.05 
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Xetro.C01685|wif1 scaffold_3 86350301 86350534 12904 11.15 
Xetro.A01936| scaffold_1 114711081 114711433 8815 11.17 
Xetro.D02390| scaffold_4 126954594 126954924 5854 11.34 
Xetro.H00096|unnamed scaffold_8 4199863 4200170 -42346 11.41 
Xetro.G00564|marveld1 scaffold_7 27671556 27671770 8772 11.89 
Xetro.H01725|foxa1 scaffold_8 86405259 86405422 -46550 11.95 
Xetro.B00348|acy3 scaffold_2 17131362 17131682 56262 13.16 
Xetro.H00632|rab39b scaffold_8 28132496 28132795 55602 13.61 
Xetro.G00383|dpysl4 scaffold_7 17115717 17116258 -1350 14.37 
Xetro.A03175|d4s234e scaffold_1 193228303 193228704 87740 19.49 
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